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Abstract 
A clear cornea comprising the front surface of the eye is essential for normal 
vision. In part, a single layer of corneal endothelial cells located on the inner 
surface of the cornea helps regulate corneal transparency. In corneal 
endothelial dysfunctions such as Fuchs’ endothelial corneal dystrophy 
(FECD), however, deteriorating endothelial cells lead to corneal cloudiness 
and a progressive loss of vision. FECD is currently treated via corneal 
replacement surgeries, which generally are successful but are associated 
with some potentially problematic issues, including donor shortage and graft 
rejections. Thus, there is a pressing need for new, less-invasive medical 
treatments for corneal endothelial dysfunction and the resultant loss of 
vision. Recently, there has been a growing interest in selective inhibitors of 
a Rho-associated kinase (ROCK) as agents that can help dysfunctional 
endothelial cells recover. 
The research described in this thesis has as its main focus an investigation 
of new treatment options for corneal endothelial diseases such as FECD. As 
a baseline, corneal endothelial development is studied because some 
biological processes in corneal healing have been reported to recapitulate 
those in corneal embryogenesis. Following this, an assessment is made of 
the human corneal endothelium and the morphologic changes that occur in 
FECD. 
Next, to judge potential new therapeutic approaches to treat vision loss 
caused by corneal endothelial dysfunction, experiments to assess the 
potential of transcoreal freezing were conducted. These identified the optimal 
use of a newly designed cryoprobe and its application for transcorneal 
freezing to reproducibly damage corneal endothelial cells that line the inner 
aspect of the cornea. Ingress into the cornea of dyes and medicinal agents 
was also tested. The concept of this approach is to eliminate the diseased 
corneal endothelial cells, prior to the medicinal encouragement of more 
peripheral corneal endothelial cells to regenerate the ablated area.  
Current research in many laboratories indicates that inhibitors of the Rho 
kinase pathway within cells lead to them becoming more fibroblast-like in 
their phenotype, accelerating the migration and inhibit cell death encouraging 
the endothelial wound healing. This study suggests that a less invasive 
transcorneal freezing using a 3.4 mm-diameter cryoprobe can be used for 
reproducible and targeted endothelial cell destruction to be followed by 
selective ROCK inhibitor application to treat corneal endothelial pathologies 
such as FECD and potentially other corneal endothelial dysfunctions. 
.
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1.1 Introduction 
A clear cornea comprising the front surface of the eye is essential for normal 
vision. In part, a single layer of corneal endothelial cells located on the inner 
surface of the cornea helps regulate corneal transparency. In corneal 
endothelial dysfunctions such as Fuchs’ endothelial corneal dystrophy 
(FECD), however, deteriorating corneal endothelial cells lead to corneal 
cloudiness and a progressive loss of vision. Corneal diseases are one of the 
primary causes of blindness in the world after cataract and glaucoma, 
according to the World Health Organisation (WHO, 2018) Corneal 
endothelial dysfunction, such as FECD in particular, affects approximately 
5% of the United States population that is over the age of 40 years (Lorenzetti 
et al., 1967; Baratz et al., 2010). This prevalence is higher in countries such 
as Singapore (7%), Iceland (10%), and some small American Islands (22%) 
(Kitagawa et al., 2002; Zoega et al., 2006; Eghrari et al., 2012). FECD is 
more common in females within a population of over 40 years of age 
(Friedenwxald and Friedenwvald, 1925; Goar, 1934; Krachmer et al., 1978; 
Okumura, Hayashi and Koizumi, 2018), although the condition may occur in 
men and younger age (early-onset) groups (Magovern et al., 1979; Biswas 
et al., 2001). It is also known to be intensified by mechanical injuries (Hayashi 
et al., 1996).  
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Currently, corneal replacement via graft surgery is the predominant 
treatment option for the endothelial diseases such as FECD. Corneal 
blindness caused by FECD is the foremost indication for more than 46,000 
corneal transplant operations performed in the USA each year, a pattern that 
is mirrored in most developed countries worldwide (Lang and Naumann, 
1987; Ramsay, Lee and Mohammed, 1997; Baratz et al., 2010; Musch et al., 
2011; Keenan et al., 2012; Wieben et al., 2012; Tan et al., 2014; Park et al., 
2015; Robert et al., 2015; Le et al., 2017). These transplants, though 
effective, can lead to numerous complications (Patel, Hodge and Bourne, 
2005). Another issue with corneal transplantations is the shortage of donor 
corneas (Hara and Cooper, 2011). Thus there is a need for a new medical 
treatment strategy for FECD and other corneal endothelial dysfunctions. 
The aims of this thesis are two-fold. First, to further investigate the normal 
morphology and morphologic changes of the corneal endothelium during 
embryonic development and following endothelial pathology. Second, to 
elucidate the possibility of deleting diseased endothelial cells by transcorneal 
freezing using a newly designed cryoprobe, and the potential for a Rho-
associated kinase (ROCK) inhibitor to promote healing of a damaged corneal 
endothelium as a prospective alternative approach to treat corneal 
endothelial dysfunctions, such as FECD. To achieve my objectives, corneas 
from a range of species were utilised; embryonic chick for the development 
studies, post-operative human FECD tissue to more fully characterise the 
pathology, in vitro pig eyes for the transcorneal freezing experiments, and 
rabbit corneas, in vivo and in vitro for the post-freeze healing experiments 
and initial studies of the influence of a ROCK inhibitor on corneal endothelial 
healing. 
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1.2 The anatomy of the eye 
The human eye is a complex sense organ that comprises multiple structures, 
as indicated in Figure. 1.1, which work together to provide us with the ability 
to see. As described at its most basic level, light enters the eye through the 
cornea and is focused by a combination of the cornea and the lens onto the 
retina at the back of the eye. Here, it is converted into electrical nerve 
impulses by the retina. The retina absorbs the light by distinct 
photoreceptors, involving cones and rods for absorption of bright and 
monochrome colours, respectively. The visual processing parts of the brain 
then interpret collected information contained in nerve impulses as an image. 
The cornea is often thought of as the eye’s “window” to the world that overlies 
the eye’s transparent interior components such as the anterior aqueous 
humour, lens, and vitreous humour (Figure 1.1). Evidently, if the cornea is 
not clear, vision is compromised. As well as allowing light to be transmitted 
into the eye, the cornea, owing to its convex profile, acts as the eye’s main 
refractive component, accounting for approximately two-thirds of its total 
refractive power. 
 
Figure 1.1 Diagram of a sagittal section of human eye anatomy. 
 (http://www.eyecare-for-you.com/anatomy-of-the-eye.php). 
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1.3 Cornea 
The cornea’s optical transparency is dependent on distinctive physiologic 
features and interplay between its multiple cellular and macromolecular 
components, such as the highly specific arrangement of extracellular matrix 
proteins and delicately balanced hydration in the corneal stroma. In human 
adults, a healthy cornea is a little over 500 μm thick in the central pre-
pupillary zone, and around 650 μm thick at its periphery. In cross-section, 
the cornea consists of five distinct layers, which listed from the outside to the 
inside of the eye are the epithelium, Bowman’s layer, stroma, Descemet’s 
membrane, and endothelium (Figure 1.2). 
The surface epithelial layer is formed of 5–7 layers of cells and is around 
50 μm thick (Reinstein et al., 2008). This stratified squamous epithelium 
possesses a defensive function, protecting the eye from various infectious 
agents. It is continuously replenished throughout life, owing to the continual 
inward migration of new corneal epithelial cells originating from corneal 
limbal epithelial stem cell niche. The latter has been found to localise at the 
juncture between the peripheral region of the cornea and sclera, called 
Figure 1.2 Cross-section of rat cornea stained with haematoxylin and eosin.  
Distinct layers can be seen: an anterior layer of the cornea consist of stratified 
squamous epithelium, proceeded by stroma, Bowman’s layer and ending with inner 
endothelium after limiting lamina, also called Descemet’s membrane. The stroma 
contains flattened keratocytes 
(http://www.lab.anhb.uwa.edu.au/mb140/corepages/eye/eye.htm). 
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limbus, which provides self-replacement of corneal epithelium when 
damaged or sloughed off (Cotsarelis et al., 1989).  
Located immediately below the surface epithelium is Bowman’s layer, which 
is a dense acellular network of thin collagen fibrils. The function of Bowman’s 
layer is thought to be as protection from external injuries due to its structural 
strength (Germundsson et al., 2013). The average thickness of this layer is 
around 8 - 10 μm, which thins with age.  
Next, is the thickest corneal layer, the stroma, which comprises nearly 
90 percent of the whole cornea. The corneal stroma maintains strength as 
well as the refractive shape of the cornea and its transparency for light 
transmission toward retina. It consists of clear fluid, flat stromal cells called 
keratocytes, thin collagen fibrils (~30 nm thick), and sulphated 
proteoglycans. The cornea is transparent owing to the precise tissue-specific 
organisation of collagen fibrils (Maurice, 1957; Meek and Boote, 2004). The 
light waves that scatter from the collagen fibrils meet each other and interact 
via interference phenomena meaning that a significant proportion of light is 
transmitted through the cornea into the eye. It is crucial that the stroma 
remains relatively dehydrated because glycosaminoglycan (GAG) molecules 
that comprise the proteoglycans that are attached to the corneal collagen 
fibrils are highly hydrophilic, so water molecules are attracted to GAGs and 
can disrupt the particular collagen fibril arrangement by swelling the stroma. 
The swollen stroma can increase light scattering and reduce corneal 
transparency (Meek, Dennis and Khan, 2003). 
A membrane lying beneath the stroma is posterior limiting lamina, termed 
Descemet’s membrane (DM) (~ 3 µm thick at birth). It consists of an 
extracellular matrix produced by the cells of the endothelium (Murphy, 
Alvarado and Juster, 1984). DM is formed of the following two layers: anterior 
banded layer and the posterior non-banded layer. The former develops 
during pregnancy, while the latter is formed after birth (Waring et al., 1982). 
The thickness of the DM, therefore, increases up to 10 µm in adulthood 
(Johnson, Bourne and Campbell, 1982). 
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The innermost layer of the cornea is the corneal endothelium, composed of 
about 4–6 μm thick and 15–25 μm wide endothelial cells. The majority of 
which are hexagonal (when looking from the posterior surface) and uniform 
in size (Tuft and Coster, 1990). Despite being the thinnest cellular layer of 
the cornea, the endothelium plays a crucial role in regulating corneal 
hydration. Therefore, endothelial cells are described in more detail in the next 
section. 
1.3.1 Corneal endothelial cells 
At birth, the number of human corneal endothelial cells (HCECs) is 
approximately 300,000 in each cornea, which is equivalent to about 
6000 cells/mm2 (Waring et al., 1982; Bourne, 2003). After birth, however, the 
number of endothelial cells continuously reduces at a rate of 0.3-0.6 % per 
year, but normally remains above about 2000 cells per mm2 (Geroski et al., 
1985; Bourne, Nelson and Hodge, 1997). The slow reduction of endothelial 
cell density throughout life occurs because these cells are terminally 
differentiated, arrested in the G1 phase of the cell cycle, and unable to divide 
mitotically in vivo (Joyce, Meklir, et al., 1996; Joyce, Navon, et al., 1996). 
Hence, the regenerative ability of HCECs to maintain endothelial function is 
limited to a compensating process of cell reorganisation: following cell loss 
during life or following injury, healthy adjacent cells spread by enlarging to 
preserve the continuous monolayer and cover a bare space on Descemet’s 
membrane. These cells alter their dimensions possessing varied sizes (up to 
1500 μm) (termed polymegethism) and varied shapes (termed 
pleomorphism) changing characteristic hexagonal morphology (Laing et al., 
1976; Kaufman and Katz, 1977; Carlson et al., 1988; Bourne, Nelson and 
Table 1.1 Summary of thicknesses of individual corneal layers. 
No. Corneal layer Thickness 
1 Epithelium ~ 50 µm 
2 Bowman’s membrane ~ 8–10 µm 
3 Stroma ~ 450 µm 
4 Descemet’s membrane ~ 2–10 µm 
5 Endothelium ~ 4–6 µm 
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Hodge, 1997). This way, an unbalanced incursion of the anterior chamber 
fluid – the aqueous humour – into the corneal stroma is hindered.  
However, when the density of endothelial cells reaches a critical point of 
approximately 500 cells per mm2 (Ventura, Wälti and Böhnke, 2001), a 
functional threshold is reached below which the ‘pump-leak’ mechanism that 
normally filters excess water out of the corneal stroma cannot keep the 
cornea in a balanced hydration state. As a consequence the cornea will 
imbibe fluid, which can result in severe swelling, opacification of the cornea 
and a loss of vision (Ventura, Wälti and Böhnke, 2001; Armitage, 2003). 
1.3.2 “Pump-leak” mechanism 
Cornea has no blood vessels, enabling the transparency of this tissue to 
prevail.  Therefore, it is reliant on the contact of the endothelium with the 
aqueous humour, a clear plasma-like physiological liquid, from where the 
essential nutrients are diffused through interendothelial cell gaps. This 
mechanism then activates downstream pathways responsible for transport 
of nutrients inside the corneal cells (Bonanno, 2012). A key function of the 
corneal endothelial cells is to drive the “pump-leak” mechanism to maintain 
the corneal hydration at a required level (below 3.5 mg H2O/mg) to allow 
corneal transparency (Bonanno, 2012). This equates to a physiologically 
Figure 1.3 Diagram of the pump-leak mechanism. 
(A-B) Shown is a relationship between endothelial cell density and metabolic 
pump function. B) Corneal decompensation takes place when endothelial cell 
reserve passes the threshold of 500 cells/mm2. 
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normal hydration (H) of a transparent cornea of around 3.2, when H is 
defined as the ratio of the wet weight of the cornea to its dry weight (i.e. H = 
(wet weight – dry weight)/dry weight), or around 74% fluid (Meek et al., 1991). 
According to the ‘pump-leak’ theory, there is a direct relationship between 
the rate of liquid flow into the cornea and that of the released out through the 
endothelium (Bourne, 1998). This mechanism is mostly controlled by the 
regulation of sodium-potassium (Na+-K+) channel activity on the endothelial 
cell membranes, the important component of which is sodium-potassium-
adenosine triphosphatase (Na+-K+-ATPase) a transmembrane protein. The 
average rate of the pump function is between 25-40 PL/cm2/hr (Dikstein, 
1973). If the endothelial pump-leak balance becomes imbalanced, owing to 
a loss of cells or lack of healthy corneal cells as happens in diseases of the 
corneal endothelium such as FECD, stromal hydration increases above 
normal values, the characteristic arrangement of the stromal collagen fibrils 
breaks-down and corneal light scattering and opacification occur. 
1.4 Fuchs’ Endothelial Corneal Dystrophy 
The deterioration of the corneal endothelium may occur in numerous 
conditions, including various eye diseases. Several corneal dystrophies that 
share functional and morphological disorders of endothelium include FECD, 
posterior polymorphous corneal dystrophy, congenital hereditary endothelial 
dystrophy, and X-linked endothelial corneal dystrophy. Among these 
conditions, FECD, which was first described, as “dystrophia epithelialis 
corneae”, by Ernst Fuchs’ in 1910, is one of the most prevalent causes of 
corneal transplantation surgery worldwide (Fuchs, 1910; Baratz et al., 2010; 
Wieben et al., 2012). Although corneal epithelial cells are affected in later 
disease stages, the primary defects seen in FECD are changes in endothelial 
cell morphology and function, accompanied by the localised thickening of 
Descemet’s membrane and the deposition of extracellular matrix between 
Descemet’s membrane and the corneal endothelium. 
1.4.1 Aetiology and pathogenesis of FECD 
Understanding the underlying mechanisms of a disease is a critical element 
in it’s study, which potentially can lead to the discovery of new treatment 
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approaches to prevent a loss of vision. Although the precise cause and 
development mechanism of the FECD are still to be determined, it is likely 
that the condition is caused by a combination of various factors (Figure 1.4). 
This section describes several hypotheses of the aetiology and pathogenesis 
of the FECD. 
1.4.2 Genetic basis 
Like many disorders, FECD has a hereditary component. Although the 
condition can occur asymmetrically - more profound in one eye than in the 
other - the genetic nature of FECD suggests that, if not treated, both eyes 
may be affected and result in a total blindness (Goar, 1934; Waring, 
Rodrigues and Laibson, 1978; Waring et al., 1982).  
To date, several genes have been associated with the condition. Although, 
some cases are of sporadic inheritance (Sundin, Broman, et al., 2006), 
cumulative evidence indicates that FECD is caused by an autosomal 
dominant pattern of inheritance (Cross, Maumenee and Cantolino, 1971; 
Krachmer et al., 1978; Magovern et al., 1979; Rosenblum et al., 1980; Iliff, 
Riazuddin and Gottsch, 2012). The first gene mutation found to be 
associated with FECD in the autosomal dominant pattern was COL8A2 
(encoding D2 subunit of collagen type VIII) located on chromosome 1 
(Biswas et al., 2001; Gottsch, Sundin, et al., 2005; Gottsch, Zhang, et al., 
2005; Liskova et al., 2007; Mok, Kim and Joo, 2009). However, this mutation 
has only been found in the rare, early-onset form of FECD (affecting people 
earlier than 40 years of age), and not in the common, late-onset FECD form 
(Kobayashi et al., 2004; Aldave et al., 2006; Hemadevi et al., 2010). Further, 
FCD1, FCD2, FCD3, and FCD4 were identified as linked to the late-onset 
FECD occurring in chromosome 13, 18, 5, and 9, respectively (Sundin, 
Broman, et al., 2006; Sundin, Jun, et al., 2006; Riazuddin et al., 2009; A S 
Riazuddin et al., 2010). Additionally, more evidence has suggested that 
mutations occur in FECD patients in the 18th chromosome in a gene called 
TCF4, which encodes a protein called E2-2 (Baratz et al., 2010; Li et al., 
2011).  
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Gene mutations associated with other diseases have also been identified in 
FECD. For example, mutations of SLC4A11 (that encodes membrane-bound 
sodium borate cotransport protein) and TCF8 (that encodes ZEB1 protein), 
which are causative for two less common endothelial dystrophies -- 
congenital hereditary endothelial dystrophy and polymorphous posterior 
corneal dystrophy, respectively – have been found in the late-onset FECD 
(Vithana et al., 2008; A S Riazuddin et al., 2010; A S. Riazuddin et al., 2010). 
Additionally, the TCF4 gene, which is found in some FECD patients, has also 
been associated with schizophrenia (Steinberg et al., 2011). This may 
suggest that individuals suffering from schizophrenia could have an 
additional risk to develop FECD and vice versa, however, there is limited 
information in the literature regarding this possibility. 
Despite these genetic studies, however, the significance of the above-
mentioned mutations in the development of FECD (i.e. the molecular 
pathways associating the genetic transmutations with the clinical 
manifestations) is yet to be determined. The water is further muddied by the 
possibility of ethnic differences as suggested by a recent multi-generational 
study on a Chinese pedigree with late-onset FECD, which did not show any 
changes in either COL8A2, SLC411, or TCF4 (Tang et al., 2016). 
Nevertheless, several theories have been suggested regarding the way in 
which FECD might develop. 
1.4.3 Epithelial-mesenchymal transformation and endoplasmic reticulum 
(ER) stress 
Based on clinical and microscopy findings, the most recognisable pathologic 
feature of FECD is the presence of corneal guttae (Chiou et al., 1999). Also 
known as corneal guttata, these are focal thickenings of the posterior surface 
of Descemet's membrane. In addition, the overall thickness of Descemet’s 
membrane in FECD may reach up to 20 μm, while in non-diseased eyes it 
only thickens to approximately 10 μm by the age of 80 years (Gottsch, 
Zhang, et al., 2005). Consistent evidence suggests that the guttae appear 
due to excessive production, release, and accumulation of extracellular 
matrix (ECM) (Waring et al., 1982; Gottsch, Sundin, et al., 2005; Vithana et 
al., 2008; Engler et al., 2010). Iwamoto (1970) and Waring (1978) also 
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reported that FECD-affected endothelial cells display changes in their cell-
to-cell contacts, desmosomes, and tight intercellular junctions, accompanied 
by atypical features such as dilated endoplasmic reticulum (ER), swollen 
mitochondria, and the presence of cytoplasmic filaments. It was suggested 
that these changes were due to a tendency of dystrophic endothelial cells to 
transform to more fibroblast-like cell phenotype that leads to overproduction 
of the extracellular fibrous matrix that is occasionally seen between 
Descemet’s membrane and the endothelium during FECD. In agreement, a 
study by Hidayat and Cockerham (2006) demonstrated that FECD 
endothelial cells may exhibit epithelial and fibroblastic phenotypes based on 
immunohistochemical staining characteristics. 
Recently, the concept of metaplasia – i.e. the reversible transformation of 
one differentiated cell type to another differentiated cell type – in FECD was 
supported by several lines of genetic evidence based on the upregulation of 
specific genes (ZEB1 and Snail1) associated with the development of fibrous 
connective tissues, known as epithelial-mesenchymal transition (EMT) 
genes (Lechner et al., 2013; Gupta et al., 2015; Okumura, Minamiyama, et 
al., 2015). It was suggested that mutated genes may disrupt cell 
homeostasis, including the correct protein folding mechanisms in the ER. 
This phenomenon of ER stress is thought to lead to the accumulation of 
unfolded proteins in Descemet’s membrane. The abnormal Descemet’s 
membrane, on which the corneal endothelium sits, is postulated to negatively 
influence cell-cell connectivity and lead to endothelial cell thinning, 
pleomegathism, polymorphism and a resultant loss of function. The 
prolonged aggregation of unfolded proteins in Descemet’s membrane is also 
thought to activate an unfolded protein response that eliminates affected 
cells via apoptosis (Schröder and Kaufman, 2005; Meng et al., 2013; 
Okumura, Hashimoto, et al., 2017).  
1.4.4 Oxidative stress 
As was mentioned previously, mature human corneal endothelial cells are in 
a post-mitotic condition (arrested in the G1 phase of the cell cycle); thus, 
susceptibility to oxidative stress due to continuous exposure to light and high 
metabolic activity (pump function) increases with age (Joyce, Zhu and Harris, 
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2009). Therefore, the role of chronic oxidative stress has also been proposed 
in FECD pathogenesis (Buddi et al., 2002; Wang et al., 2007; Jurkunas et 
al., 2010). The cornea is rich in antioxidant enzymes that inhibit endothelial 
cell death by removing free radicals and reactive oxygen species (ROS) 
(Buddi et al., 2002). The findings of a proteomic analysis of endothelium 
reported by Jurkunas and colleagues (2010) demonstrated the decreased 
expression of antioxidants such as peroxiredoxin (PRDX) in FECD cells, 
compared to normal endothelial cells that have an anti-apoptotic function by 
removing hydrogen peroxide. It is unclear, however, whether the oxidative 
stress is the cause or the effect of FECD and needs further investigations. 
FECD thus involves corneal endothelial cell death followed by the failure of 
the corneal endothelium to function as a barrier between the aqueous 
humour and corneal stroma and regulate water levels of the cornea, hence, 
clinical manifestations such as corneal swelling leading to opacification and 
reduced visual acuity. 
Oxidative stress
Genetic basis
EMT & ER stress
Cell apoptosis
↑Corneal thickness
↓Barrier function
Guttae
Normal cornea
FECD cornea
Cell death
Thickened 
Descemet’s 
membrane
Stroma
Endothelium
Corneal edema
Morphological changes
Figure 1.4 Schematic diagram of possible pathological mechanisms of FECD. 
Genetic factors combined with oxidative stress and ER stress may lead to 
morphological changes in corneal endothelium, cell death and corneal oedema 
seen in FECD. 
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1.4.5 Clinical manifestations of FECD 
FECD is generally diagnosed by an eye exam, involving measurements of 
corneal thickness and specular imaging of the corneal endothelium (Chiou 
et al., 1999). This condition has been categorised into four clinical stages 
(Waring, Rodrigues and Laibson, 1978; Adamis et al., 1993; Weiss et al., 
2015).  
Absence of symptoms 
In the first stage, the FECD patients do not have any complaints, although 
characteristic small elevations that appear as dark drop-like spots on the 
back of the cornea, termed guttae (plural of ‘gutta’, translated as ‘drop’ from 
Latin terminology), can be observed on the backside of the cornea during 
regular specular microscopy examination; 
Presence of corneal swelling  
Guttae begin to accumulate from the central corneal area and as the disease 
progresses symptoms include a thickening of the cornea in the central area 
overlying the abnormal endothelial cells. In the second symptomatic phase, 
patients have light glares, photophobia, and feel less comfortable in the 
mornings. This eases throughout the day due to aqueous evaporation from 
the overly hydrated cornea while the eyelids are open; 
Painful epithelial bullous ruptures 
As the disease evolves, haziness of vision is present the whole time. In 
subsequent stages, clear blisters produced from the stored liquid can appear 
in the corneal epithelium, causing severe pain when they rupture (bullous 
keratopathy); 
Impaired sensitivity (painless) decompensated state of the cornea.  
Eventually, irreversible morphological changes such as scarring and 
subepithelial fibrosis occur on cornea and vision becomes impaired during 
the final phase, resulting in vision loss and the need for surgical intervention. 
Chapter 1. Introduction 
   
14 
1.5 Current Treatment of Endothelial Dysfunction 
1.5.1 Symptomatic Therapy 
Approaches to treating vision reduction caused by endothelial dysfunction in 
the initial stages of FECD involve various symptomatic approaches to relieve 
the swelling of the cornea. These include a topical application of hypertonic 
saline solution drops, ointments, or even cool temperature hair-dryer use 
from lateral sides of the face to help water to evaporate from the ocular 
surface (Tuft and Coster, 1990). Although these procedures can be 
beneficial temporarily, they do not alleviate the cause of the disease and its 
progression through pathologic stages. Once the above-mentioned attempts 
to treat developed symptoms fail to help control the corneal thickness and 
transparency, endothelial replacement therapy is generally required to 
promote visual recovery. 
1.5.2 Corneal Graft Surgery 
In its later stages, FECD is typically treated via a corneal transplantation (Tan 
et al., 2012). The graft of a full-thickness donor cornea, a surgery known as 
a penetrating keratoplasty, has been the traditional surgical treatment for 
people with severe corneal endothelial dysfunctions for nearly a century. 
Around 50,000 patients experience corneal transplants to replace diseased 
or injured corneas in the United States of America every year (Park et al., 
2015). Even though the success rate of penetrating keratoplasties is 
relatively high, there is a risk of inducing irreversible mechanical or functional 
impairment of the desired endothelial tissue during the surgical interruption 
(Pineros et al., 1996; Thompson et al., 2003). However, one of the most 
frequent complications has been identified as a graft rejection, in which the 
corneal endothelium can become detached, resulting in endothelial graft 
failure with a continuous decrease in endothelial cell density (Dandona et al., 
1997; Armitage, 2003; Patel, Hodge and Bourne, 2005; Terry et al., 2008). 
Questions have also been raised regarding the long-term survival of a donor 
tissue after the transplantation (Akanda et al., 2015). Furthermore, patients 
must be maintained by immunosuppressing steroid medicine for an extended 
period following graft surgery, as it can take from months to years after 
surgery for the corneal wound to heal (Yureeda and Hamrah, 2013). 
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Prolonged administration of immunosuppressant’s, in turn, may contribute to 
side effects such as secondary infections. In addition to risks associated with 
graft failure, corneal graft surgery for FECD can be hampered by difficulties 
obtaining transplantable corneal tissue, which is accentuated by the fact that 
significant numbers of donated corneas (up to 30% by some estimates) are 
discarded to variety of reasons including insufficient endothelial cells density 
(Armitage et al., 1990). Other potential complications of penetrating 
keratoplasty include suture-related haemorrhages and the induction of an 
irregular corneal surface causing high astigmatism (Tan et al., 2012).  
Based on the sub-optimal nature of penetrating keratoplasty as a treatment 
for FECD, certain improvements have been achieved in surgical approaches 
by developing partial-thickness (lamellar) keratoplasty (Melles et al., 1999; 
Bahar, Kaiserman and Mcallum, 2008). These methods involve selective 
replacement of only the pathologic corneal layer leaving the healthy layers 
of the recipient’s cornea untouched. Anterior lamellar keratoplasty surgeries 
are used to treat diseases of the anterior cornea or even diseases of the 
stroma in the case of DLK (deep lamellar keratoplasty) which dissects away 
the whole thickness of the cornea down to the level of Descemet’s 
membrane). Posterior lamellar corneal grafts are technically more 
challenging for the surgeon because they involve intraocular manipulation of 
tissue using specialised instruments. However, these are becoming 
increasingly popular and surgeries such as Descemet’s stripping 
(automated) endothelial keratoplasty (DS(A)EK) or Descemet’s membrane 
endothelial keratoplasty (DMEK) have become preferred methods to treat 
endothelial dystrophies such as FECD, due to a lower risk of graft rejection, 
faster recovery rates, and improved visual quality (Keenan et al., 2011; 
Lichtinger et al., 2012; Galvis et al., 2013; Robert et al., 2015; Le et al., 2017).  
Despite the contemporary popularity of posterior lamellar keratoplasties for 
FECD, difficulties acquiring suitable donor corneas still exist as do potential 
complications due to the invasiveness of the procedure. For instance, injuries 
associated with inserting, unfolding and positioning of the graft corneal layers 
may occur. Also, the risk of unsutured graft detachment is high and 
development of endophthalmitis, an inflammatory infection of the 
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endothelium, may necessitate repeated surgeries (Nieuwendaal et al., 2006; 
Lee et al., 2009). Evaluation studies show that although DSEK surgeries 
generally have good outcomes, the duration of these expectations is only a 
short-term (Stocker and Irish, 1969; Borderie et al., 2009). Furthermore, 
many countries with restricted access to donor corneas would benefit from a 
therapy alternative to transplantation (Gain et al., 2016).  
Since the corneal endothelium is arrested in the post-mitotic state and has a 
restricted regenerative capacity in vivo (Joyce, Meklir, et al., 1996; Joyce, 
Navon, et al., 1996), it has long been considered essential to replace the 
diseased corneal endothelial layer with donor endothelial layer during the 
DSEK/DMEK procedures (Dirisamer et al., 2011). Surprisingly, however, 
several case reports have described a spontaneous corneal endothelial 
recovery and improved visual outcomes despite graft detachments (Watson, 
Abiad and Coroneo, 2006; Balachandran et al., 2009; Zafirakis et al., 2010; 
Shah, Randleman and Grossniklaus, 2012; Ziaei, Barsam and Mearza, 
2013; Kymionis et al., 2017). For instance, a spontaneous corneal 
endothelial repopulation and improved visual acuity was reported in patients 
diagnosed with FECD after removing detached endothelial graft (Shah, 
Randleman and Grossniklaus, 2012). These cases suggest that either 
remaining healthy host endothelial cells or cells that had become detached 
from the donor tissue may have the ability to migrate onto the bare central 
area of Descemet’s membrane from which diseased endothelial cells had 
been surgically removed and reproduce an integrated endothelial barrier. 
This led to further case reports of keratoplasty without a donor endothelial 
replacement, where a smaller area of endothelium was stripped (3-4 mm) in 
an FECD patient resulting in a complete corneal clearing within four months 
(Kymionis et al., 2017).  
Another less-invasive approach, currently under investigation is a cell-based 
therapy, whereby a cultivated cell suspension derived from post-mortem 
donor corneal endothelium combined with a trophic pharmaceutical agent, 
ROCK inhibitor, is directly injected into the anterior chamber (Okumura et al., 
2012, 2018; Okumura, Sakamoto, et al., 2016). This has been shown to have 
success in small-scale human trials to treat corneal endothelial disease 
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(Kinoshita et al., 2018a); however, issues still exist with cultivation of 
endothelial cells in vitro due to limited proliferative ability. The above-
mentioned studies have encouraged more ideas for modification of the 
existing surgical interventions towards simplifying the management of 
corneal endothelial diseases without using a donor corneal tissue to reduce 
potential post-operational complications. 
1.6 Transcorneal freezing 
One alternative approach that has been used to remove diseased corneal 
endothelial cells from eyes with corneal endothelial dysfunction is via 
cryosurgery, using a minimally invasive procedure to locally destroy 
diseased cells by freezing. Cryosurgery has been used, historically, to treat 
a variety of tissues which are easily accessible to the surgeon such as skin 
defects, oral cancers, and corneal conditions including endothelial 
dysfunctions (Yeh, 2000; Okumura et al., 2011, 2013; Chang and Yu, 2013; 
Koizumi et al., 2013, 2014). For example, Koizumi and colleagues (2013) 
used first-in-man transcorneal freezing on a 52-year old male to destroy 
guttae caused by FECD. A 2-mm steel rod immersed in liquid-nitrogen was 
directly applied onto the central corneal surface of the patient for a duration 
of 15 seconds. This was followed by topical administration of Y-27632 ROCK 
inhibitor in the form of eye drops to stimulate remaining cells to recover. A 
week of treatment with the ROCK inhibitor applied in the form of eye drops 
six times a day demonstrated major improvement in the patient’s visual 
acuity and function of the endothelial cells, with a significant and maintained 
reduction in corneal thickness back to normal levels. 
Despite the potential of this approach it is likely that endothelial damage of 
diseased FECD cells via the application of a liquid-nitrogen-cooled steel rod 
for an arbitrary period cannot achieve surgical consistency, as the wound is 
dependent on the instrument features such as rod diameter and temperature, 
and the duration of freezing (Okumura et al., 2011). Although a controlled 
transcorneal freezing could potentially be an appropriate alternative 
procedure to remove diseased corneal endothelial cells in FECD patients, 
there is no optimised reproducible procedure to be used in a clinical setting. 
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Thus, promising results of the combination of transcorneal freezing with the 
ROCK inhibitor eye drop administration have produced an incentive to 
engage further experiments on improving the transcorneal freezing 
technique as well as to study endothelial cell responses toward the ROCK 
inhibitor treatment. 
1.7 ROCK inhibitor application 
Recent mounting evidence suggests that activation of the ROCK pathway 
occurs in the pathogenesis of numerous systemic diseases, such as, cancer, 
neurodegenerative, and cardiovascular diseases, which raises the prospects 
of this molecule to be pursued as a therapeutic target (Itoh et al., 1999; 
Fukata et al., 2001; Mukai et al., 2001; Lingor et al., 2008). For example, the 
important role of a selective ROCK inhibitor has been demonstrated in 
arterial hypertension development (Mukai et al., 2001). Also, Fukata (2001) 
suggested that ROCK plays a crucial role in the Ca2+ sensitisation of smooth 
muscle contraction involved in hypertension. A study on cultivated human 
embryonic stem cells by Watanabe and colleagues (2007) demonstrated that 
ROCK inhibitor Y27632 has anti-apoptotic activity as well as an effect on the 
differentiation of the cells. Despite the involvement of ROCK signalling in 
multiple cells and tissues, until recently, only one drug, Fasudil, has been 
clinically approved (in Japan and China in 1995) and is marketed as a 
selective and potent inhibitor of Rho-kinase for human cerebral vasospasm 
(Uehata et al., 1997). 
1.7.1 ROCK inhibitor application in the eyes 
Owing to the demonstrable value of ROCK inhibitors, the discovery of them 
has attracted high interest in various research and medical fields including in 
the ophthalmology community. One successful discovery regarding the 
effect of ROCK inhibitors in the field of ocular pathology resulted in the eye 
drop solution, Ripasudil (ROCK inhibitor, also named as Glatanec, K-115), 
being approved in Japan in 2014 for the treatment of glaucoma and ocular 
hypertension. The investigators found that ROCK inhibitor reduces the 
intraocular pressure by increasing outflow of aqueous humour through the 
trabecular meshwork (Garnock-Jones, 2015).  
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Despite the approval of Ripasudil for clinical use, its mechanism of action 
continues to be explored in relation to glaucoma as well as other eye 
disorders, including corneal endothelial dysfunctions. An increasing number 
of studies have been conducted in recent years, which have focused on the 
beneficial effects of ROCK inhibitors on corneal endothelial cells in multiple 
models including cell cultures, animal models, and early-stage human clinical 
trials. These have shown some results of promise in clinical setting (Okumura 
et al., 2009, 2012; Li et al., 2013; Pipparelli et al., 2013; Peh et al., 2015).  
According to Okumura (2012), the selective ROCK inhibitor, Y27632, has a 
beneficial effect when cultivating monkey corneal endothelial cells by 
increasing cell survival, cell adhesion, and cell proliferation in vitro with 
normal expression of endothelial function-related markers. This led to the 
concept of the potential use of human cultivated endothelial cells as a cell-
based therapy for the endothelial dysfunctions, such as those resulting from 
FECD or a complicated cataract surgery. Li (2013) and Lee (Lee et al., 2016) 
studied cultured bovine and porcine corneal endothelial cells in the presence 
of Y27632 and suggested that the ROCK inhibitor remarkably benefits cell 
cultures by promoting corneal endothelial cell proliferation, migration, whilst 
also preventing cell death. The proliferative and wound healing effects of the 
ROCK inhibitor 
↑stimulate cell proliferation
↑migration
↓apoptosis
Figure 1.5 Effect of ROCK inhibitors on corneal endothelial cells. 
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ROCK inhibitors were supported by further studies involving administration 
of the Y27632 inhibitor on in vivo rabbit and monkey eyes, delivered in the 
form of eye drops (Okumura et al., 2011, 2013, 2014; Okumura, Okazaki, et 
al., 2016). The same group of researchers has carried out more advanced 
studies that implicated human clinical trial using the ROCK inhibitor eye 
drops on diseased corneal endothelium (Koizumi et al., 2013, 2014; 
Okumura et al., 2013).  
1.8 Aims and Objectives 
As mentioned at the start of this chapter, the overarching aims of this doctoral 
research are to provide improved knowledge about the dynamics of corneal 
endothelial development as a natural model of endothelial cell migration, and 
the changes that occur in late-stage corneal endothelial disease (FECD) in 
two- and three-dimensions and at high magnification using advanced 
electron optical imaging technologies not previously applied to corneal 
endothelia (Chapters 2 and 3). The cornea’s response, in pig eyes in vitro 
and in rabbit eyes in vivo, to a series of newly designed cryoprobes for 
transcorneal freezing to be used as part of a new minimally invasive surgical 
treatment for FECD (Chapters 4 and 5) were also investigated. The effect on 
endothelial cell behaviour of the Y27643 ROCK inhibitor as a therapeutic 
agent and new potential ways of delivering it to the cornea were also 
investigated (Chapters 4 and 6). 
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2.1 Introduction 
To be able to treat corneal endothelial dysfunction effectively, it is important 
to first understand factors involved in the process of cell migration from 
regions of intact endothelial integrity and function, to repopulate damaged 
areas from which viable cells are missing. Useful information on the 
mechanisms and events influencing corneal endothelial cell migration might 
be gained from observations on the initial establishment of the endothelial 
monolayer in the embryo. Several studies have already been published on 
the subject of corneal development, but the majority of these - using a 
number of approaches, including scanning and transmission electron 
microscopies  - have focussed on epithelial and stromal development 
(Trelstad and Coulombre, 1971; Wulle, 1972; Linsenmayer et al., 1998; 
Hirsch et al., 1999; Koudouna, Mikula, et al., 2018; Koudouna, Winkler, et 
al., 2018). Significant additional work remains to be carried out, therefore, 
before we fully understand the events sequence and control mechanisms 
involved in the process of corneal endothelial development. To comprehend 
the formation of endothelial cells in the cornea, it is helpful first to consider in 
the context of how the eye itself develops. A brief description of how eye 
develops will be covered in the following sections of this chapter.
Chapter 2: Early Development of the Corneal 
Endothelium 
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After progressively dividing from two cells, embryonic cells form a blastula 
characterised by an outer epithelial layer, called the blastoderm, which 
during gastrulation forms three layers: ectoderm, mesoderm, and endoderm. 
The eye originates from the ectodermal derivatives (surface ectoderm, 
neural crest, and neural ectoderm) starting at prenatal week 3 (embryonic 
day 22) by forming an optic groove first, then an optic vesicle (Figure 2.1A). 
Then in weeks 4 and 5 the lateral walls of optic vesicles expand towards the 
surface ectoderm and invaginate to form a two-layered optic cup (Figure 
2.1B). The inner layer of the optic cup gives rise to the retina, ciliary body 
epithelium, iris, and the optic nerve, while the outer layer gives rise to the 
lens structure, the corneal and conjunctival epithelium, and eyelids with the 
lacrimal system. When the free edges of the optic cup merge together, the 
lens separates from the ectoderm creating an anterior chamber (Figure 
2.1C). Finally, in the 7th week of gastrulation, invasion of mesenchymal cells 
takes place to form corneal endothelium and stroma by a two-step cell 
migration from the neural crest, which originates from the area where the 
surface ectoderm and neural ectoderm fuse. First, the crest cells migrate to 
central cornea to form endothelium. The second wave then migrates to the 
space between epithelium and endothelium to differentiate into stromal cells, 
keratocytes, to form a highly collagenous stroma.  
Avian corneal development is known to involve the analogous two-step 
migration of the mesenchyme cells from the neural crest to develop the 
Figure 2.1 Diagram of the stages of early eye development.  
A: Formation of optic vesicle; B: Invagination of lens placode and formation of optic 
cup; C: Invagination of lens vesicle; D: Separation of lens from surface ectoderm 
(adapted from Hay and Revel, 1969) 
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endothelial layer (Hay and Revel, 1969). Some other animals such as mice 
and rabbits, however, have only a 1-step migration (Cintron, Covington and 
Kublin, 1988; Kidson et al., 1999). Owing to the similarity between human 
and avian ocular embryogenesis and easier accessibility of the chick tissue 
than that of human origin, morphology of embryonic avian development has 
been studied widely (Hay and Revel, 1969; Johnston et al., 1979; Hay, 1980). 
In addition, because corneal development occurs more rapidly in chick 
compared to that in humans, the avian eye was chosen as the most suitable 
model in which to investigate corneal development. 
The first migration of neural crest-derived cells to the proximal surface of the 
primary stroma in developing avian corneas occurs between embryonic day 
4 and 5 (E4 and E5). N-cadherin has been reported to be expressed as the 
first marker of the presumptive endothelial cells in a 3-day old chick cornea. 
It is thought to aid the mesenchymal-to-endothelial transition from the neural 
crest to endothelial monolayer during the avian eye development (Hatta and 
Takeichi, 1986; Reneker et al., 2000). As seen in Figure 2.2, by the end of 
Figure 2.2 Light micrograph illustrating all distinct layers of the chick cornea at 
embryonic day 6 (E6):  
Epithelium (Ep), stroma containing migrating stromal cells (SC) and endothelial 
layer (EC) migrated from the periphery. The image was kindly provided by Dr Rob 
Young (Cardiff University). Scale bar, 100µm. 
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E6 the endothelium has formed a continuous sheet across the proximal 
corneal surface but does not yet represent an organised cell monolayer at 
this stage. Keratocyte invasion from the periphery forms a continuous cell 
population in the mid-depth stroma, which is surfaced by stratifying epithelial 
layer. As the keratocytes develop, the stroma will become denser, containing 
less fluid to help maintain the transparency. These events form a highly 
organised cornea with three distinct layers of epithelium, stroma, and 
endothelium.  
The emphasis in this study is placed on morphological events that underlie 
corneal development that will give an understanding of endothelial cell 
migration. Intensive research has been carried out on corneal endothelial 
cells leading to identification of their major function and mechanisms involved 
in maintaining corneal transparency. However, the formation of endothelial 
cells into a monolayer is not completely clear.  
In the work described below, morphogenesis of corneal endothelial cells was 
investigated in chick cornea at days three to five of embryonic development 
using serial block face scanning electron microscopy (SBF-SEM) to 
visualise, for the first time in three-dimensional (3D) reconstructions, the 
events in endothelial cell migration. The underlying premise was that 
knowledge of endothelial migration in the embryo cornea could provide 
insights into the mechanism by which endothelial cells might be stimulated 
to respond in repair processes following injuries, such as scrape wounds or 
transcorneal freezing, for example. 
2.2 Materials and Methods 
This section describes experimental materials and methods that were used 
in this study. 
2.2.1 Experimental models 
Embryonic chick cornea 
Chick embryos were selected in this study as the most suitable experimental 
model in which to investigate corneal development on account of the ready 
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availability of tissue, obtained at specific stages of development in the course 
of a relatively rapid 21-day incubation period. In addition, the endothelial 
layer is known to develop in analogous way in both birds and humans. 
Therefore, the findings can be comparable and relevant to human corneal 
development. 
To capture the sequence of events involved in migration of presumptive 
endothelial cells from periphery to the central cornea, chicks between 
embryonic days 3 (E3) and 5 (E5) were used. It was considered that these 
observations on how endothelial cells spread to form a coherent population 
in the embryo might also provide some clues towards the mechanisms of 
induced endothelial repair following wounding or disease in adult healing 
tissue. The migration of the endothelial cells occurs rapidly during the first 
days of embryonic development, and individual corneas can develop at a 
slightly variable rate. Based on this, considering this outcome, an additional 
time-point at day 4 (E4) + 12 hours was chosen to include in the representing 
the logical order of events and capture the phase of endothelial migration. 
Fertilised chicken eggs were obtained from a commercial hatchery (Henry 
Stewart & Co Limited, Louth, UK). After a ‘rest period’ of 1-3 days following 
receipt from the supplier, to reach the desired developmental stage (E3 – 
E5) the eggs were placed in a humidified atmosphere (~60% relative 
humidity) inside a Brinsea Octagon 100 incubator (Brinsea Products Ltd, 
Sandford, UK) at temperatures of 37 to 38° C. At E3, E4, E4 + 12 h, and E5, 
eggs were removed from the humidified chamber and processed further for 
serial block face scanning electron microscopy. 
2.2.2 Experimental methods 
Excision of chick embryos 
At the completion of the required incubation time (E3, E4, E4 + 12 hours, and 
E5), developing eye tissue was obtained from the chick embryos using a filter 
paper template as described by Chapman (2001) (Figure 2.3). First, an 
eggshell was gently cracked by tapping and rolling the egg’s side on a solid 
bench surface. The intact egg contents were then carefully released directly 
into a petri dish. The middle of a filter paper was centred over the embryo, 
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placed gently onto the surface of the yolk sac after which the membrane 
around the filter paper was cut using scissors. After ensuring the attachment 
of the embryo to the filter paper, the embryonic tissue was pulled away using 
forceps to detach from the rest of the yolk membrane. The excised embryo 
was then transferred to a glass embryo dish filled with a fixative solution as 
described below. 
Fixation 
The extracted portion of a chick embryo was immersed in 
2.5% glutaraldehyde and 2% paraformaldehyde in 0.1 M sodium cacodylate 
buffer, pH 7.2, for 3 hours. 
Staining and Embedding 
Preservation of the whole corneas started with post-fixation in fresh fixative 
for 2 hours, after which chick embryo specimens were washed with 
cacodylate buffer 5 times for 3 min each time. To increase the contrast of 
cellular structures within the fixed corneas, the specimens were post-fixed 
with 1% osmium tetroxide and 1.5% potassium ferricyanide in 0.1 M sodium 
cacodylate buffer. After washing 5 times for 3 min each in the buffer, this was 
followed by immersion of the specimens in 1% tannic acid for 2 hours. The 
samples were then replaced with a fresh 1% tannic acid solution for another 
2-hour incubation. After washing specimens for 5 x 3 min in a distilled water, 
they were immersed in 1% osmium tetroxide for 40 min, then in 1% uranyl 
acetate for 1 hour, following washes of 3 times for 5 min each. 
Figure 2.3 Isolation of early stage chick embryo (E3).  
A: High magnification of chick embryo at E3 by light microscopy; B: filter paper 
centred over the embryo; C: embryo attached to the filter paper transferred to a 
fresh petri dish with saline solution to wash away excess yolk. 
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The samples were then dehydrated by immersion in a graded ethanol series 
of 50%, 70%, 90%, and 100% in distilled water for 10 min at each step. 
Specimens were then infiltrated with Araldite CY212 resin, placed in labelled 
embedding moulds and polymerised at 60° C for 72 hours.  
Making glass knives 
Glass knives were used first to cut semithin sections for light microscopy and 
then ultrathin sections for SBF-SEM investigation. Knives were made with an 
EM KMR2 glass knifemaker (Leica Microsystems (UK) Ltd). Initially, glass 
squares were prepared from a clean 6.4 mm thick glass strip (Leica) of 
200 mm in length placed onto the cover plate of the knife-maker and secured 
by the locking lever. Then the scoring shaft was pulled out to score the glass 
at a pre-set position. Next, the breaking knob was turned clockwise until the 
glass was broken into a square. This was followed by making two triangular 
glass pieces from the prepared square glass by rotating it by 45°and securing 
it with both front and rear clamping holders. Then a line was scored in the 
middle of the glass square via the scoring shaft before the square was broken 
again via the breaking knob. After several triangular glass knives were 
prepared, a piece of aluminium tape was attached around the top of the glass 
knife to form a ‘boat’ to hold a small volume of Millipore–filtered distilled water 
for collecting cut sections. The knife boats were sealed to the glass knives 
using warmed paraffin wax and kept in a dust-free environment in a special 
box until ready to use for sectioning. 
Ultramicrotomy 
First, a polymerised specimen block was firmly fixed in the sample holder, 
and the binocular eyepiece of the ultramicrotome (Ultracut E, Reichert-Jung) 
zoomed in to focus on the block surface. A glass knife was then introduced 
into the knife block, set with a cutting angle of 6º and clamped in place ready 
for sectioning. Following this, the specimen block was trimmed into a 
trapezium shape via using a razor blade to remove excess resin and expose 
the corneal tissue. The block surface was planed and polished by a glass 
knife using first the coarse then fine manual advance controls for the knife 
stage. Then the knife boats were filled with filtered distilled water to catch the 
cut sections. Then several semi-thin sections of around 2-4 µm in thickness 
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were cut and transferred onto a microscope slide for the primary observation 
via light microscope to ensure the area of interest was exposed on the cut 
section prior to SBF-SEM investigation.  
Light microscopy 
After cutting semi-thin sections, they were transferred onto a drop of distilled 
water on a microscope slide. The cut sections were then dried on a hotplate 
(Stuart, UK) at approximately 60 ºC. Sections were stained on the hotplate 
for a few minutes with 1% toluidine blue in 1% sodium tetraborate. Excess 
stain on the microscope slide was gently rinsed off using a wash bottle filled 
with distilled water. The rinsed glass slide was then air-dried before 
examination on a light microscope (Olympus BH-2). 
Serial Block Face Scanning Electron Microscopy (SBF-SEM) 
To enable critical events in corneal endothelial morphogenesis in detail, 
SBF-SEM was carried out using a Zeiss Sigma VP FEG scanning electron 
microscope equipped with a Gatan 3View2 system. This is a powerful 
Figure 2.4 Schematic diagram showing set up of SBF-SEM.  
An electron beam scans the resin block surface automatically producing a 
digitalised image (inset). Then an ultrathin slice of the block surface is cut by 
diamond knife and a stack of images is obtained in a reproducible manner. Image 
was obtained from a video at: http://www.gatan.com/products/sem-imaging-
spectroscopy/3view-system.  
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scientific approach to view microstructures of samples at high resolution with 
the potential to generate a specific 3D reconstruction of the sample. The 3D 
images add new information about a sample compared to the 2D imaging 
capabilities of conventional transmission electron microscopes, which can 
help better understand a material, solve research problems, and contribute 
to new knowledge. The SBF-SEM operates in a similar approach to 
conventional scanning and transmission electron microscopes (TEM), as the 
name implies, however, rather than imaging a sliced ribbon of sections on a 
specimen support grid as in TEM, the instrument scans and collects images 
of the block surface, alternating with removal of a surface slice by the Gatan 
3View ultramicrotome inside the microscope chamber. SBF-SEM also has 
the advantage of high-resolution imaging at the level of cellular organelles 
and collagen fibrils normally requiring TEM for their visualisation. The 
thickness of each slice cut via the ultramicrotome with a diamond knife is 
adjustable (100 nm was selected in this study). After the knife cuts off a slice 
of the block to reveal a new surface, the block is raised up to a focal point 
and is scanned by the electron beam over again, until a sequence of images 
of the complete desired tissue volume is obtained. 
Preparation for SBF-SEM 
After finding the area of interest by light microscopy, the trimmed sample was 
glued onto an aluminium specimen pin using conductive epoxy adhesive 
(2400 Circuit Works Conductive Epoxy Kit, Agar Scientific). Then, to avoid 
electrostatic charging of the sample, it was coated with a 6 nm layer of gold 
in an EM ACE 200 Sputter coater (Leica Microsystems (UK) Ltd, Milton 
Keynes, UK).  
Acquisition of images  
Each image sequence of approximately 1000 serial images at embryonic 
days E4 and E5, including additional E4 + 12 hours was collected every 
100 nm at 4 kV with a dwell time of 10 ms. The scan resolution was 
4096 x 4096, or approximately 10 nm per pixel.  
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Three-dimensional reconstruction 
Once the datasets of images of embryonic chick corneas were collected 
between embryonic days E4 and E5, including additional time-point of 
E4 + 12 hours, 3D models were generated using ImageJ/Fiji and Amira 6.2 
software. In ImageJ/Fiji, image sequences of each developmental stage 
were “Imported”, then “Inverted”, and then the “Brightness/Contrast” settings 
were adjusted for the differential contrast between structural elements of 
developing eye cells. Using the “3D Viewer” plugin, a 3D illustration of the 
selected image sequence was generated. Finally, the data was “Saved” or 
“Recorded” as a movie, when a representative view was identified. 
In Amira, the raw sequential data was imported, and modules such as “Ortho 
Slice” and “Volren” were utilised to form a three-dimensional reconstruction 
of the sample. 
2.3 Results 
This section includes findings of developing chick cornea via imaging 
techniques involving light microscopy and 3-View SBF-SEM. 
2.3.1 Light microscopy 
Light microscopical observations at low magnification of early stages (days 
3-5) of anterior eye development in toluidine blue-stained semi-thin sections 
showed the progress of endothelial cell invasion along the primary stroma at 
the inner surface of the forming cornea in the chick embryo.  
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Figure 2.5 Toluidine blue light micrograph showing early eye development stage of 
chick embryo at E3. 
Surface ectoderm formed a presumptive continuous corneal epithelium (Ep) and 
detached lens (L). A thin primary stroma (PS) stained lightly with a toluidine blue is 
indicated between the surface epithelium (Ep) and the lens (L). Neural crest cells 
(NCC) are evident peripheral to the lens. Scale bar, 100 µm. 
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Figure 2.7 Light micrograph of chick corneal development at the embryonic stage 
between day 4 and 5 (i.e. E4 + 12 hours).  
Presumptive corneal endothelial cell (EC) progress towards the central corneal 
area on the posterior surface of primary stroma (PS). Scale bar, 100 µm. 
Figure 2.6 Light micrograph of corneal development at E4.  
Presumptive multi-layered epithelium (Ep), acellular primary stroma (PS) between 
the epithelium and the lens (L) are indicated. Scale bar, 100 µm. 
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Light microscopy of endothelial cells during corneal development indicated 
stages when endothelium starts to enter the corneal inner surface. As light 
micrographs were obtained from different samples of fertilised eggs, corneas 
sometimes were found to have developed slightly differently. Thus the 
thickness of the corneas at each stage did not always match precisely. These 
small individual variations between embryos presumably reflect slightly 
different rates of development at these early stages post-fertilisation. 
At day 3 of incubation, as illustrated in Figure 2.5, structures of ectodermal 
origin were evident, including a continuous, surface epithelium and 
subepithelially, the formative lens, separated by the primary stroma. 
Between E4 and E5 endothelial cells became evident, first peripherally, then 
extending towards the centre and appearing in these 2D images to cover the 
entire proximal surface of the primary stroma. 
In summary, these light microscopical observations confirm cell migration to 
form the presumptive endothelium between days 4 and 5 of chick embryonic 
development. Although several previous studies have described endothelial 
development in the cornea using 2D microscopy, the nature of endothelial 
Figure 2.8 Light micrograph of chick embryo showing corneal development at E5.  
Endothelial cells (EC) appear to cover the inner surface of the corneal primary 
stroma (PS) in a discontinuous manner with some gaps. Scale bar, 100 µm. 
Chapter 2. Endothelial development 
 
34 
cell interactions and establishment of the corneal endothelial monolayer has 
not before been examined at high resolution in 3D.  
In the next section, this approach is explored through the results of 3D 
reconstructions from data acquired by 3-View SBF-SEM. 
2.3.2 3-view serial block face scanning electron microscopy 
This section presents 3D reconstructions generated from data obtained from 
3View SBF-SEM using ImageJ/Fiji to demonstrate morphology of endothelial 
cells during development at early stages of days 4 to 5: at E4, E4+12 h, E5.  
Figure 2.9 Snapshot of 3D reconstruction of developing chick cornea at E4. 
Corneal structures formed prior to the appearance of endothelial cells: presumptive 
corneal epithelium (Ep), primary stroma (PS) and lens (L) are indicated. This image 
corresponds to the light microscopy image in Figure 2.6. A three-dimensional 
reconstruction movie is available at: https://figshare.com/s/d90fa231776e1edf8a0a. 
Scale bar, 5 µm. 
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Figure 2.11 Snapshot of 3D reconstruction of chick embryo corneal endothelium at 
E4 + 12 hours. 
Epithelium (Ep) and endothelial cells (En) migrating from the periphery to the 
central cornea are demonstrated. A sheet of irregular shaped endothelial cells is 
present at this stage but consolidation as a monolayer has not yet occurred. The 
cells exhibit numerous filamentous processes, which extend both into the overlying 
primary stroma (PS) and proximally into the anterior chamber. Orientation: 
epithelium towards top and the lens is below, both out of field of view. The image 
refers to Figure 2.8. 3D movie available at: 
https://figshare.com/s/e126be80ef2ffea4fe65. Scale bar, 5 µm. 
 
Figure 2.10 Snapshot of 3D reconstruction of developing chick cornea at 
E4+12 hours. 
The beginnings of migration of presumptive endothelial cells (NC) toward the 
central cornea. Epithelium (Ep); Primary stroma (PS). The image corresponds to 
Figure 2.7. 3D movie available at: https://figshare.com/s/9315bda9907202cab428. 
Scale bar, 5 µm. 
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Figure 2.12 Snapshot of 3D reconstruction of developing chick corneal endothelial 
monolayer at E5. 
Hexagonal morphology of the cells is becoming apparent in the 5-day old avian 
embryonic cornea (angle looking from the posterior side). 3D movie reconstruction 
available at: https://figshare.com/s/e9b1da724bf40cb46306. Scale bar, 5 µm. 
Figure 2.13 Snapshot of 3D reconstruction of the mature porcine corneal 
endothelium. 
The similarity of the characteristic hexagonal shape of the endothelial cells with 
those of the E5 chick cornea is evident. 3D movie reconstruction is available at: 
https://figshare.com/s/cc2f4363a2ae674cf406. Scale bar, 5 µm. 
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Electron microscopical reconstructions in 3D showed that at early embryonic 
stages (i.e. E4) no endothelial cells had arrived at the inner corneal surface. 
Surface epithelium appears multi-layered, and its cells bear a resemblance 
morphologically and ultrastructurally to those of the lens, both of which have 
common origin. Epithelial cells seem to be still differentiating as evidenced 
by similar cell and nuclear morphology with no evidence of columnar, basal 
or wing cell characteristics, which is typical of a well-formed stratified corneal 
epithelium. Sandwiched between the two components, epithelium and lens, 
a fine fibrillar extracellular matrix representing the primary stroma was 
evident (Figure 2.9).  
Figure 2.10 demonstrates endothelial cell migration from the peripheral 
limbal region towards the central inner corneal surface at E4+12 hours. This 
three-dimensional image corresponds to the light micrograph shown in 
Figure 2.7. Surface epithelium appears to consist of up to two layers of cells, 
thinner than the example of an earlier phase at E4. Endothelial cells are 
moving from the peripheral limbal area towards the central cornea (right of 
field of view). 
Looking at Figure 2.11, it is clear that endothelial cells of irregular shape have 
reached the central posterior corneal surface forming a sheet. This has not 
yet consolidated as a continuous monolayer, however. An interesting 
morphological feature of the endothelial cells at this stage is the presence of 
long, thin, cell processes that extend in several directions: some are directed 
into the primary stroma towards the epithelium, whereas others extend 
towards the lens. Fine filamentous material is also seen at this time weaving 
its way into the primary stroma in the direction of the epithelium. 
Observations on chick embryo cornea at E5 clearly reveal the development 
of hexagonal endothelial cell morphology (Figure 2.12), characteristic of 
adult avian and mammalian corneas, and illustrated in the example of 
porcine cornea shown in Fig. 2.13.  
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2.4 Discussion 
Several novel features of migrating endothelial cells were identified in the 
course of this study using large-volume 3D reconstructions, previously only 
examined in 2D.  
The familiar polygonal or hexagonal shape of cells in the mature endothelial 
monolayer is not evident in cells of the neural crest origin which migrate 
around E4.5 from the periphery of the growing chick cornea to populate the 
posterior surface of the primary stroma. The cells do not appear to migrate 
as a coherent layer, as do cells growing from an explant in vitro, but resemble 
more a wave of closely associated but individual entities. By E5 they extend 
across the full extent of the posterior stroma but are not continuous, exhibit 
wide intercellular spaces, and have not established a proper complement of 
intercellular junctions at that time. In general, the cells are flattened in the 
plane of the stroma, but not to the same extent as appears later when they 
spread to exclude the intercellular spaces.  
A conspicuous feature of the cells throughout their migration to the corneal 
centre is the presence of numerous fine cell processes, filopodia, which 
extend both proximally into the newly forming anterior chamber and also 
distally to project well into the primary stroma. These structures were 
originally identified by Hay & Revel (1969) in early seminal studies of 
developing chick cornea although, without the advantage of 3D imaging, their 
extent was not fully appreciated and they were considered to normally 
terminate on the primary stromal surface, or on adjacent cells. SBF-SEM 
clearly showed that instead, they extend for some distance from the cell of 
origin to penetrate into the loose collagenous matrix of the stroma or appear 
freely exposed in the expanding space of the anterior chamber. Filopodia are 
considered typical of migrating cells, are rich in actin and common, for 
example, in neurite growth cones, and are thought to have a role in detection 
of extracellular cues, influencing cell orientation and motility (Kim, Kolodziej 
and Chiba, 2002; Mattila and Lappalainen, 2008). 
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Endothelial cells appear to be highly sensitive to environmental stimuli. 
Human endothelial cells of vascular origin grown in an in vitro culture model 
were found to develop several corneal cell characteristics, such as 
hexagonal shape and expression of the bicarbonate pump enzyme, 
sodium/potassium adenine triphosphatase, in response to different substrate 
topographies (Chua, Liew and Yim, 2013).  
In the chick embryo, the neural crest cells destined to become the 
endothelium migrate between the lens surface and the posterior surface of 
the primary stroma, mainly attaching to the latter (Bard and Hay, 1975). This 
substrate likely presents very different topographical cues for the cells 
compared to that of the nanoscale fibre and pore microsurface of Descemet’s 
membrane upon which spreading or healing adult endothelial cells are 
supposed to move and attach. At E4 the primary stroma is not thought to 
exhibit substantial orthogonal collagen fibril order which might be expected 
to provide an obvious conduit for cell alignment and movement. Maybe, 
therefore, the most significant signals for embryonic cell movement are 
derived from cues in the fluid environment at the interface between the 
primary stroma and the lens?  
Distal projecting filopodia may facilitate detection of subtle changes in 
stromal matrix composition towards E5, such as levels of expression of 
type II and type IX collagens (Fitch et al., 1988), as signals for consolidation 
of the endothelium through alterations in cell shape and synthesis of 
intercellular junction components. There is currently great interest in 
understanding potential routes for stimulation of endothelial cell mitosis and 
migration from the standpoint of developing new therapies to promote 
endothelial repair and to treat endothelial dysfunction in the clinic. This has 
resulted in numerous studies revealing factors which influence endothelial 
cell activity. Filopodial cell processes reaching into the anterior chamber 
probably enables exposure of the cell to growth factors, such as TGFβ, 
known to increase endothelial cell migration through activation of p38 MAPK 
(mitogen-activated protein kinase) signalling (Joko et al., 2017). Interleukin-
1β (IL-1β) has also been shown to have a similar effect on endothelial cell 
motility, but through Wnt5a induction (Lee and Heur, 2014). IL1-β appears to 
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act on mature human endothelial cell activity through stimulation of fibroblast 
growth factor2, but this is believed to lead to transition of endothelial cells to 
mesenchymal cells capable of fibrotic activity, via activation of transcription 
factor pathways involving SNAI1, CDK2 and ZEB1 (Lee, Jung and Heur, 
2018). These mechanisms are probably suppressed during development; 
otherwise, the biosynthesis of a collagen type I-rich retro corneal membrane 
might be the outcome. A recent study has implicated the Ephrin receptor 
signalling pathway in corneal endothelial cell migration acting through effects 
on cadherin expression (Walshe et al., 2018). Whether embryonic cell 
filopodial membranes show enrichment for receptors to these molecules 
remains to be investigated, although EphA1 and EphA2 receptors were 
detected on endothelial cells by Walshe et al. (2018).  
An interesting observation at E4.5 was the apparent interaction of migrating 
corneal endothelial cells with connective tissue structures within the 
overlying primary stroma. ‘Interactions’ were present as close associations 
between these structures and the processes of the migrating cells. The 
structures appeared as ‘strands’ or ‘cords’ of condensed matrix material 
extending in a distal to proximal orientation. These matrix strings are 
presumed to be the same as structures first identified by Bee et al. (1988), 
and later termed ‘strings’ (Fitch et al., 1991; Linsenmayer et al., 1998). These 
previous studies showed the matrix strings to label positively with antibodies 
specific for fibronectin and type VI collagen, and they seemed to be 
connected to the basement membrane of the epithelial cells. It was 
speculated that they might have a role in the acquisition of transparency by 
the developing stroma, but this has never been fully confirmed, and their 
precise function is currently unknown. Association between these structures 
and the presumptive endothelium suggests that they may fulfil some function 
in cell guidance, perhaps providing navigational cues to the migrating neural 
crest cells. 
One important and accepted, yet largely under-researched, source of 
stimulatory control of neural crest cell differentiation in the anterior segment 
of the embryonic eye, including endothelial growth, is represented by the lens 
(Beebe and Coats, 2000; Alkatan, 2017). It has been known for many years 
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that if the lens is ablated at E4, the endothelium fails to form (Zinn, 1970), 
being replaced instead by a multi-layered mass of disorganised 
mesenchymal cells. Signals from the lens are apparently vital for expression 
of the cell adhesion molecule N-cadherin by endothelial cells (Beebe and 
Coats, 2000), and other research suggests that if the endothelium fails to 
form normally, development of the anterior chamber also does not proceed 
(Kidson et al., 1999; Reneker et al., 2000). The influence of lens-derived 
signals on embryonic endothelial cell morphogenesis is known to persist until 
at least E15 in the chick (Beebe and Coats, 2000). However, it seems 
unlikely that regulatory molecules, whatever their nature, would be available 
from this source for regulation of endothelial regeneration in the adult eye. 
Similar to TEM, one of the limitations of the 3view SBF-SEM imaging 
technique is that this only provides for observation of static stages at selected 
developmental timepoints. Continuous observation throughout the entire 
process of endothelial morphogenesis is the ultimate objective, but demands 
live cell imaging, which has rarely been attempted (Bard and Hay, 1975), and 
was beyond the capabilities of the present research project.  
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3.1 Introduction 
Human corneal endothelial cells are terminally differentiated cells lining the 
inner surface of the cornea and forming a monolayer attached to Descemet’s 
membrane with its apical surface exposed to the aqueous humour. Corneal 
endothelium allows fluid to enter the stroma from the aqueous, but has an 
essential function in controlling stromal hydration, and thus corneal 
transparency, by actively pumping water back into the anterior chamber in 
the form of bicarbonate. A recent study in rabbits showed that stromal water 
currents determined by the endothelium exist in the horizontal plane from 
centre to periphery challenging the long-held concept of dynamic flow solely 
in the vertical plane (Inoue et al., 2014). Potential implications of these 
findings on the dynamics of pump activity and ultrastructure of cells across 
the endothelium have yet to be investigated. Water currents cease upon 
deactivation of the endothelial pump, and stromal swelling rapidly ensues 
clearly indicating the importance of the endothelium in corneal integrity and 
the severe consequences of endothelial disease such as Fuchs’ endothelial 
corneal dystrophy (FECD). 
The pathogenic mechanisms underlying FECD are still not well-understood. 
This investigation was undertaken to examine diseased corneal endothelial 
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cells and compare their fine structure to that in normal, healthy tissue. Earlier 
studies identified some intracellular changes at the organelle level 
associated with the diseased condition. In the present study, it was 
postulated that additional ultrastructural changes might be expressed by 
organelles in endothelial cells in FECD, which could throw further light on the 
nature of disease mechanisms. Observations presented in this section were 
made to compare endothelial cell ultrastructure in normal human cornea with 
that in Fuchs’ endothelial corneal dystrophy. Comparisons were also made 
with corneal endothelium in the pig eye, widely considered to be closer 
equivalent anatomically to human (Lee et al., 2014; Choi et al., 2015) and 
thus an invaluable experimental model. 
3.2 Materials and Methods 
Various imaging techniques were used to examine samples of pig and 
human corneal endothelium (healthy and FECD-diseased), including 
transmission electron microscopy and three-view serial block face scanning 
electron microscopy.  
3.2.1 Experimental models 
Human corneal tissues 
To better understand the pathophysiology of FECD, the samples of the 
healthy and FECD-diseased human corneas were used for comparison on 
an ultrastructural level. The archived specimens were obtained from corneal 
surgeries carried out in Addenbrookes Hospital, Cambridge, UK. Thus, 
already processed and embedded to preserve the subcellular structure and 
ready for ultramicrotomy for further transmission electron examination. 
Pig corneal tissue 
To compare corneal endothelial structures with those of humans, porcine 
cornea was chosen as an animal model to investigate normal endothelial 
ultrastructure using transmission and 3D viewing scanning electron 
microscopy. Pig eyes were obtained from a regional abattoir, W.T. Maddock 
(Maddock Kembery Meats, Maesteg) within 6 hours of slaughter and 
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transported on ice to the laboratory for dissection of corneas and further 
processing. 
3.2.2 Experimental methods 
Transmission Electron Microscopy (TEM) 
To study ultrastructure of corneal samples TEM was employed. To protect 
delicate tissue ultrastructure from the destructive effects of high vacuum and 
electron beam irradiation inside the column of the electron microscope, the 
samples were processed prior to the TEM examination by conventional 
methods for biological material. The main steps of preparation for TEM 
investigation involved preservation of in vivo appearance of the samples 
using fixation, infiltration with resin, sectioning, and staining as described 
below. 
Sample processing 
Initially, corneal samples were fixed using a modification of the method 
introduced by Karnovsky (Karnovsky, 1965) in 2.5% glutaraldehyde and 
2% paraformaldehyde in 0.1 M cacodylate buffer, pH 7.2 -7.4 for 2-3 hours. 
Before the secondary fixation with osmium tetroxide, they were washed with 
the cacodylate buffer in two changes for 10 minutes each. The specimens 
were then placed in a secondary fixative of 1% osmium tetroxide in 0.1 M 
sodium cacodylate buffer for 1 hour. Followed by three washes in distilled 
water three times for 5 minutes each, they were then placed in 
0.5% aqueous uranyl acetate solution for another hour. To completely 
replace the water within the specimen tissue, gradual dehydration steps were 
then carried out with a series of ethanol solutions (EtOH) of 70%, 90%, and 
twice with absolute ethanol (100%). The specimens were placed in each 
EtOH concentration for 10-15 minutes. Because epoxy resin is not miscible 
mix with ethanol, a transitional solvent, propylene oxide, that mixes with both 
ethanol and resin, was used for further dehydration; tissues were twice 
replaced into propylene oxide-resin mixture for 15 minutes, and 1 hour in 1:1 
propylene oxide : Araldite CY212 resin mixture on a rotary mixer. The 
specimens were then placed into fresh resin three times for approximately 2 
hours each, prepared as described below. After the third resin infiltration, the 
samples were left on the rotator in the fume hood overnight and subsequently 
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replaced with fresh resin three further times for 1 hour each. After tissues 
were infiltrated with resin, they were placed into further resin in moulds and 
cured in an oven at 60°C for at least 24 hours to polymerise the resin. The 
polymerised resin containing corneal tissue was then ready for section 
cutting using glass knives. A pig cornea was similarly processed for 
examination of the mature corneal endothelium by SBF-SEM. 
Preparation of resin 
To embed the corneal tissue, Araldite CY212 epoxy resin mixture 
(approximately 3 ml per sample) was prepared. First, 14 ml of Araldite 
monomer CY212 was put in a prewarmed conical flask, then prewarmed 
16 ml of Dodecenyl succinic anhydride (DDSA) hardener and 0.6 ml Benzyl 
dimethylamine (BDMA) accelerator were added and thoroughly mixed by 
swirling before use.  
Light microscopy 
To ensure that the cut section area was appropriate for subsequent 
examination using the transmission electron microscope, the samples were 
observed by the conventional light microscopy (Olympus BH-2). To expose 
the corneal tissue, the blocks with samples were first trimmed with a razor 
blade. Once the tissue region of interest was bared, several semi-thin 
sections of 2-4 µm thickness were sliced using a glass knife attached to the 
ultramicrotome (Ultracut E, Reichert Jung). 
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Specimen collection for TEM 
Once the area of interest was found by light microscopy, ultrathin sections of 
70-90 nm in thickness were cut. As sections came off the knife edge to float 
on the water surface, they were stretched by exposure to the vapour from a 
piece of filter paper soaked in chloroform held in the proximity to the knife 
boat. After cutting several sections, they were picked up using a meshed 
specimen grid made of copper (G300 HEX-C3 Hexagonal mesh, Gilder 
Grids) (Figure 3.1). 
Following collection of corneal sections onto copper grids, they were ‘stained’ 
to generate electron contrast in the microscope with solutions of heavy 
metals, as described below. 
Staining and TEM examination 
To obtain differential contrast in transmission electron micrographs, copper 
grids containing ultrathin sections were stained in aqueous solutions of 
uranyl acetate followed by lead citrate as described below. 
Figure 3.1 Schematic diagram of corneal specimen collection. 
The area of interest (grey) in trapezoid-shaped resin (blue) section is collected on a 
copper grid, 3.05 mm in diameter, before staining and examining using the 
transmission electron microscope. 
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First, to get rid of any precipitates, prepared stain solutions were transferred 
into microcentrifuge tubes and spun down in the centrifuge (MIKRO 120 
Hettich zentrifugen, Andrea Hettich GmbH & Co.KG, Germany) at 14000 rpm 
for 5 min. The staining process was carried out in the clean dust-free 
environment using parafilm, on which droplets of the uranyl acetate and lead 
citrate stains were dripped (Figure 3.2). Once the samples were stained, the 
grids were air dried and stored in a covered grid holder until ready to be 
examined on the TEM (JEOL JEM-1010 Electron microscope). Finally, 
transmission electron micrographs were digitalised by the 11megapixel 
14 bit CCD camera (Orius SC1000, Gatan) (Figure 3.3). 
Figure 3.2 Schematic diagram showing of the staining process 
Staining steps on example of six grids are shown above (A-D). A: the grids were 
first dipped using forceps in uranyl acetate (UA) solution for 15 minutes; B: the 
grids were then transferred in water droplets for 1 minute each; C: next, lead citrate 
(Pb) for 5 minutes; D: final washing step. To prevent Pb precipitation by 
scavenging carbon dioxide molecules, sodium hydroxide (NaOH) pellets were 
placed onto the parafilm between lead citrate droplets  
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3.3 Results 
This section includes the results of the TEM examination of three different 
samples including normal human corneal endothelium, corneal tissue from 
FECD patient, and porcine corneal endothelial cells.  
 
Figure 3.3 Image of transmission electron microscope set up. 
The main components of the TEM are shown: Electron gun; specimen holder; 
binoculars; viewing window. 
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3.3.1 Normal human corneal endothelial cells  
 
Figure 3.4 Transmission electron micrograph of normal human cornea. 
Endothelial cell cytoplasm containing typical intracellular organelles is shown: oval 
shaped nucleus (N), mitochondria (M), and Descemet’s membrane (DM). 
Extensive interdigitation (I) between adjacent cells typical to corneal endothelial 
cells is visible. Scale bar, 0.5 µm. 
Figure 3.5 Higher magnification of transmission electron micrograph of normal  
human cornea. 
Nucleus (N), multiple mitochondria (M), endoplasmic reticulum (ER), and Golgi 
apparatus (GA) are present in the endothelial cytoplasm. Scale bar, 0.5 µm. 
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3.3.2 Human Fuchs’ endothelial corneal dystrophy 
 
Figure 3.6 Transmission electron micrograph of human FECD endothelium. 
Irregularly attenuated endothelial layer is shown. Nucleus (N) of endothelial cell is 
visible and the cells are packed with vesicles. A gutta, typical of FECD is present 
as an extension of Descemet’s membrane and covered by thin processes from the 
cells. Scale bar, 2 µm. 
Figure 3.7 Higher magnification transmission electron micrograph of human FECD 
corneal endothelium. 
Dilated endoplasmic reticulum (ER) and mitochondria (M) are evident. The 
endothelial cell basal membrane shows pathological irregular profile where it 
adjoins Descemet’s membrane (DM). Scale bar, 0.5 µm. 
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3.3.3 Normal pig corneal endothelial cells 
 
3.3.4 Three-dimensional reconstruction of normal pig cornea 
 
Figure 3.9 Three-dimensional reconstruction of mature pig cornea.  
Original snapshot (left panel). Right panel indicating hexagonal shaped cells 
characteristic to normal human corneal endothelial cells. 
Figure 3.8 Transmission electron micrograph of pig corneal endothelium. 
Cytoplasmic organelles including nucleus (N), mitochondria (M), and endoplasmic 
reticulum (arrowheads) are comparable to those of normal human cornea. Fixation 
in the presence of Ruthenium red provides additional contrast to intercellular 
junctions (IJ). DM – Descemet’s membrane. Scale bar, 0.5 µm. 
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3.3.5  Transmission electron microscopy of corneal endothelium 
The ultrastructures of corneal endothelium in normal pig and human corneas 
were compared and contrasted with pathological changes seen in a 
specimen of a human cornea with FECD. Ultrathin sections of all tissue 
specimens were stained via the same procedure with uranyl acetate and lead 
citrate and prepared for TEM examination as described in Materials and 
Methods section 3.2.2. A pig corneal sample was fixed in the presence of 
ruthenium red to provide additional contrast to endothelial cell intercellular 
junctions. 
The examination of the normal corneal endothelium by TEM demonstrated a 
continuous endothelial monolayer formed from flattened cells tightly apposed 
to Descemet’s membrane. The mean thickness of the layer was 
approximately 3–4 µm. Figure 3.4 presents some of the main morphological 
characteristics indicating that corneal endothelial cells interdigitate 
extensively at their periphery with the membranes of neighbouring cells. At 
high magnification, multiple profiles of endoplasmic reticulum were detected 
in the cytoplasm. In addition, vesicles were very numerous in endothelial 
cells, clearly seen at higher magnification (Figure 3.7). 
An FECD corneal sample studied by TEM revealed a grossly irregular inner 
corneal surface composed of impaired endothelial cells. Endothelial cells 
were depleted and even absent in some areas. The approximate range of 
endothelial thickness was between 0–3 µm, while Descemet’s membrane 
was at least 12 µm. There was an evident difference in the intracellular 
component from that present in normal corneal endothelium, in particular in 
the endoplasmic reticulum which appeared clearly increased in thickness. 
3.4 Discussion 
In agreement with previous studies (Wulle, 1972; Ringvold, Davanger and 
Olsen, 1984), endothelial cells in normal human and pig corneas formed an 
integrated layer, tightly apposed to Descemet’s membrane, but without 
apparent specialised membrane attachments to this structure. The 
appearance of abundant mitochondria and conspicuous, well-developed 
Chapter 3. Mature endothelial cells 
   
53 
Golgi complexes and mitochondria were all features associated with a highly 
metabolically-active cell population, consistent with its role in supporting an 
active fluid pumping mechanism responsible for maintaining stromal 
hydration and thickness.  
It was considered that further information on the ultrastructural anatomy of 
cellular interactions within the corneal endothelium might be achieved by 
three-dimensional imaging of the monolayer. In order to achieve this, as no 
fresh human material was available, samples of pig cornea were processed 
for serial block face scanning electron microscopy. Fixation was carried out 
in the presence of ruthenium red to induce enhanced contrast in the 
intercellular junctions. 
The flat, hexagonal appearance of corneal endothelial cells seen in two-
dimensional imaging by transmission electron microscopy, is evidently more 
complex when viewed in 3D reconstructions generated from serial data sets 
acquired by 3View SBF-SEM. Lateral interdigitations of the peripheral cell 
membrane of adjacent endothelial cells presumably increase the surface 
area of the cells perhaps as a specialisation associated with membrane 
transport during fluid transport.  
In contrast to normal endothelial cells, morphology was significantly altered 
in the FECD cornea examined, with greatly attenuated cell shape, some 
areas of Descemet’s membrane completely devoid of cells, and substantial 
localised thickening of the membrane, so-called guttae, where adjacent cells 
were thinned and barely maintaining the integrity of the endothelial layer. 
Characteristic alterations in cytoplasmic organelles within FECD 
endothelium were consistent with those already reported in the literature, 
including dilation of endoplasmic reticulum and an increase in size and 
apparent number of mitochondria. The endoplasmic reticulum dilation is 
thought to indicate to the ER stress caused by overproduction of extracellular 
matrix, which leads to protein aggregation resulting in cell death (Iwamoto 
and Devoe, 1970; Engler et al., 2010; Okumura, Hashimoto, et al., 2017). 
Previously, high expression levels of ER chaperons that help protein folding, 
GRP78 phosphorylated eIF2D and CHOP, were found in FECD corneal 
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endothelial cells (Engler et al., 2010; Okumura, Kitahara, et al., 2017). Also, 
caspase 9 and caspase 3 levels were reported to be increased through ER 
stress mechanism suggesting the connection between the ER stress and 
induction of apoptosis in FECD pathology (Engler et al., 2010). 
Even using two-dimensional TEM imaging, the extensive nature of 
endothelial cellular interactions can be seen to be greatly perturbed in FECD. 
Examination of these changes in 3D reconstructions is highly desirable to 
fully characterise them, but unfortunately, a fresh sample of FECD cornea 
was not available for processing via the high contrasting method essential 
for successful imaging by SBF-SEM.
To conclude, this study demonstrated the ultrastructural differences between 
corneal endothelial cells in normal and FECD corneas. The markedly-
increased amount of endoplasmic reticulum within the diseased corneal 
endothelium supports the hypothesis of the involvement of ER stress during 
the pathogenesis of FECD. 
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4.1 Introduction 
Surgical intervention in the form of penetrating keratoplasty is the main 
treatment route for severe corneal oedema and the accompanying loss of 
vision caused by Fuchs’ endothelial corneal dystrophy (FECD). The scarcity 
of donor corneas and frequency of post-operative complications with the 
corneal transplantation such as graft rejection continue to limit the success 
of this invasive procedure, despite the availability of approaches for selective 
replacement of the endothelium, which are now more commonly used, such 
as Descemet’s stripping (automated) endothelial keratoplasty (DS(A)EK) 
and Descemet’s membrane endothelial keratoplasty (DMEK). To improve 
surgical methods and outcomes, eye researchers continue to seek less 
invasive alternative treatment options for endothelial dysfunctions. One such 
approach, pioneered by our surgical collaborators in Kyoto Prefectural 
University of Medicine and Doshisha University in Kyoto, Japan, was based 
on the pharmacological encouragement of non-diseased corneal endothelial 
cells to regenerate and resurface the damaged central area of the cornea in 
patients with FECD following the removal of the diseased and dysfunctional 
endothelial cells lining the central region of the posterior cornea. 
Chapter 4: Transcorneal Freezing for Corneal 
Endothelial Cell Removal: In Vitro Porcine 
Eye Studies 
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Conceptually, this could have been achieved by intraocular surgery and the 
mechanical scraping off of these cells via a full thickness peripheral corneal 
incision. However, to make the surgery less invasive, transcorneal freezing 
was selected as a way of destroying the diseased FECD cells at the cornea’s 
inner surface (Koizumi et al., 2013, 2014; Okumura et al., 2013). Of course, 
the corneal epithelial and stromal cells will also be damaged by the cryo-
injury, but these are expected to regenerate. In the first-in-man experimental 
surgeries conducted in Kyoto, a stainless steel rod that had been immersed 
in liquid nitrogen was used to induce the transcorneal freezing. If this surgical 
approach is to be more widely adopted into medical practice, however, the 
freezing would likely need to be achieved in a more controlled manner, thus 
the reason for the investigations described in this chapter. 
Various cryoprobes have been used for therapeutic purposes in the medical 
field to remove diseased tissue, and methodologies have exploited a variety 
of materials and cooling agents to achieve low temperature. Extreme low 
temperature has a destructive effect on tissues because of extremely rapid 
heat transfer from the cells and extracellular matrix to the cryo-agent, which 
can break cell membranes by disrupting their structural integrity via the 
formation of ice crystals that breach the cell membrane, eventually leading 
to cell death. Damage can also occur owing to the conversion of liquid water 
to ice crystals, which leads to an unsustainable osmotic imbalance that can 
render a cell non-functional. In the ophthalmic field, the response of cells to 
freezing is described by Fraunfelder (2008) in his comprehensive review of 
corneal cryotherapy. 
Cryoprobes for use in ophthalmic surgery do exist. However, these were not 
designed for corneal use, and are more commonly used for cataract 
extraction via a “freeze-grip” mechanism whereby the cold probe adheres to 
the cataractous lens, enabling the surgeon to manipulate and remove it (Ben-
nun and Barkana, 2002). The use of such probes would not be desirable for 
transcorneal freezing to damage dysfunctional corneal endothelial cells in 
our proposed FECD surgery since adherence of the cold probe to the corneal 
surface would be an unwanted effect. Also, existing cryoprobes tend to have 
a convex curved probe-tip profile, so were thought by us not be optimal for 
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transcorneal freezing and that a concave curved probe-tip surface would be 
preferable and result in better freezing. 
Freezing of corneal tissue has been used experimentally as a modality to 
induce an injury to facilitate basic research into corneal wound healing 
(Maumenee and Kornblueth, 1948; Chi and Kelman, 1966; Faure, Kim and 
Graf, 1971; Buco et al., 1973; Minkowski et al., 1984; Tuft, Williams and 
Coster, 1986; Ichijima et al., 1993; Fullwood et al., 1996; Petroll et al., 1997; 
Mimura, Yamagami, Yokoo, Yanagi, et al., 2005; Mimura, Yokoo, et al., 
2005; Han et al., 2013). But, if corneal freezing is to be used in a clinical 
setting (either for the destruction of diseased cells in the central endothelium 
prior to ROCK inhibitor eye drop application for FECD, as described above, 
or to pre-treat the cornea prior to targeted drug delivery to combat conditions 
such as fungal keratitis as an additional potential use), it needs to be 
achieved in a more sophisticated, reliable and reproducible manner than that 
achieved with an immersion-cooled steel rod. In this chapter, investigations 
into the effects on the porcine eye of a new cryoprobe for transcorneal 
freezing in FECD surgery are described. 
4.2 Materials and Methods 
4.2.1 Experimental materials 
Cryoprobe development 
A console that uses nitrous oxide as a cryogen was designed and 
manufactured specifically for use as a tool to achieve transcorneal freezing 
as a treatment for FECD. It was designed and manufactured in 
collaboration with a medical device company based in Ripon, North 
Yorkshire (Network Medical Products Ltd., UK) (Figure 4.1). A patent has 
been granted in Japan (No. 6104249) for the device and a European patent 
application currently under examination. Cardiff University holds this 
intellectual property (IP). Two prototypes exist, one in Cardiff University and 
the other in our collaborator’s laboratory at Doshisha University, Kyoto, 
Japan. The console is attached to a hand-held cryoprobe, which was used 
for corneal freezing. Enclosed nitrous oxide gas expanded within a tip and 
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was recycled inside the tip of the cryoprobe, achieving a low temperature 
based on the Joule/Thomson effect.  
To allow good contact with the cornea’s surface the tip of the cryoprobe was 
not convex (as it the case for existing ocular cryoprobes), but was designed 
either to be flat or to be concave with a similar average radius of curvature 
of the human cornea itself (approx. 8 mm) around the probe’s main axis, 
and several designs were tested with probe tips measuring 1.8 mm, 2.4 mm, 
or 3.4 mm in diameter laterally. The tips are made of silver for high thermal 
conductivity. Probe tip diameters larger than 3.4 mm were not considered 
because it was decided that if relatively large areas of tissue needed to be 
treated, then multiple freezing procedures could take place.  
Figure 4.1 The transcorneal freezing machine, attached to a cylinder of medical 
grade nitrous oxide (the cryogen). 
 The machine comprises of a main console with a monitor screen that displays 
freeze time, cryogen levels and readiness for freeze plus interchangeable probe 
tips, and a footswitch (not shown). Inset: the 3.4 mm diameter concave probe tip 
manufactured from silver for high thermal conductivity.
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For ease of use, a foot-pedal was incorporated into the design, which initiates 
cooling at the cryoprobe tip and maintains the reduced temperature 
throughout the whole time the pedal is depressed. Freezing temperature at 
the probe tip (approximately -50◦C, according to the manufacturer), is 
reached within 2 seconds of depressing the foot-pedal; after its release, 
ambient temperature is achieved within seconds concomitant with a thawing 
effect. The hand-held cryoprobe has an ergonomic angled design to allow 
easy application to the corneal surface (Figure 4.1).  
4.2.2 Experimental models 
This chapter describes a series of in vitro experiments in pig eyes to 
ascertain the optimal surgical parameters using a newly designed corneal 
cryoprobe needed to induce corneal endothelial cell removal via transcorneal 
freezing, as well as the permeability of the cornea to a topically applied 
solution (potentially a therapeutic pharmaceutical agent) following 
transcorneal freezing. 
The porcine eye was used as an experimental model to evaluate the impact of 
various designs of cryoprobe tip attached to the newly-manufactured 
cryoprobe. On average the human cornea is about 550 µm thick, though 
some small ethnic differences have been reported (Ma et al., 2018). The pig 
cornea, on the other hand, tends to be approximately 670 µm thick (Hatami-
Marbini, Etebu and Rahimi, 2013; Guindolet et al., 2017). A comprehensive 
study by Repp and colleagues has shown that owing to the corneal stromal 
swelling that occurs as a result of the corneal endothelial dysfunction in 
FECD the central corneal thickness (in 118 patients included in Repp’s 
study) was 652 ± 61 μm, compared to the average thickness in 267 normal 
corneas they measured, which was 559 ± 31 μm (P<0.001) (Repp et al., 
2013). Serendipitously then, it appears that, based on average central 
corneal stromal thickness, the pig cornea is a representative proxy of the 
human FECD cornea. For the studies described here, intact pig eyeballs with 
associated extraocular tissues were obtained from bacon-weight pigs within 
6 hours of slaughter at a local abattoir (W.T. Maddock, Kembery Meats, 
Maesteg, Wales, UK) delivered by a dedicated technician for the laboratory. 
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These were transported to the laboratory on ice and experiments began 
within 8–9 hours of the animals’ death.  
4.2.3 Experimental methods 
Reducing Corneal Thickness 
When the porcine eyes arrived at the home laboratory, measurements of 
central corneal thickness were taken with an ultrasound pachymeter (Tomey 
SP-100), which revealed that the corneas had thickened post-mortem to 
approximately 1000 µm-thick, compared to published in vivo values in the 
600–700 µm range (Ruiz-Ederra et al., 2005; Faber et al., 2008). Preliminary 
experiments suggested that intraocular pressure was low in enucleated eyes. 
Thus 500 µl of 0.9% saline solution was injected with a syringe into the 
vitreous chamber via the optic nerve. Additionally, the corneal surface of 
each eye was dampened with droplets (approx. 1 ml each) of the saline 
solution prior to pachymetry measurements to mimic the tear film and help 
avoid any abrasive damage caused by the application of a dry device (i.e. 
pachymeter and/or tonopen) to the cornea’s surface. The average thickness 
of the cornea was evaluated by taking eight readings from the same location 
on the central corneal surface. An initial analysis revealed that the average 
corneal thickness of the pig eyes that had arrived on ice from the abattoir 
was in the region of 1000 µm (average 1079 ± 64.6, n=7). Evidently, this was 
not appropriate for experiments on corneal tissue that was intended to mimic 
a typical human FECD cornea, so steps needed to be taken to de-swell the 
corneas in the intact pig eyes prior to the experiments being conducted. 
Several different approaches have been used by other researchers to reduce 
the corneal thickness for in vitro experimentation, including positioning the 
anterior surface of an eyeball in a dextran solution to allow osmotic effects to 
thin the cornea (Thuret et al., 2005; Zhao et al., 2008; Wolf et al., 2009). 
Attempts to optimise the de-swelling of the porcine corneas using an 8% 
dextran solution and immersion time of up to 24 hrs, however, failed to 
sufficiently thin the corneas to thicknesses that resembled normal pig corneal 
thicknesses/human FECD corneal thicknesses. Humidified dehydration at 
high temperature was thus chosen as an alternative mechanism by which to 
thin the pig corneas to usable thicknesses. A series of empirical tests 
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disclosed that placing the intact pig eyes in a humidified incubator (Brinsea 
Octagon 100 Incubator, Brinsea Products Ltd, Sandford, UK) at 45ºC for 30 
- 45 min was able to reverse the post-mortem swelling and obtain a suitable 
thickness for all subsequent experiments.  
Transcorneal Freezing 
Transcorneal freezing was achieved by placing the cryoprobe tip on the 
central corneal surface and initiating cooling by pressing down on the foot-
pedal to control the flow of nitrous oxide gas. The cryoprobe design team 
advised that 2 sec was needed for the probe tip to reach the low temperature 
subsequent to the foot pedal being depressed. Thus, initial experiments to 
ascertain whether or not freezing time influenced the extent of endothelial 
cell damage were conducted, and freezing times of 3 sec, 5 sec, 9 sec, and 
13 sec were tested. An additional 2 sec was included for the freezing 
temperature to be reached. Thus, a 3-sec freeze required a 5-sec application 
and foot-pedal depression of the foot pedal. The cryo-console has a light-
emitting diode (LED) time display that counts upwards in seconds, plus an 
audible beep, to allow the operator to conduct the freeze for the designated 
time. 
Epithelial On/Off Testing 
The pig eyes I used were from animals that had not undergone hot water 
immersion scalding, as happens in some abattoirs. This makes the eyes 
much more relevant for experimentation, and there was a likelihood that the 
corneal epithelium would still be present. To investigate whether or not the 
presence of this cell layer might have an effect on corneal endothelial 
damage via transcorneal freezing, experiments were conducted from which 
the epithelial layer had been removed in 20 eyes using a sponge to gently 
debride the corneal epithelium from the ocular surface prior to application of 
the cryoprobe. The intactness of the corneal endothelium was then assessed 
using the cell viability test described below. 
Pre-Cool or not Pre-Cool 
To establish whether or not the cryoprobe tip should be cooled prior to 
application to the cornea or cooled after it was in contact with the cornea, 
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tests were conducted on eyes with pre-cooled and non-precooled probe tips. 
The intactness of the corneal endothelium was then assessed using the cell 
viability test described below. 
Cell Viability Test 
Following transcorneal freezing, the in vitro pig corneas were carefully 
excised at the limbus, retaining a peripheral rim of anterior sclera, after which 
staining solutions of 0.2% alizarin red (approx.1 ml) and 0.25% trypan blue 
were applied sequentially to the endothelial surface for 60 - 90 sec each to 
identify live and dead cells. The stains were gently rinsed off using 
approximately 5 ml of buffer solution and left in the corneal cup until light 
microscopy examination. 
Light Microscopy 
Digital images of the corneal endothelial surface were captured on a Zeiss 
Stemi 1000 light microscope (Carl Zeiss) via a digital camera (Nikon Coolpix 
4500 4MP). The magnification was calibrated during every set of 
experiments using the image of an eyepiece graticule. The trypan-blue-
stained endothelial wound area in each corneal image was manually traced 
and measured using ImageJ/Fiji software (http://imagej.nih.gov/ij/). 
Averages of three measurements were calculated, and data were further 
collated using Microsoft Excel software (Microsoft Corporation).  
Statistical Analysis 
Statistical analysis was carried out operating IBM SPSS Statistics software 
(Version 23.0, IBM Corporation). For the evaluation of the success rate of 
transcorneal freezing using each probe, only images with circular shaped 
endothelial wound areas that mirrored the probe were included.  Spearman’s 
rank order correlation test was run to determine the relationship between 
central corneal thickness and endothelial wound areas induced by the 
freezing. 
Scanning Electron Microscopy 
To investigate the endothelial cell damage caused by transcorneal freezing 
in the in vitro pig eye model in more detail, four treated corneas were 
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examined by scanning electron microscopy (SEM). Immediately after 
excision, the corneas were fixed in 2.5% glutaraldehyde, 
2% paraformaldehyde in 0.1 M sodium cacodylate buffer, pH 7.3, for at least 
2 h. Samples in fresh fixative were then sent to Lancaster University, UK to 
be further processed for SEM examination where they were first washed free 
from fixative in phosphate-buffered saline (PBS). This was followed by 
gradual dehydration through a graded ethanol series (from 50% to 100% in 
30 min steps), after which the ethanol was replaced by the sublimation 
dehydrating agent, hexamethyldisilazane for 20 min to minimise the 
shrinkage of the specimens. After drying, the corneas were placed on 
aluminium specimen stubs (Agar Scientific) and sputter coated with gold 
(Edwards S150 sputter coater, Edwards High Vacuum Co. International) to 
allow imaging in a JEOL JSM 5600 scanning electron microscope (JEOL 
Company) with a beam accelerating voltage of 15.0 kV. Final sample 
processing and SEM data acquisition in this part of the study was kindly 
conducted by Dr Nigel Fullwood, Lancaster University, UK. 
Corneal Permeability 
To investigate whether transcorneal freezing enhances penetration of a 
solution (potentially, a pharmaceutical agent) across the stroma to the inner 
endothelial layer, 12 corneas were studied. As reported below, the 3.4 mm 
diameter concave profile cryoprobe tip was found to be the most effective in 
inducing prominent endothelial damage in the porcine eye in vitro. Thus, 
cryofreezing was carried out on six of the twelve in vitro pig eyes using the 
3.4 mm diameter concave probe for a total of 5 sec following the procedure 
described above. The six eyes that were not exposed to transcorneal 
freezing acted as controls. Methylene blue is readily visible to the naked eye 
and on light microscopy, and was used as a visual guide of solution 
penetration into the cornea after transcorneal freezing, and this was either 
delivered in the form of eye drops or was incorporated into a thin contact 
lens-like polymeric film that could be placed on the corneal surface for the 
slow release of the agent into the cornea. The polymeric mucoadhesive films 
were pliable and 0.1 mm thick approximately, and were developed by 
colleagues in the School of Pharmacy and Pharmaceutical Sciences, Cardiff 
University (Chan, Akhbanbetova, A. J. A. J. Quantock, et al., 2016).  
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4.3 Results 
4.3.1 Transcorneal freezing of porcine cornea in vitro: freezing time and epi-
on or epi-off. 
Experiments into the extent of endothelial damage caused by transcorneal 
freezing induced by the 2.4 mm diameter/concave profile cryoprobe tip 
revealed that the time of cryoprobe tip contact with the corneal surface did 
not affect the area of endothelial damage, seen as a blue stained area of the 
corneal endothelium, with freezing times of 3, 5, 9, or 13 seconds tested 
(Figure 4.2).  
This indicated that the endothelial damage was more consistent when the 
cryoprobe tip was in contact with the corneal surface prior to the initiation of 
cooling, whereas precooling of the tip for 2 seconds before surface 
application resulted in an unreliable removal of endothelial cells. A series of 
epi-off/epi-on tests revealed that removing the corneal epithelium prior to a 
Figure 4.2 Table of images show the effect of 3-second freeze with no precool and 
2 second precool with different freeze times (3,5, 9,13 seconds) on pig corneal 
endothelium. 
The 2.4 mm cryoprobe tip with concave shape was used. Endothelial damage as a 
result of freeze-thaw effect is indicated by blue stain.
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transcorneal freeze caused no observable difference in corneal endothelial 
cell damage. Thus, for the all further experiments, the cryoprobe tip was not 
pre-cooled, and the corneal epithelium was not removed. 
4.3.2 Transcorneal freezing on porcine cornea in vitro: An optimisation of 
probe design. 
Based on the experiments described above, a freezing time of 3 seconds 
with no cryoprobe tip pre-freeze was chosen for the experiments described 
in this section to ascertain the best performing tip design. 
Light microscopy of the endothelial surfaces of post-freeze, trypan blue-
stained corneas indicated the area of cell damage caused by the four 
different probes used in these experiments. Representative images of 426 
technical replicates, denoting the typical extent of endothelial damage, are 
shown in Figure 4.4, with examples of what were considered to be successful 
Figure 4.3 Effect of epithelial scrape removal prior to 3 sec freeze using the 
2.4 mm diameter concave probe tip on porcine corneas. 
No observable difference was seen in the extend of endothelial damage following 
removal of corneal epithelial cells compared to the endothelial damage in eyes 
from which the epithelium had not been removed prior to the freeze. Endothelial 
damage is indicated by blue stain.
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or unsuccessful freeze injuries. A successful freeze injury was defined as 
one that resulted in a well-delineated circular area of cell damage; whereas 
an unsuccessful one was considered to have occurred, either when there 
Figure 4.4 Representative images of corneal endothelial freeze-injury on pig eye 
in vitro induced by a 3 sec freeze with four different cryoprobe tips and assessed 
by trypan blue staining. 
The thickness of each cornea is indicated on each panel (±SD) based on eight 
pachymetry readings. The area of cell damage is seen via blue stain and 
successful and non-/less successful freeze injuries are shown in the left and right 
columns, respectively. Freezing with the 1.8-mm diameter/flat profile probe only 
rarely resulted in a reproducible wound (A, B). Endothelial freeze injury was more 
reliably achieved with 2.4 mm diameter probe tips with flat or concave profiles (C-
F), but the optimal result and best consistency were achieved using the 3.4 mm 
diameter/concave profile cryoprobe (G, H). Scale bar, 3 mm. See table 4.1, also.
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was no evidence of any cell damage, or when the area of induced damage 
was irregular. Based on these criteria only 14 of 102 eyes (14%) treated with 
the 1.8 mm flat probe were judged to have been successfully wounded, 
whereas 78 of 108 (73%) treated with the 2.4 mm flat probe displayed 
successful endothelial injuries, as did 76 eyes of 108 (70%), treated with the 
2.4 mm concave probe. The 3.4 mm concave cryoprobe, however, resulted 
in the most reproducible endothelial damage with 90 eyes of 108 (83%) being 
successfully wounded in a reproducible manner (Table 4.1). 
To quantify the extent of endothelial cell damage, ImageJ/Fiji software was 
used to manually trace around each wound deemed to have been 
successfully created (i.e. n=258 of 426 technical replicates). The area of 
each wound was calculated, which, perhaps unsurprisingly, disclosed that 
larger probe tips led to more extensive endothelial damage (Table 4.1). All 
of the 426 corneas examined were subjected to multiple pachymetry 
measurements immediately prior to transcorneal freezing. This revealed that 
the average corneal thickness was 649 µm (±61.4 standard deviation (SD)), 
which is a fair representative value for corneal oedema in humans with 
endothelial dysfunction (Koizumi, Okumura and Kinoshita, 2012; Repp et al., 
2013). Moreover, when the corneal thickness of individual corneas was taken 
into account, a statistical Spearman’s rank order correlation test identified 
that there was a weak relationship between central corneal thickness and 
endothelial damage when treated with the smallest and largest probes (1.8-
mm (r=–0.208, n=102, p=0.408) and 3.4-mm (r=–0.258, n=108, p=0.007), 
   Table 4.1 Summary of transcorneal freezing for 3 seconds on porcine eyes. 
Probe tip 
(mm)/type 
No. 
eyes 
No. eyes 
with 
successful 
freeze (%) 
Mean/SD 
damaged 
area 
(mm2) 
Mean 
diameter 
(mm) 
Mean/SD 
corneal 
thickness 
(μm) 
Spearman’s 
correlation 
coefficient 
(rs) 
1.8/Flat 102 14 (13.73) 0.79/0.4 1.0 642/63.7 –0.208 
2.4/Flat 108 78 (72.89) 2.12/1.0 1.6 650/71.2 –0.433 
2.4/Concave 108 76 (70.37) 2.29/1.0 1.6 651/60.1 –0.466| 
3.4/Concave 108 90 (83.33) 6.91/1.9 2.9 654/59.4 –0.258# 
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but a stronger relationship using 2.4-mm probe tips with concave and flat 
profiles (r=–0.433, n=108, p<0.001; r=–0.466, n=108, p<0.001, respectively) 
(Table 4.1). 
To provide higher resolution information as to the status of the cells after 
freeze injury in the in vitro pig eye model, a series of SEM studies were 
conducted (Figure 4.5). This indicated that the corneal endothelial monolayer 
was severely disrupted in the central portion of the cornea beneath the site 
of a cryoprobe injury with a 2.4 mm-diameter concave-profile tip. Injured cells 
tended to become damaged and/or disassociated from each other, whereas 
non-injured cells adjacent to the area of damage exhibited a classic 
hexagonal endothelial cell morphology.  
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Figure 4.5 SEM of the endothelium of pig corneas after transcorneal freezing. 
(A) An untreated pig cornea with cell borders in white showing a characteristic 
hexagonal mosaic. The outline of the cell nucleus is evident as a slightly lighter 
area within each cell. Scale bar, 10 µm. (B) A representative image taken at the 
same magnification of the freeze damaged area after treatment with a 2.4 mm 
diameter/concave profile tip, illustrating severe damage to endothelial cells by 
freezing. Scale bar, 10 µm (C, D) Lower magnification images of endothelial freeze 
injury showing circular areas of endothelial cell damage including some endothelial 
debridement, exposing Descemet’s membrane (C: 2.4 mm diameter/concave 
profile cryoprobe (scale bar, 200 µm); D: 3.4 mm diameter/concave profile 
cryoprobe (scale bar, 500 µm)) As expected the larger probe induces more 
widespread damage (see Table 4.1 also). (E-H) Transition zones (double headed 
arrows) between unfrozen endothelial cells and those that were destroyed by 
freeze injury are often sharp (E and G); same area, but different magnification. 
Scale bars, 10 µm, apart from G which is 50 µm.
Chapter 4. Transcorneal freezing: In vitro porcine cornea 
   
70 
Interestingly, there appear to be two transitional zones between healthy non-
frozen cells and the more central damaged ones. The immediate transition 
at the inner edge of the morphologically normal cells was fairly abrupt, and 
in some cases, this was on a micron scale (Figure 4.5 E, F, G). More centrally 
there was evidence of cellular dissociation (Figure 5 E), and also the total 
removal of large areas of frozen endothelial cells, exposing a bare 
Descemet’s membrane (Fig. 4.5 D, H). 
Transcorneal freezing on porcine cornea in vitro to test ‘drug’ infiltration 
The corneal endothelium is the layer intended to be treated via transcorneal 
freezing followed by ROCK inhibitor application to the corneal surface. 
Therefore, it was important that the ability of an agent to penetrate the cornea 
and reach the posterior endothelial region should be assessed. To do this a 
blue stain, methylene blue was used a visible proxy of a medicated solution. 
This was incorporated for slow release from a thin mucoadhesive polymeric 
film that was applied to the surface of the in vitro intact or cryoprobe-treated 
pig cornea overnight. 
As illustrated in Figure 4.6, it is evident that methylene blue is released from 
the thin mucoadhesive film into the cornea. The whole thickness of the 
porcine cornea, including the posterior endothelial layer was visibly blue in 
colour in the central area, suggesting that an agent reaches the targeted 
posterior cornea following the transcorneal freezing. These studies 
demonstrate not only that the transcorneal freezing is a promising topical 
Figure 4.6 Cross sections of porcine corneas topically treated with thin 
mucoadhesive film incorporated with methylene blue solution for overnight: 
(A) intact porcine cornea prior to treatment, (B) treated following transcorneal 
freezing. It is evident with that the methylene blue penetrated through all corneal 
layers reaching the posterior layer, endothelium in cryoprobe-treated sample, 
unlike (A) intact control.
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approach to remove the endothelial cells, but also helps a potential 
pharmaceutical agent to be delivered. 
4.4 Discussion 
A number of investigative surgical procedures that utilise the selective ROCK 
inhibitor, Y27632, to combat FECD and bullous keratopathy are under 
investigation, including cell-injection therapy (Koizumi et al., 2013, 2014; 
Okumura et al., 2013; Okumura, Okazaki, et al., 2015). Indeed, a recent fairly 
high-profile paper has reported promising results when donor-derived 
cultivated in a solution containing Y27632 ROCK inhibitor were injected into 
the anterior chambers of the eye of 11 patients with bullous keratopathy 
(Kinoshita et al., 2018b). However, an alternative less-invasive approach for 
corneal endothelial dysfunction owing to FECD or bullous keratopathy, which 
doesn’t require intraocular surgery or the need to obtain post-mortem donor 
eye tissue and inject cultivated allogenic corneal endothelial cells into the 
patient’s eye, involves freezing the central cornea using a cold probe to 
damage corneal endothelial cells beneath the surface contact area. This is 
then followed by the short-term delivery, for one week, of Y27632 in eye drop 
formulation (Koizumi et al., 2013, 2014; Okumura et al., 2013). In these 
surgeries, conducted by colleagues with whom I worked, freezing was 
achieved by touching the corneal surface with a stainless-steel rod, which 
had been immersed in liquid nitrogen. An arbitrary freezing time of 15 sec 
was chosen for these experiments, along with a 2-mm diameter for the steel 
rod used. Encouragingly, the outcomes of these surgeries showed promise, 
but if the approach was to be adopted more widely by the ophthalmic 
community the corneal freeze would probably need to be achieved in a more 
reliable manner and with more knowledge of the nature and extent of the 
freeze damage. Thus, the experiments described here. 
Historically, and up to the present day, corneal freezing has been carried out 
by a variety of methods, most of which use it to induce an experimental injury 
for research into corneal endothelial wound healing and regeneration 
(Maumenee and Kornblueth, 1948; Faure, Kim and Graf, 1971; Van Horn 
and Hyndiuk, 1975; Van Horn et al., 1977). Freezing studies tend either to 
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employ a brass rod or dowel, which had been immersed in liquid nitrogen 
(Buco et al., 1973; Van Horn et al., 1977; Minkowski et al., 1984; Mimura, 
Yamagami, Yokoo, Araie, et al., 2005; Mimura, Yokoo, et al., 2005) or 
similarly cooled steel ones (Ichijima et al., 1993; Fullwood et al., 1996; Petroll 
et al., 1997) Retinal cryoprobes have also been used in investigational 
studies of transcorneal freezing (Tuft, Williams and Coster, 1986)(Olsen and 
Davanger, 1984). 
In this chapter, the design and manufacture of a corneal cryoprobe that uses 
circulating nitrous oxide as a cryogen and the type of freeze damage it 
induces are reported. Typically, the tips of cryoprobes that use high-pressure 
gas as a cryogen are made of stainless-steel owing to the need to contain 
high-pressure gas safely. In the new design, however, the use of stainless 
steel would have resulted in a freeze that started in the centre of the tip and 
thereafter spread, albeit quickly, to its outer circumference at a speed which 
relies on the thermal conductivity of the metal. To achieve a more uniform 
cooling across the probe tip, a cryoprobe tip was manufactured out of silver, 
which has a higher thermal conductivity than that of steel. The benefit of this 
design feature is that the diameter of the freeze in the cornea is based on 
the expansion and internal recycling of nitrous oxide inside the cryoprobe tip. 
At the point of its transition from liquid to gas inside the cryoprobe tip, nitrous 
oxide exists at a temperature of - 88.5ºC, and this transition, which occurs 
inside the probe tip, of course, rapidly cools it. Owing to thermal conductivity 
within the whole probe and thermal loss at ambient room temperature, an 
equilibrium is reached, which in this novel design means that the temperature 
at the outer surface of the probe tip reaches - 50ºC. 
Cryobiology is an area of study that investigates the response of biological 
cells and tissue to low temperature. Here, the focus is in how low temperature 
can destroy diseased cells in the human corneal endothelium in FECD or 
bullous keratopathy to allow the recovery of an intact function corneal 
endothelium by healthy peripheral endothelial cells away from the diseased 
area, perhaps encouraged to recover the endothelium via the action of the 
Y27643 ROCK inhibitor. Armitage (2009) describes corneal freezing from the 
opposite perspective, however, showing how careful freezing using time-
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mediated freeze-thaw protocols accompanied by the use of cryoprotectants 
can lead to cell survival (Armitage 2009). For example, with rapid freezing 
techniques, such as high-pressure freezing, the structure of cells is 
preserved, and non-crystalline, amorphous ice is produced instead of crystals 
preventing cell membranes from damage. Cells and tissue can also be 
protected by being immersed in cryoprotectants and cooled and thawed at 
controlled rates. Indeed, Armitage and associates, experimenting on excised 
rabbit corneas, have shown how ice-free cryopreservation of the corneas by 
vitrification to temperatures as low as -110°C can be achieved in the 
presence of a cryoprotectant and with cooling and rewarming rates of 
7°C/min and 12°C/min, respectively, in which some corneal endothelial cell 
function was retained (Armitage, Hall and Routledge, 2002). These 
sophisticated freeze-thaw protocols, however, are the flip side of the coin of 
our approach, which is a purposely seeks to damage by freeze-injury the 
diseased corneal endothelial cells of the central cornea in FECD. The 
concept is to remove them from the inner surface of the cornea, with cell 
fragments floating away into the aqueous humour and to be later removed 
from the eye via the regular ocular outflow pathway. An exposed Descemet’s 
membrane will then remain (as seen in Figure 4.5) on which peripheral, non-
diseased corneal cells can migrate prompted by the presence of Y27632 
ROCK inhibitor to recover corneal endothelial function. The data presented 
in this chapter clearly show that a 3.4 mm-diameter cryoprobe tip with a 
concave profile that approximates the radius of curvature of the corneal 
surface results in the optimal amount of reproducible freeze damage to the 
corneal endothelium. It is also, evident that the corneal epithelium need not 
be chemically or mechanically removed before the transcorneal freezing 
procedure and that the desired effect can be achieved with a brief, 3 sec, 
freeze, with prolonged freezing times not required. 
Experiments described here also found that if the foot pedal was depressed 
to initiate the cooling of the probe tip before it was brought into contact with 
the corneal surface, then no appreciable endothelial freeze damage was 
seen, even if the cryoprobe was kept in contact with the cornea for periods 
of up to 15 sec. It is not immediately clear why this is the case, but perhaps 
frosting of the probe tip, when it is cooled in air, is the reason, reducing the 
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efficiency of cooling rate on corneal contact. This possible lack of frosting, 
when the tip is cooled after application, also might help facilitate the easy 
release of the probe tip from the corneal surface after the foot-switch is 
released, which happens within a second or two of the cryogenic circulation 
being suspended. 
According to the Spearman’s correlation test results, the area of damage 
caused by transcorneal freezing was inversely dependent statistically on the 
increasing thickness of the cornea. It was expected that there would be a 
negative correlation between corneal thickness and endothelial wound area 
as the stromal layer likely has some conductive properties, which would 
explain the gradual reduction of cooling effect on the endothelium. Thus, the 
thicker the cornea, the less damage, it warms the cryogen, thus having less 
cryo-damaging effect on the endothelium. Therefore, application of the 
largest probe with 3.4 mm diameter seems likely to be more effective in 
removing diseased endothelial cells in FECD patients with the swollen 
corneas. 
As the endothelium is the target for a potential pharmaceutical strategy in 
endothelial dysfunction, it is essential that an agent applied via the corneal 
surface is delivered into the posterior cornea. Incubation with methylene blue 
in the mucoadhesive thin film evidently demonstrated that a potential agent for 
endothelial repair can reach the posterior cornea following transcorneal 
freezing. This is most likely due to loosening of intercellular spaces and 
structures located anteriorly to the endothelium, as a result of the transcorneal 
freezing. Therefore, this study proposes that destroying the dysfunctional 
endothelial cells is as important as to provide the route for targeted drug 
delivery, proposing a promising approach to treat FECD. 
The data presented here show that endothelial cells can be functionally 
damaged and/or removed by the application to the corneal surface of a 
cryogenic cold probe and that this can be done in a targeted and reproducible 
manner with cell damage restricted to the area below the surface contact. 
Use of the 3.4-mm-diameter cryoprobe with a concave profile was 
discovered to be the optimal design of those tested. It thus has the potential 
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to rapidly and reliably induce damage to the human corneal endothelium via 
transcorneal freezing. The approach using a patented new device has the 
potential to be used prior to the application of ROCK inhibitors to the eye in 
the form of eye drops (Koizumi et al., 2013, 2014; Okumura et al., 2013), or as 
slow-release chemicals from thin films (Chan, Akhbanbetova, A. J. Quantock, et 
al., 2016) to aid the recovery of corneal endothelial function.
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5.1 Introduction 
The previous chapter described the rationale for the desire to destroy 
diseased corneal endothelial cells as part of a minimally invasive treatment 
for vision loss owing to corneal dysfunction in conditions such as FECD and 
bullous keratopathy. The in vitro studies using pig eyes, which had corneas 
of a similar thickness to pathologically swollen FECD corneas, were 
instrumental in establishing preferred treatment modalities and identified the 
3.4 mm-diameter cryoprobe tip with a concave surface as the optimal one to 
achieve the best endothelial cell damage. This work also showed that prior 
removal of the corneal epithelium had no beneficial effect on the outcome of 
the procedure, that the cryoprobe tip should only be cooled after brought into 
contact with the corneal surface and that prolonged freezing times beyond 
3 sec were of no advantage. Of course, in vitro experiments such as these 
can tell us nothing about the biological response of the living eye to 
transcorneal freezing, thus in this chapter, a small number of rabbits were 
used to ascertain some healing characteristics of eyes post-transcorneal 
freeze.
 
Chapter 5: Transcorneal Freezing for Corneal 
Endothelial Cell Removal: In vivo Rabbit Eye 
Studies 
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Rabbits are fairly widely used in the field of corneal research, and whilst not 
a perfect proxy for understanding human corneal biology, they represent a 
highly valuable model to augment data acquired from studies on mice, rats, 
and chicks and less commonly tree-shrews, mini-pigs and primates due to 
similar corneal structure. Due to increased regenerative ability of rabbit 
corneas, wound healing, in particular, is a field that often utilises rabbits to 
study the cornea’s response to interventions such as corneal refractive 
surgery (Kivanany et al., 2018), ultraviolet A (UVA)-induced corneal 
crosslinking (Bradford et al., 2018), implantation of tissue-engineered 
constructs (Cui et al., 2018; Jia et al., 2018) and even the use of human-
derived stem cells as potential therapeutic materials for the corneal 
epithelium and endothelium (Hayashi et al., 2016; Yamashita et al., 2018). 
Thus, rabbits were utilised for the experiments described in this chapter, the 
main aim of which was to assess the healing response to transcorneal 
freezing via a series of clinical and morphological examinations of the cornea 
with a focus on the structural integrity of the corneal epithelial basement 
membrane, corneal stroma and central and peripheral regions of the corneal 
endothelium. These in vivo investigations were conducted in the laboratories 
of Professor Noriko Koizumi and Dr Naoki Okumura in the Department of 
Biomedical Engineering, Doshisha University, Kyoto, Japan, where the 
author spent time as part of this doctoral research. The 3.4-mm diameter 
concave cryoprobe tip was found to be most suitable to achieve reliable 
endothelial destruction in the in vitro pig studies described in Chapter 4. 
However, owing to the fact that the rabbit cornea is thinner than that of the 
pig, at <400 µm thick compared to >600 µm in the pig, the smaller, 2.4 mm 
diameter, concave tip was used in the in vivo rabbit experiments described 
here. 
5.2 Materials and Methods 
5.2.1 In vivo transcorneal freezing 
To investigate the corneal wound healing response to transcorneal freeze, 
experiments on a small number of rabbit corneas were conducted in 
Doshisha University, Japan, using the second prototype of the newly-
designed cryoprobe that was used for porcine ex vivo experiments, adjusted 
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for Japanese power differences. At all stages, the animals were treated in 
accordance with the Association for Research in Vision and Ophthalmology 
(ARVO) Statement for the use of Animals in Ophthalmic and Vision Research 
and the research was approved by the Doshisha University. The surgical 
procedure mimicked that used for the in vitro experiments on pig corneas 
(i.e. no epithelial scrape, a 3-sec freeze, and freeze initiation after contact). 
For these investigations, a 2.4 mm diameter concave profile cryoprobe tip 
was used rather than the 3.4 mm concave one owing to the relative thinness 
(approximately 350–400 µm) of rabbit cornea, compared to that of the pig 
(approximately 660 µm). The transcorneal freezing treatments were 
conducted by Mr Shinichiro Nakano, who had spent time in Cardiff University 
observing and assisting with the in vitro porcine transcorneal work, and who 
was thus highly familiar with the operation of the cryoprobe. It was performed 
on one eye of each rabbit (each was under general anaesthesia). The 
contralateral eyes of all three rabbits represented untreated controls, which 
is in line with best practice as bilateral experimental corneal surgeries are 
not permitted in Japan based on animal welfare grounds. The treatments 
were overseen by an experienced corneal surgeon, Dr Naoki Okumura, 
Associate Professor of Biomedical Engineering in Doshisha University.  
Following transcorneal freezing, at the 24-hr, 10-day, and 30-day time-points, 
the anterior segment of each rabbit eye was assessed with a slit-lamp 
microscope, which showed that the procedure had not resulted in any severe 
general adverse effects. Corneal thicknesses were also determined at these 
times using an ultrasound pachymeter (SP-2000, Tomey), and the mean of 
eight measured values was calculated. Two rabbits were euthanised (one at 
24 hrs, the other 30 days) after transcorneal freezing by intravenous injection 
of 64.8 mg/kg pentobarbital sodium solution (Somnopenthyl, Kyoritsu 
Yakuhin Corporation). Corneas were excised from treated and untreated 
eyes and prepared for transmission electron microscopy as described below. 
5.2.2 Transmission Electron Microscopy (TEM) 
Rabbits were euthanised 24 hrs and 30 days following in vivo transcorneal 
freezing. After excision at the limbus, the corneas were fixed in 2.5% 
glutaraldehyde and 2% paraformaldehyde in 0.1 M Sorensen buffer (pH 
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7.2—7.4) overnight at 4ºC. Samples in a fresh buffer solution were then sent 
to Cardiff to be further processed for TEM as described previously (Chapter 
3.2.2). 
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5.3 Results 
5.3.1 Transcorneal freezing on rabbit eyes in vivo 
 
Figure 5.1 Slit lamp microscopy images showing effects of 3 sec freeze on rabbit 
cornea in vivo using 2.4 mm diameter/concave profile cryoprobe tip. 
(A) 24 h after freeze, central corneal thickness (CCT) is increased considerably 
(769 µm) compared to before freeze (383 µm) and the cornea is hazy, indicative of 
corneal endothelial damage, as well as epithelial and stromal cell damage. (B) 10 
days after a freeze injury (in a different animal) CCT was at normal levels. (C) This 
was the case also, 1 month after treatment. (B, C) Some corneal haziness at the 
level of the posterior stroma or Descemet’s membrane is evident at 10 days and 1 
month.
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Transcorneal freezing using 2.4 mm diameter concave cryoprobe revealed that 
one day after a 3-sec surface freeze the rabbit cornea had become 
significantly oedematous, with its thickness approximately twice the normal 
value (Figure 5.1 A). The central corneal thickness returned to normal values 
by day 10, and this was maintained up to one-month post-freeze (Figure 5.1 
C). Transcorneal freezing did not induce any general health adverse effects 
in rabbits. Slit-lamp images of three cryo-treated rabbit eyes showed some 
evidence of corneal haze at the level of the posterior stroma or Descemet’s 
membrane at 10 days and 1 month (Figure 5.1 B and C). 
Figure 5.2 TEM of the corneal epithelium (Ep), epithelial basement membrane 
(BM), and stroma (St) following a 3 sec transcorneal freeze injury using 2.4 mm 
diameter/concave profile cryoprobe on rabbit cornea in vivo. 
(A) The wound periphery surface at 24 hrs is epithelialized. Arrowheads indicate 
microvilli on the apical surface of epithelial cells. (B) Intact basement membrane is 
observed in the central freeze-injured area 24 hrs post-freeze. (C) After 24 hr 
freeze-injury, occasional focal regions of stromal matrix disruption were evident in 
the cornea, manifesting as tissue regions with increased spacing between collagen 
fibrils. (D) One month after the freezing, throughout the cornea, the spacing 
between collagen fibrils appeared normal. Scale bars, 1 µm (A, B) and 0.5 µm (C, 
D).
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TEM examinations of one rabbit cornea 24 hrs after transcorneal freeze 
indicated that the corneal epithelium peripheral to the wound area was 
structurally normal, with typical epithelial stratification, cell-cell contact and 
surface microvilli (Figure 5.2 A). In all likelihood, these healthy-looking cells, 
or a sub-set of them, are migrating inwardly to repopulate the denuded area 
of the central corneal epithelium. As expected, the corneal epithelium was 
severely damaged in the central freeze-injured region of the cornea. Notably, 
though, the corneal epithelial basement membrane remained intact, which 
presumably is important to aid subsequent epithelial resurfacing of the 
wound area (Figure 5.2 B). In the deep stroma, increased collagen fibril 
spacing and disorder in the collagen fibril arrangement were apparent 24 hr 
post-freeze (Figure 5.2 C), but this had resolved by the 1-month timepoint by 
Figure 5.3 TEM of corneal endothelium following a 3 sec transcorneal freeze injury 
using 2.4 mm diameter/concave profile cryoprobe on rabbit cornea in vivo. 
(A) An endothelial cell (Endo) at 24 h post- freeze in a region peripheral to the 
freeze-injured area appeared morphologically normal, with normal organelles and 
nucleus (n). It adhered to Descemet’s membrane (DM).  (B) Closer to the region 
below the cryoprobe surface application there were clear signs of cell damage. 
More centrally (C), the cell damage was more extreme revealing a bare 
Descemet’s membrane. (D) 30 days after the transcorneal freezing was performed, 
the central region of the inner cornea contained fairly normal endothelial cells that 
were sometimes accompanied by extracellular matrix material (white arrowheads) 
in the area posterior to Descemet’s membrane. Scale bar, 2 µm.
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which time the stromal architecture appeared normal (Figure 5.2 D). These 
structural matrix changes likely contribute to the increased corneal thickness 
and opacity seen at 24 hrs after transcorneal freeze (Figure 5.1 A). 
Similar to the epithelium, the corneal endothelium in the periphery of the 
cornea away from the region of the tissue under the surface wound zone 
remained unaffected 24 hrs after the transcorneal freeze of the central rabbit 
cornea (Figure 5.3 A). In this region, cells appeared morphologically normal 
with typical intracellular structures and were adhered to Descemet’s 
membrane. The endothelium more centrally, however, began to exhibit clear 
signs of damage (Figure 5.3 B), including the destruction of the cell 
membrane. The central endothelium (Figure 5.3 C) was found to be fully 
debrided with a bare Descemet’s membrane consistent with the SEM 
analysis of in vitro pig corneas (Figure 4.5). One month after the freeze the 
central corneal endothelium had re-attained its normal character, although 
occasionally fibrous tissue deposition between Descemet’s membrane and 
the recovered endothelium was observed (Figure 5.3 D). 
5.4 Discussion 
In the experiments described in this chapter describing the effect of 
transcorneal freezing on the corneas of three rabbits show that the central 
corneal epithelium was totally destroyed by the application of the cryoprobe. 
Of course, this would be fully expected. However, it is important to note that 
the corneal epithelial basement membrane remains intact (Figure 5.2 B). 
This apparent absence of epithelial basement membrane damage, based on 
TEM observations, will almost certainly be of benefit to the epithelial 
resurfacing of the debrided epithelial area. It is well known that corneal 
epithelial cells migrate inwardly from the limbal region at the edge of the 
cornea to continuously replenish the central superficial cells that are lost into 
the tear film as part of the natural turnover of the corneal epithelium 
(Kinoshita et al., 2001). After injury, the inward migration of corneal epithelial 
cells also occurs, and having an intact basement membrane as a substratum 
on which to recover an epithelium is postulated to be beneficial. Previous 
studies conducted as part of the long-term collaboration between eye 
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researchers in Cardiff and Doshisha universities indicated that corneal 
epithelial recovery following an experimental injury in which the corneal 
epithelial basement membrane is surgically removed takes around five days 
(Yamamoto et al., 2012). Unfortunately, this study is unable to provide 
comparable information about the early stage dynamics of epithelial 
resurfacing in the transcorneal freeze rabbit eyes, but the timeline is likely to 
be significantly shorter than that reported in the study by Yamamoto et al. 
(2012) because the corneal wound in their experiments was more substantial 
than the freeze wound described here, being 7.5 mm in diameter and 
including the removal of not only the epithelial basement membrane but 
some anterior stromal cornea too. That research also showed that the 
application of Y27632 ROCK inhibitor in eye drop form to the wounded 
corneal surface delayed, but did not prevent corneal epithelial resurfacing by 
a few days. Any delay in corneal epithelial recovery following transcorneal 
freezing is likely to be less pronounced owing to the retained epithelial 
basement membrane and the less extensive lateral extent of the initial 
wound. 
Signs of ultrastructural disruption in the extracellular matrix are apparent in 
the stroma after the in vivo rabbit freeze-injury, but these are transient, and 
the increased collagen fibril separation and disorganisation which are seen 
24 hrs after the treatment subsequently decrease as corneal thickness 
reduces. These results match those observed in earlier studies, where rabbit 
corneal endothelial cell density and thickness were reached normal values 
as prior to injury by day 13 following similar endothelial damage caused by 
transcorneal freezing (Van Horn et al., 1977; Staatz and Van Horn, 1980). 
The obvious conclusion is that the initial freeze damage to the corneal 
endothelium leads to corneal oedema (evident in the thickness 
measurements in Figure 5.1 A) and that the healing corneal endothelium 
recovers this. It should be noted that in vivo corneal endothelial wound 
healing studies in rabbits, such as those reported here, do not fully reflect 
the situation in the human cornea because of the manifestly different 
behaviour of the endothelial cells and their constrained replicative ability in 
humans (Van Horn et al., 1977). Pre-clinical experiments in primates closer 
replicate the situation in humans, and  have been conducted to examine new 
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corneal endothelial surgeries, but these are limited in number owing to 
ethical concerns (Okumura et al., 2013)  
My examinations of the rabbit cornea treated by transcorneal freezing and 
examined by TEM one month after treatment discloses the presence of 
fibrotic extracellular matrix in the region of Descemet’s membrane 
(Figure 5.3D). The presence of such an abnormal extracellular matrix is not 
totally unexpected, and such material has been fairly widely reported in rabbit 
corneas following a corneal wound (Leung et al., 2000) and in human 
corneas that had experienced prolonged wounding or undergone multiple 
surgeries (Jakobiec and Bhat, 2010). I postulate that the presence of 
abnormal fibrous tissue in the deep corneal stroma following transcorneal 
freezing likely contributes to the deep stromal haze seen in the cornea at this 
time. Additional light scatters owing to a refractive index mismatch between 
freeze-injured stromal keratocytes, and their immediate surrounding matrix 
might also contribute to the reduction in corneal transparency it should be 
noted though. A contribution to the loss of corneal transparency because of 
collagen fibril disorganisation, such as that illustrated in Figure 5.2 seems to 
be unlikely, as the fibril alterations seen in the early 24-hrs stages were not 
detected later at one month. 
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6.1 Introduction 
It has been identified that the Rho subfamily of serine-threonine kinases, 
known as Rho GTPases, regulate numerous signal transduction pathways 
common for numerous critical cell activities in the body. One of the best 
characterised downstream pathways of the Rho GTPases is Rho-associated 
coiled-coil kinase (ROCK) that is known to play an essential role in signal 
transduction pathways common for numerous vital activities in cell life cycle. 
The most well-described roles of these molecules include regulation of 
intracellular actin cytoskeleton dynamics responsible for the shape and size 
of a cell as well as cell polarity, motility, adhesion, migration, proliferation, 
and apoptosis (Hodge and Ridley, 2016). 
Chapter 6: The Effect of ROCK Inhibitor on 
Injured Corneal Endothelial Cells 
Figure 6.1 Schematic diagram of ROCK protein consisting of N-terminal kinase 
domain followed by a coiled-coil region including receptor binding domain (RBD), a 
C-terminal cysteine-rich domain (CRD), and a pleckstrin homology (PH) domain. 
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The ROCK gene is located in chromosome 18 and encodes 1354 amino 
acids. Having 158 kDa of molecular mass, a ROCK protein contains an 
amino-terminal kinase domain, followed by a mid-coiled-coil forming region 
including a Rho-binding domain (RBD) and a carboxy-terminal cysteine-rich 
domain (CRD) located in plekstrin homology (PH) domain (Sebbagh et al., 
2001). Several molecules regulate ROCK pathway via these multiple contact 
point domains. The activity of Rho-associated kinases is regulated by signals 
originating from various surface receptors such as G-protein-coupled, 
cytokine receptors, adhesion receptors. Molecular studies suggest that 
ROCK controls myosin light chain (MLC) phosphorylation which in turn 
switches on myosin ATPase to enhance production of energy and ability of 
cell contraction (Lai, Hsieh and Chang, 2003).  
Recently, there is mounting interest in investigating the potential effects of 
employing the inhibition of the ROCK molecules to normalise cell activities, 
especially in diseased corneal endothelial cells (Okumura et al., 2009, 2012; 
Li et al., 2013; Pipparelli et al., 2013; Peh et al., 2015). Y27632 is a specific 
inhibitor of the ROCK signalling pathway that has been demonstrated to 
promote cell proliferation and adhesion of corneal endothelial cells, while 
restraining apoptotic process (Okumura et al., 2011, 2013). However, the 
underlying mechanisms of action of their ROCK inhibitor remain unclear.  
Based on the current understanding of the literature, it is expected that 
blocking the Rho-kinase signalling pathway using the selective ROCK 
inhibitor, Y27632, will accelerate endothelial cell migration for wound healing 
and suppress apoptosis following a damage. In order to test this, the current 
work attempts to elucidate the effect of the active treating agent, Y27632, on 
in vitro scrape and UV injured rabbit corneal endothelium by using the 
expression of related proteins that were analysed by confocal microscopy. 
This study would also bring more understanding on the regenerative 
mechanism of the Y27632 by investigating the ultrastructural changes in 
endothelial cells after treatment via inspection of the cells by transmission 
electron microscopy. 
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The study reported here was carried out as part of a collaboration between 
my group in Cardiff University and that of Professor Noriko Koizumi and Dr 
Naoki Okumura in Doshisha University, Kyoto, Japan, who have performed 
extensive research on the subject of blocking Rho-kinase signalling pathway 
for treating corneal endothelial dysfunctions. 
6.2 Materials and Methods 
6.2.1 Experimental models 
To mimic pathologic changes that may affect the corneal endothelium as a 
result of cataract surgery, transcorneal freezing, or FECD, damage was 
induced by setting up two types of in vitro rabbit corneal endothelial injury 
models: 1) a mechanical scrape of the exposed corneal endothelial surface; 
2) exposure of the endothelium to the ultraviolet light (UV) irradiation. In both 
situations, this was followed by treatment with Y27632 ROCK inhibitor at a 
concentration of 10 µM. To bring more understanding of the regenerative 
influence of the active agent, Y27632, on the damaged endothelium, the 
status of the endothelial cells and their ultrastructures were evaluated using 
immunohistochemistry and transmission electron microscopy. Vehicle-
treated rabbit corneas were used as negative controls. In total ten in vitro 
corneas of New Zealand white rabbits were used in this study. The 
experiments were performed in duplicate. All animals that were used in this 
study were handled in accordance with the ARVO Statement for the Use of 
Animals in Ophthalmic and Vision Research.  
6.2.2 Experimental methods 
To obtain the corneas, rabbits were first euthanized by an intravenous 
injection of pentobarbital sodium solution (Somnopenthyl, Kyoritsu Yakuhin 
Corporation) into a marginal ear vein (64.8 mg/kg of body weight). Eyes were 
enucleated within 5 minutes after the euthanasia, and corneas excised and 
cultured in growth medium consisting of Dulbecco's modified Eagle’s 
medium (DMEM) with streptomycin (Nacalai Tesque) + 1% Penicillin-
streptomycin.  
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Scrape wound injury on rabbit corneal endothelium 
To have enough samples for the examinations and to reduce the number of 
rabbits used for the experiments, each cornea was bisected (endothelial side 
to epithelial side), then cut in quarters with a razor blade. A half of each 
cornea was prepared for the immunohistochemistry, and the other half was 
prepared for electron microscopy. To create an injury, a straight mechanical 
scrape wound was then created on the endothelial side of each corneal piece 
using a tip of 10 mL plastic pipette to bare the Descemet’s membrane. 
Figure 6.2 Schematic diagram of scrape injury experiment.
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Following a mechanical scrape, corneas were transferred into a well plate 
containing culture medium of DMEM + 1% Penicillin/Streptomycin with or 
without Y27632 and incubated for 3 and 24 hours.  
Immunostaining with Phalloidin – DAPI stain kit 
To evaluate the cell response to the Y27632 treatment, the contraction of the 
scrape wound, and endothelial cell features were monitored using 
immunohistochemical analyses at various times of incubation.  
To visualise the endothelial cell nucleus and cytoskeleton, scrape-injured 
corneas were stained using binding buffer (1% bovine serum albumin 
(BSA)): DAPI: Phalloidin 546 (Alexa Fluor, Invitrogen, USA) at ratio 
1000:1:2.5 after the 3 and 24 hours of Y27632 treatment. The samples were 
first fixed in 4% paraformaldehyde in PBS for 10 minutes at room 
temperature. The specimens were then washed in PBS three times gently, 
not to further damage fragile endothelial cells. Specimens were then 
incubated in 0.5% Triton solution in PBS for 5 minutes after washing with 
PBS. This was followed by placing the corneas in a blocking solution of 1% 
BSA for 60 minutes at room temperature. Finally, after blocking step, the 
samples were placed in DAPI/Phalloidin in 1% BSA for 60 minutes, followed 
by embedding on a glass microscope slide ready to examine by confocal 
Figure 6.3 Schematic diagram of scrapes (orange) on each quarter of a rabbit 
corneal endothelium.
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microscopy. For the control, organ culture medium without the ROCK 
inhibitor was used. 
Ultraviolet (UV) injury on rabbit corneal endothelium 
UV light is suggested to be relatively safe in small portions, such as 60 J/cm2. 
In humans, 0.33 J/cm2 intensity is used during corneal cross-linking 
treatments, which is considered nontoxic for the corneal endothelium. 
However, when the exposure is increased over 70J/cm2, the survival of the 
endothelial cells decreases due to its destructive effect on cell DNA 
(Lichtinger et al., 2011). To cause experimental damage to corneal 
endothelial cells via UV radiation, we chose the fluence of 100J/cm2. 
However, in an attempt to prevent complete endothelial cell death and 
increase chances of survival of some endothelial cells, corneas in this group 
were pre-treated in a culture medium comprising of DMEM with the Y27632 
ROCK inhibitor (10 µm) for 2 hours at 37◦C. After the pre-treatment in the 
medium, corneas were gently washed by dipping them in a PBS solution. To 
induce the endothelial cell injury, irradiation of UV light of 100 J/cm2 in UPV 
CrossLinker CX-2000 for 5 seconds was used.  
Detection of apoptosis and necrosis in vitro using immunostaining with 
annexin V – propodium iodide (PI) stain kit. 
To test the protective effect of the Y27632 ROCK inhibitor, endothelial cell 
death as a response to the UV irradiation was examined on in vitro rabbit 
cornea after 3, 6, and 24 hours of incubation, with or without the ROCK 
inhibitor, by immunohistochemical analysis. To evaluate the apoptotic and 
necrotic cell status, related antibody markers (annexin V and propidium 
iodide, respectively) were used (Medical and Biological Laboratories Co. 
LTD) at a ratio of 100:1:2.5. A stain solution with a binding buffer of 250 mL 
per well was prepared, and the specimens thereafter gently washed twice in 
Figure 6.4 Schematic diagram of UV-induced damage on corneal endothelium (the 
endothelial side facing upwards). 
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PBS. The corneas were then fixed in 4% paraformaldehyde for 10 minutes. 
After additional washing with PBS corneas were incubated in 0.5% Triton, 
followed by blocking with 1% BSA for 60 minutes at room temperature. 
6.2.3 Confocal fluorescence microscopy 
Following treatment, experimental and control corneas were investigated by 
confocal fluorescence microscopy (Leica Microsystems Confocal 
Microscope) along with Leica Application Suite AF software. Before 
examining the samples, Beam Paths (Scans 1-5) were chosen according to 
the staining. Once the area of interest was found and the z-stack adjusted, 
digital images were acquired. 
6.2.4 Transmission electron microscopy (TEM) 
To examine the ultrastructural changes in corneal endothelial cells following 
both scrape and UV-induced injuries, and following treatment with Y27632 
ROCK Inhibitor, images of the same samples were obtained by TEM. For 
this, Y-27632-treated and vehicle-only corneas were immersed in a fixative 
Figure 6.5 Schematic diagram of UV injury experiment.
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solution of 2.5% glutaraldehyde and 2% paraformaldehyde in 0.1 M in 
Sorensen buffer for 2 hours at room temperature on a rotator. Following initial 
fixation, the specimens were rinsed with 0.1 M Sorensen buffer and then 
fixed with a fresh solution of 2.5% glutaraldehyde and 2% paraformaldehyde 
in 0.1 M in Sorensen buffer and stored in glass bottles in at 4 degrees C prior 
to dehydration, infiltration, and polymerisation with resin, sectioning, and 
staining steps described in detail in the Chapter 3.2.2. 
6.3 Results 
This section presents a comparison of Y27632-treated and vehicle-treated 
corneas following endothelial injury in vitro as examined by 
immunohistochemistry and electron microscopy imaging.  
6.3.1 Confocal microscopy 
Results below compare confocal micrographs of the wounded endothelial 
cells that were incubated with or without the presence of the Y27632 ROCK 
inhibitor. 
 
Figure 6.6 Immunohistochemical image of rabbit corneal endothelium observed via 
confocal microscopy. 
Cell cytoskeleton (red fluorescence) and cell nuclei (blue fluorescence) in scraped 
wound areas of a corneal endothelium incubated for 3 hours with or without 
Y27632 are shown. The scrape wound area is visibly narrower in the Y27632-
treated corneal endothelium (lower row panel) compared to the control (upper row 
panel). The width of scrape wound edges treated with Y27632 measured 295.5 
µm, compared to 606.9 µm in the control cornea. Scale bar, 100 µm.
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Figure 6.7 Higher magnification of immunohistochemical analysis via confocal 
microscopy revealing the cell cytoskeleton and nuclei in scraped wound areas in 
samples incubated with or without Y27632 for 3 hours.  
Elongation of endothelial cells adjacent to the wound edge can be seen in the 
Y27632-treated corneal sample. The control sample (upper panel) seems to have 
tightly compacted endothelial cells and enlarged cells at the immediate edge of the 
wound. Scale bar, 100 µm.
Figure 6.8 Low magnification confocal micrograph showing endothelial cells 
following a mechanical scrape incubated for 24 hours in the presence or absence 
of the ROCK inhibitor Y27632.  
The lower panel shows that the endothelial cells assume a fibroblast-like irregular 
in shape when treated with Y27632. In the vehicle-treated sample (upper row), 
there seem to be less fibroblast-transformed cells and more hexagonal shaped 
cells characteristic of normal endothelial cells. Scale bar, 100 µm. 
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Summary for confocal microscopy results on scraped injured corneas 
The results obtained from the immunohistochemistry analysis of scrape-
injured corneas are presented in Figures 6.6–6.9. To assess the healing 
effect of ROCK inhibitor at covering the defect after a mechanical scrape, the 
gaps between two opposite wound edges were measured by ImageJ 
software (Figure 6.6). This showed that the wound had contracted to by 
about half in the presence of Y27632, (i.e. 295.5 µm compared to 606.9 µm 
in the control wound). Furthermore, in Figure 6.7, phalloidin staining shows 
that the cytoskeleton of the cells immediately adjacent to the wound edge 
appear to be altered from characteristic hexagonal shape to elongated shape 
in the presence of Y27632. In the control sample, the cells at the edge of the 
wound appear to be slightly enlarged in size. Closer inspection of this data 
also shows that endothelial cells retain their cell-cell contact in the vehicle-
treated cornea and that more loose cells are seen in the ROCK inhibitor-
treated cornea.  
After 24 hour incubation, differences in wound areas were not obvious 
between the Y27632 and vehicle-treated groups. However, differences in the 
Figure 6.9 Higher magnification confocal micrograph showing outlines of 
endothelial cells following a mechanical scrape incubated for 24 hours of the 
treatment with (lower row) and without (upper row) ROCK inhibitor following a 
mechanical scrape injury. 
The Y27632-treated cells appear irregular shape, while the cells of the control 
sample have a typical endothelial hexagonal mosaic pattern. Scale bar, 100 µm. 
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morphological pattern of the cell cytoskeleton were more apparent compared 
to those that were incubated for 3 hours (Figures 6.8, 6.9). Corneas that were 
incubated with the ROCK inhibitor seemed to have a higher prevalence of 
contact inhibited fibroblastic-like cell phenotype, whereas in the control group 
the endothelial cells tended to retain the classic hexagonal outline.  
  
Figure 6.10 Immunohistochemical detection of apoptotic (green fluorescence) and 
necrotic (red fluorescence) endothelial cells after 3-hour incubation without [upper 
panel Y(-)] and with [lower panel Y(+)] Rho-kinase inhibitor, Y27632.  
Actin cytoskeleton stained with purple phalloidin dye, demonstrated a hexagonal 
mosaic of the endothelial cells. It is evident that there were less apoptotic cells in 
the presence of Y27632 compared to the control of corneal endothelium after 3-
hour incubation. Scale bar, 100 µm.
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Figure 6.11 Further fluorescent staining of endothelial cells showing apoptotic and 
necrotic cells after 6-hour incubation with [Y(+)] or without [Y(-)] ROCK inhibitor. 
A decreased expression of apoptotic and necrotic markers was evident in Y27632-
treated corneal endothelium. Scale bar, 100 µm. 
Figure 6.12 Immunoreactivity of apoptotic and necrotic endothelial cells after 24-
hour incubation with or without ROCK inhibitor. 
Similar to 3 and 6 hours post-treatment, more endothelial cells were damaged in 
the corneal samples incubated in the absence of the Y27632. Scale bar, 100 µm. 
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Immunohistochemical investigation of the corneal endothelial surface 
indicated that the incubation with ROCK inhibitor reduced cell death caused 
by UV irradiation in rabbit corneal endothelium. As shown in Figure 6.10, the 
Y27632-treated endothelial cells had a higher survival rate even after the first 
3-hour treatment, suggesting that cell death is delayed in the presence of 
Y27632. As seen in the merged panel, the same cells were stained with both 
PI and annexin V. Being a membrane-impermeable dye, PI only enters the 
cell in membrane breakdown, meaning that the UV-induced apoptotic cells 
that were stained by annexin were in the late stage of the apoptosis and had 
irreversible damage to the cell membrane.  
Further incubation for 6 hours led to more cell deaths in the control group, 
but not in the Y27632-treated group where the amount of cell death remained 
at the minimal level in the presence of the ROCK inhibitor. From the Figures 
6.10-12 above, it can be seen that the proportions of cells stained for 
apoptosis and necrosis increased in vehicle-treated corneas in a time-
dependent manner following UV irradiation, even in the ROCK inhibitor-
treated cornea (Figure 6.12). The growing number of dead cells with time 
was expected due to a gradual deterioration of cells in the culture medium.  
Analysis of corneas from ten animals showed that the UV light caused 
selective cell death of endothelial cells and, most importantly, that these 
apoptotic and necrotic cells were visibly reduced when the ROCK inhibitor 
was present in the culture medium throughout all incubation time periods of 
3, 6, and 24 hours. These data suggest that Y27632 treatment prolongs cell 
survival by inhibiting cell death in rabbit corneal endothelium. 
6.3.2 Transmission electron microscopy (TEM) 
Results below compare electron micrographs of the wounded cells that were 
incubated with or without the presence of the Y27632 ROCK inhibitor. These 
TEM images refer to the same samples as in confocal micrographs above. 
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Figure 6.13 Transmission electron micrographs of scraped rabbit corneas after 3-
hour incubation in culture medium without (A, B) or with (B, D) ROCK inhibitor at 
low and high magnifications showing what looks like the edges of the scrape 
wounds with endothelial cell with filopodia. 
The part of the cytoplasm that attaches to Descemet’s membrane (DM) has low 
contrast (arrowheads). The nuclei (N) appear normal. The low electron density 
areas have swollen endoplasmic reticulum in cells near the wound edge. Scale 
bar, 1 µm. 
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Summary of TEM results for scraped injury 
Transmission electron microscope results of scrape-injured rabbit corneal 
endothelium treated with or without ROCK inhibitor, Y27632, can be 
compared in Figures 6.13-14. Figure 6.13 shows what seems like a 
demarcated edge of the scrape wound in corneas that were treated for 
Figure 6.14 Low and high magnifications of endothelia that were induced by using 
a scrape wound after 24 hours in culture medium without (A, B) and with ROCK 
inhibitor treatment (C, D).  
Panels A and B show cells that look like normal endothelial cells with normal nuclei 
(N) and cell structure, although detached from the Descemet’s membrane (DM). C 
and D show corneal endothelial cells following 24-hour-treatment with ROCK 
inhibitor revealing an altered phenotype, with cells that appear thinner and have 
extended protrusion towards the adjacent cell (C). Also, the Y27632-treated 
endothelium (C, D) seems to have more than one cell layer. Arrows indicate to low 
electron dense cell layer (degenerating cell) between Descemet’s membrane that 
is covered with another cell layer. Higher magnification transmission electron 
microscopy shows an elevated number of mitochondria in endothelia of both 
groups (B, D). Corneal endothelial cells treated with ROCK inhibitor show more 
elongated and enlarged mitochondria compared to the control. Scale bar, 1 µm. 
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3 hours. The endothelial cell with the filopodia appears to be edging toward 
the wound site in the control sample, although the apparent elongation of the 
endothelial cell is not visible in the Y27632-treated cornea. The images 
indicate that the region of the cell that attaches to Descemet’s membrane 
has a low electron density, whereas the other side of the cells appears to 
have high electron density.  
Further incubation for 24 hours with ROCK inhibitor showed cells that appear 
to be thinner and create more than one layer covering the degenerating cells 
(Figure 6.14). The figure also shows an endothelial cell that seems to have 
extension protruding towards a neighbouring cell where it is migrating on top 
of the deteriorating cell. Higher magnification micrographs of 24 hour-
incubated corneas showed an increased number of enlarged mitochondria 
in both Y27632 and vehicle-treated cells, suggesting their elevated activity 
(Figure 12 B, D). No abnormal change in the nucleus or endoplasmic 
reticulum in either vehicle or Y27632-treated corneal endothelial cells was 
observed after 24 hours of incubation following scrape injury. As shown in 
Figure 6.14 D, there was a clear thinning of endothelial cells after ROCK 
inhibitor treatment. Thus, ROCK inhibitor treatment in vitro changes the 
ultrastructure of corneal endothelial cells, and the changes include cell 
thinning and elongation as well as abundant mitochondrial activity.  
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Figure 6.15 Transmission electron micrographs showing endothelial cells 3 hours 
after UV irradiation followed by vehicle-treatment (upper panel - A, B) and ROCK 
inhibitor-treatment (lower panel - C, D).  
Panel A shows a cell-free area on the vehicle-treated cornea and detached cellular 
organelle remnants are visible floating underneath bare Descemet’s membrane 
(DM) in the cornea treated without the ROCK inhibitor. Lower panel, which was 
treated with the ROCK inhibitor the endothelial cells appear thicker compared to 
control sample (upper panel). Panels C and D show that some endothelial cell 
structures are still attached to Descemet’s membrane in Y27632-treated corneas, 
despite having altered morphology (blebs). Scale bar, 1 µm. 
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Summary of results of the UV-injured cornea 
Following UV-injury, pathologic changes in endothelial cell morphology are 
seen (e.g. Figure 6.15), and this is evident to varying degrees including in 
cells treated for 3 hours in the presence of ROCK inhibitor. Fluctuating 
cellular organelles are evident, suggesting cell damage. This is most likely a 
consequence of the destructive imprint of UV light leading to plasma 
membrane breakdown and leakage of components of the cell underneath 
Figure 6.16 Transmission electron micrograph showing vehicle-treated (A, B) and 
Y27632-treated (C, D) rabbit corneal endothelial cells 24 hours following UV 
exposure.  
In panels A and B the endothelial cells seem to have separated from Descemet’s 
membrane (DM). The organelles of the vehicle-treated rabbit cornea (A, B) 
appeared normal. Higher magnification of rabbit corneal endothelial cells shows 
regularly sized mitochondria (M) and endoplasmic reticulum (ER). In ROCK 
inhibitor-treated sample (C and D), the endothelial cells seem to have two layers 
instead of one, with a low electron dense cell layer close to Descemet's membrane. 
In panel C, there is an artefact of staining covering Descemet’s membrane. Scale 
bar, 1 µm. 
Chapter 6. Effect of ROCK inhibitor 
   
104 
Descemet’s membrane. In contrast, micrographs in Figure 6.15 C, D 
demonstrate that numerous endothelial cells survived the UV impact in the 
Y27632-treated cornea, despite some morphological alteration. Figure 6.15 
B, D compares the 3 hour treated corneas at higher magnification and 
reveals that endothelial cells survived better in the presence of the ROCK 
inhibitor compared to the control group. Vehicle-treated posterior cornea 
(Figure 6.16 A, B) appears similar to a normal endothelial cell, apart from the 
fact that it is detached from Descemet's membrane, unlike the Y27632-
treated cornea (Figure 6.16 C, D). What is interesting in the ROCK inhibitor-
treated sample, is that the endothelial cell has an altered ultrastructure, 
appearing thinner and more elongated and covering a degenerating cell 
underneath.  
6.4 Discussion 
Previous studies demonstrated the enhanced migration of corneal 
endothelial cells in a culture to cover a linear defect (Okumura et al., 2011, 
2014). As was expected, the results of confocal microscopy in this study 
suggested that the wound healing rate through the migration of rabbit corneal 
endothelial cells was accelerated when subjected to ROCK inhibitor 
treatment following an injury compared to wound healing in control vehicle-
treated corneas. Transmission electron micrographs also indicated that 
endothelial cells transformed their phenotype to more fibroblast-like cells. 
Fibroblast-like morphological changes and a proliferative effect of the ROCK 
inhibitor, Y27623, in corneal endothelial cells were also reported previously 
in corneal endothelial cell cultures by Li (2013) and Okumura (Okumura, 
Okazaki, et al., 2015), suggesting that the Y27632 may inhibit cell-cell 
contact between endothelial cells and allow them to transform into thin, 
active, elongated cells, which likely have an increased cell motility to promote 
wound healing.  
The role of the ROCK kinase as a regulator of cell cytoskeleton architecture 
through downstream molecules such as myosin light chain (MLC) activity is 
well recognised. MLC is phosphorylated by ROCK activity resulting in the 
contraction of a cell by actin, with a myosin interaction area sacrificing their 
neural-crest-like phenotype (Kimura et al., 1996). Possibly, there are various 
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other effectors of ROCK kinase that are also involved in endothelial cell 
behaviour resulting in wound healing. For example, LIM kinase, which can 
also contribute to the actin cytoskeleton reorganisation and cell shape 
transformations through cofilin phosphorylation (Maekawa, 1999). These 
signalling pathways may explain the prevalence of a fibroblast-like cell 
phenotype exhibited by the endothelial cells treated with the Y27632. The 
epithelial-mesenchymal transition (EMT) may also reflect the increased motility 
of the cells (Savagner, 2001). One of the features of the EMT transformation is 
the loss of cell-cell contact due to disruption of intercellular junctions, which may 
explain the enhanced wound contraction encouraged by application of the 
ROCK inhibitor to a wounded endothelium, by perhaps triggering active 
endothelial cells to migrate to the wounded cell-free area. Similar cellular 
transformations in the endothelium were observed in ROCK inhibitor-treated 
corneas in rabbits, as well as in glaucoma patients that showed temporary 
guttae on clinical observation (Okumura, Okazaki, et al., 2015). However, the 
abnormal cell transformation was transient, and a normal cell phenotype was 
regained once the administration of the Y27632 was discontinued. Perhaps, 
after discontinuing ROCK inhibitor administration, the endothelial cells slow 
down their motility and migration and reconnect to adjacent cells using typical 
proliferation mechanism through stretching.  
Both in scraped and UV injured endothelial cells, the detachment of 
endothelial cells from Descemet’s membrane was evident in the control 
samples. This could be an artefact of physical handling during cutting 
corneas or tissue preparation for microscopy. However, most likely, the 
attachment of the endothelial cells to the Descemet’s membrane on Y27632-
treated samples suggests that the cells are better adhered with the ROCK 
inhibitor. The increase in endothelial cell adhesion by ROCK inhibitor is also 
supported by previous studies (Okumura et al., 2009, 2012; Pipparelli et al., 
2013). 
The next question this study sought to address was the possible protective 
effect of Y27632 ROCK inhibitor against the UV radiation. Findings of TEM 
showed that despite the same pre-treatment, more endothelial cell death was 
seen in the vehicle-treated corneas compared to those treated in the 
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presence of Y27632. This occurred at all time-points. This suggests that the 
ROCK inhibitor slows down the apoptotic mechanism in endothelial cells 
induced by UV exposure. A possible explanation for this might be that the 
inhibition of the ROCK signalling pathway acts as a survival signal, defending 
cells from the activation of apoptosis. This effect could potentially occur 
through the activation of complex cellular signalling that involves caspase 3 
induced apoptosis (Liu et al., 2016). Lack of internal survival signals 
combined with an external damage-provoking agent like excess UV 
irradiation, leading to subcellular reaction such as cell shrinkage may also be 
involved in FECD endothelial cell death. One possible implication of this is 
that ROCK inhibitor applied as a preventative measure may help reduce 
endothelial degeneration, particularly in elderly patients with the 
predisposition for FECD who had extended exposure of their corneas to UV 
light during their lifetime.  
Clearly, there are differences in cell stress induced by FECD and UV, such 
as the initiation of guttae in the central cornea during FECD, while in our 
experiment the cells were damaged regardless of which area of the corneal 
endothelium, central or peripheral, in which they existed. The nature of the 
pathology of FECD which starts centrally would allow the possibility of 
removing the diseased endothelial cells in the central corneal region by 
transcorneal freezing for subsequent application of the ROCK inhibitor 
treatment, as discussed earlier in this thesis. According to clinical studies, an 
injury itself (e.g. scraping, stripping) can initiate the proliferative reaction of 
the endothelial cells, where corneal transparency can be recovered following 
descemetorhexis procedures or subsequent to detached endothelial grafts 
(Zafirakis et al., 2010; Shah, Randleman and Grossniklaus, 2012; Kymionis 
et al., 2017). Nevertheless, it appears that in the presence of ROCK inhibitor, 
the recovery of a corneal endothelial wound is enhanced.  
It is widely accepted that, unlike humans, rabbit corneal endothelial cells 
have the regenerative ability in vivo (Van Horn et al., 1977). Although animal 
organ culture may be a better approximation to the human endothelial 
environment in vivo than cell culture systems, my findings may be somewhat 
limited by in vitro conditions, fairly small sample size, and the likelihood that 
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the effect of ROCK inhibitor on rabbit cells will differ from those of human 
cells in vivo. It has been shown, however, that human cultured endothelial 
cells have proliferative activity in vitro (Joyce and Harris, 2010; Peh et al., 
2015). Also, clinical study shows that human corneal endothelial cells can 
regenerate with the help of ROCK inhibitor in vivo when there is sufficient 
endothelial reserve to help the defect areas to be covered (Koizumi et al., 
2013). 
Another possible limitation is that damage caused by a scrape wound and 
by FECD might elicit a different endothelial response. In FECD, cells start to 
degenerate from the central corneal endothelium, and are not removed from 
the surface completely as was the case in the scrape injury. Endothelial 
injuries similar to the mechanical scrape are sometimes caused by cataract 
surgery (Lundberg, Jonsson and Behndig, 2005). It can therefore be 
assumed that patients who have undergone cataract surgery, which result in 
complications associated with traumatic endothelial cell loss could possibly 
benefit from the ROCK inhibitor to promote regeneration and, eventually, 
reduce the demand for donor corneal transplantation.  
To conclude, the results of the present experiments confirm that ROCK 
inhibitor, Y27632, can promote the proliferative ability of endothelial cells, 
provide cell adhesion to Descemet’s membrane, and extend the survival rate 
of corneal endothelial cells. Findings in this chapter propose that ROCK 
inhibitors that are used for therapeutic or research purposes are agents that 
have the potential to be involved in innovative treatments for corneal 
endothelial dysfunctions as FECD. These results confirm that the therapeutic 
use of Y27632 can be a promising approach to help regenerate cells in FECD 
patients where central endothelial cells need replacement due to 
degeneration. For this, an approach like transcorneal freezing, as described 
in the previous chapter, can be used to remove the deteriorating cells and 
then administer the ROCK inhibitor treatment as a solution to repair the 
defect faster. 
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The overarching purpose of the research described in this thesis was to 
consolidate and improve our knowledge of corneal endothelial cell behaviour 
during development, maturity and disease, and to investigate the potential of 
transcorneal freezing as a minimally invasive approach to destroy 
dysfunctional/diseased corneal endothelial cells in corneas that are 
oedematous and hazy due to endothelial pathology. The proliferative and 
protective efficiency of a ROCK inhibitor, Y27632, was also studied in an 
attempt to help discover the effects of alternative treatment procedures for 
corneal dysfunctions such as FECD.
The first experimental chapter describes corneal development because it has 
been reported that wound healing in the mature cornea recapitulates some 
events in corneal embryogenesis (Cinrron, Covingron and Kublin, 1990). 
This provided baseline knowledge of corneal endothelial development, and 
also revealed features such as cell processes and extracellular matrix strings 
projecting from emerging endothelial cells in embryonic avian cornea at E4.5 
using large-volume 3D reconstructions from SBF-SEM. Cell processes 
extended from the emerging corneal endothelial cells towards both primary 
stroma (distally) and the lens (proximally), while the matrix strings were 
observed extending through the loose collagenous matrix of the primary 
stroma up to the basement membrane of epithelium. The corneal 
endothelium assumes its typical morphology as development proceeds, 
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becoming an interlinked monolayer. The role of the matrix strings in corneal 
development and their impact on the endothelium is currently unknown; 
further studies using SBF-SEM and other techniques might clarify the 
situation more fully. 
Following the investigation of the corneal endothelium in development (using 
the well-established chick model), TEM inspections of this cell monolayer in 
human corneas were conducted. This demonstrated changes in intracellular 
organelles within corneal endothelial cells of patients who received a corneal 
transplantation for FECD, supporting the hypothesis that ER stress has some 
involvement in FECD pathogenesis. Given the multifactorial nature of human 
disease, however, is likely that various other factors may be involved in the 
development of FECD and the precise mechanisms are yet to be 
determined.  
Subsequent to the inspection of corneal endothelial development (in 
embryonic chick cornea) and changes during pathology (in FECD in human 
cornea), an investigation into the effects of a newly designed cryoprobe for 
removing endothelial cells via transcorneal freezing was conducted. The 
results demonstrated (see Appendix (Akhbanbetova et al., 2017)) that the 
use of a 3.4 mm diameter cryoprobe with a concave profile, amongst other 
designs tested, was the optimal tool to consistently destroy endothelial cells 
in the central cornea, proposing the reliability of a minimally invasive 
procedure for removing FECD-diseased cells to stimulate healthy peripheral 
endothelial migration and subsequent treatment. Experiments also indicated 
that transcorneal freezing permitted the ingress of agents into the corneal 
stroma (see Appendix (Chan, Akhbanbetova, A. J. Quantock, et al., 2016)). 
The question, then, was how to encourage healthy corneal endothelial cells 
outside the diseased are to migrate and repopulate the central area of the 
inside of the cornea from which the diseased cells had been removed. To 
investigate this, in vivo studies on rabbit corneas demonstrated the extent of 
damage on other corneal layers affected by the freezing in the central region. 
The study suggested that the fast recovery of the epithelial cells was likely 
because the basement membrane remained intact. As expected, cells of all 
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corneal layers (epithelium, stroma, and endothelium) had recovered in the 
central zone within one-month post-freeze. The efficacy of the simple 
transcorneal freezing procedure for endothelial cell removal should be further 
studied in more sophisticated animal models and attempts made to prevent 
occurrence of fibrous tissue. 
In conclusion, the application of Y27632 ROCK inhibitor enhances cell 
migration, adhesion, and cell survival in the corneal endothelium. It is likely 
that the ROCK inhibitor administration might be beneficial in assisting the 
restoration of mild endothelial dysfunctions such as early-stage FECD or 
cataract-surgery-related trauma (bullous keratopathy). Considering the 
typical age group of the late-stage FECD with lower proliferative endothelial 
capacity, additional cell-based therapy via in vitro cultured endothelial cell 
injection might be inevitable. The precise mechanism of these activities in 
endothelial wound healing is still yet to be understood and needs to be 
studied further. Conventional transmission electron microscopy and 
SBF/SEM could be useful approaches to visualise the bigger picture of 
endothelial cell injuries treated with the ROCK inhibitor, where interactions 
between migrating cells could be examined. Also, the long-term medical 
effect of Y27632 would need to be studied following treatment. Potentially, 
though, transcorneal freezing followed by ROCK inhibitor treatment would be 
simple, minimally invasive, and cost-effective approach for FECD treatment.
Figure 7.1 Schematic diagram of possible future work. 
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The application of inhibitors of the Rho kinase pathway (ROCK inhibitors) to the surface of the eye in the form of
eyedrops has beneﬁcial effects which aid the recovery of diseased or injured endothelial cells that line the inner
surface of the cornea. The aim of this study was to test the plausibility of delivering a selective ROCK inhibitor, Y-
27632, to the cornea using a thin polymeric ﬁlm. Mucoadhesive polymeric thin ﬁlms were prepared incorporat-
ing Y-27632 and diffusional release into PBS was determined. Topical ocular delivery from the applied ﬁlm was
investigated using freshly excised porcine eyes and eyedrops of equivalent concentration acted as comparators;
after 24 h the formulationswere removed and the corneas extracted. Drug-loaded thinpolymericﬁlms,with high
clarity and pliability were produced. ROCK inhibitor Y-27632 was weakly retained within the ﬁlm, with release
attaining equilibrium after 1 h. This in turn facilitated its rapid ocular delivery, and an approximately three-fold
greater penetration of Y-27632 into cryoprobe-treated corneas was observed from the thin ﬁlm (p b 0.01) com-
pared to eyedrops. These ﬁndings support the further development of ROCK inhibitor delivery to the cornea via
release from thin mucoadhesive ﬁlms to treat vision loss cause by corneal endothelial dysfunction.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
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1. Introduction
The cornea of the eye, which is just over 0.5 mm thick in humans,
owes its transparency to the characteristic spatial arrangement of its
constituent collagens and other extracellular matrix components
which make up much of its thickness (Knupp et al., 2009; Meek and
Knupp, 2015). Lining the inner surface of the cornea is a single layer of
metabolically active endothelial cells which separate the corneal matrix
from the adjacent aqueous humor and prevent the ingress of ﬂuid into
the cornea (Hodson and Miller, 1976). If the endothelial cell layer is
compromised the cornea swells and becomes oedematous, scatters
light and loses its transparency. This results in severe vision loss and
in most cases the only option is corneal transplant surgery. Typically,
corneal endothelial dysfunction occurs because of an inherited disease
called Fuch's endothelial corneal dystrophy (FECD) inwhich corneal en-
dothelial cells deteriorate or are lost over the years. It can also occur as a
result of accidental damage to the corneal endothelium during cataract
surgery to remove or replace the lens of the eye, and this condition is
often referred to as bullous keratopathy. Either way, the endothelial
cell damage causes cornea to imbibe excess ﬂuid and swell, making
the cornea appear hazy (Fig. 1) clouding vision (Fig. 2) (Heiting, 2015;
Royal National Institute of Blind People, 2015).
Techniques to treat vision loss caused by corneal endothelial dysfunc-
tion include an anterior corneal micropuncture and laser treatment to
puncture the corneal epithelium. Although these procedures can be effec-
tive they carry a high risk of rejection and sometimes result in complica-
tions including corneal perforation and scarring (Rahman et al., 2008).
But, by far the most common treatment for corneal endothelial dysfunc-
tion is a corneal graft, and the numbers of surgeries performed indicate
the scale of the problem. The prevalence of FECD, generally, is estimated
to be around 4% of individuals over the age of 40, but in inbred American,
Singaporean and Icelandic populations this rises to 22%, 7% and9% respec-
tively (Zoega et al., 2006; Eghrari et al., 2012; Kitagawa et al., 2002).
In terms of drug therapy, the ROCK signaling pathway has received
recent attention in light of the diverse therapeutic potential of changing
cell behaviour in various diseases such as hypertension, vasospasm, and
glaucoma (Arnold et al., 2013); andmore recently FECD (Koizumi et al.,
2013; Okumura et al., 2009, 2011, 2013, 2015; Nakagawa et al., 2015).
ROCK inhibitors are protein serine/threonine kinases with various func-
tions throughout the body (Riento and Ridley, 2003). Out of several dif-
ferent ROCK inhibitors with different therapeutic effects (Liao et al.,
2007; Wang and Chang, 2014), a selective ROCK inhibitor Y-27632
was reported to have promoted the proliferation of corneal endothelial
cells in vitro (Okumura et al., 2009) and the healing of the corneal endo-
thelium in vivo (Okumura et al., 2011). Sufﬁcient corneal endothelial
cell density is crucial for the ionic pump and barrier functions
(Okumura et al., 2013), which in FECDwould lead to an increased over-
all cell size and cell shape alteration, resulting in endothelial
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dysfunction, and it was reported that Y-27632 was able to enhance cell
density to the normal levels and resume the pump and barrier function,
providing a functional recovery of the cornea. Koizumi et al. (2013) re-
ported that some patients with FECD could be treatedwith ROCK inhib-
itor Y-27632 eye drops subsequent to transcorneal freezing to destroy
damaged corneal endothelial cells.
The delivery of drugs to the eye is basically divided into three routes;
topical, systemic and intraocular. The intraocular route involves an injec-
tion into the eye or use of implants, which is surgically fairly invasive,
carries the risk if infection and is seen undesirable by patients. Systemic
delivery is inefﬁcientwith potential unwanted side effects. The topical de-
livery of drugs to the eye is thus judged to be an attractive route. Examples
of topical delivery include the use of eye drop solutions, ointments, sus-
pensions and emulsions. Eye drops arewidely used, but are easilywashed
out by blinking and nasolacrimal drainage; this means that only a small
amount of the applied dose is likely to penetrate the cornea. Ointment,
suspension and emulsion formulations are widely reported to cause ocu-
lar adverse effects, which include irritation and visual disturbance (Patel
et al., 2013). Studies have been carried out on alternative topical ap-
proaches such as theOCUSERT® system, Topical Opthalmic DrugDelivery
Device,medicated contact lenses and intraocular lenses (Morrison, 2015).
However, none of these approaches are available commercially on the
market. In this study, we investigated an alternative approach based
upon drug-eluting thin polymeric muacoadhesive ﬁlms that afﬁx to the
cornea, in an effort to improve the drawbacks of currentmethods. Our ap-
proach could conceivably lead to amore efﬁcacious and user-friendly de-
vice capable of targeted delivery of ROCK inhibitors to attain improved
clinical effect. Such therapy would also minimize wastage of costly
ROCK inhibitor and avoid potential toxicity from dosing other tissues un-
necessarily, in particular the tear duct and nasal cavity. Therefore, the hy-
pothesis of this study is that topical delivery of ROCK inhibitor Y-27632
from thin mucoadhesive ﬁlms is a superior alternative to eye drops for
trans-corneal drug delivery. This study aimed to test the plausibility of
topical delivery to the cornea from polymeric ﬁlms by the fabrication of
appropriate ﬁlms, determination of drug release and ﬁnally the determi-
nation of trancorneal drug delivery in vitro.
2. Materials and methods
2.1. Materials
ROCK inhibitor Y-27632 dihydrochloride (MW 247.3) was obtained
fromApexBio Technology LLC (Houston, US). Acetonitrile (HPLC grade),
water (HPLC grade) and phosphate buffered saline (PBS) tablets were
obtained from Fisher Scientiﬁc (Loughborough, UK). Methylene blue
(MW 319.9), polyethylene glycol 400 (PEG 400) and triﬂuoroacetic
acid (≥99.0%) were from Sigma-Aldrich Company Ltd. (Poole, UK).
Carbopol 917 (CP) was a gift from Noveon Inc. (Cleveland, U.S.) and
hydroxyproplymethyl cellulose (HPMC) was a gift from Shin-Etsu
Chemical Co. Ltd. (Tokyo, Japan). Porcine eyeballs were obtained from
a local abattoir by blunt dissection, immediately following slaughter.
2.2. Preparation of thin ﬁlms
Ingredients were weighed into a 250 mL conical ﬂask as detailed in
Table 1 to provide a 1% w/v polymeric solution loaded with either 1.7,
5.2 or 10 mg Y-27632·2HCl; the aqueous solubility of Y-27632·2HCl is
reported as 14 mg/mL (Santa Cruz Biotechnology) and that of methy-
lene blue 43.6 mg/L (Pubchem). The mixtures were stirred overnight
on a magnetic stirrer at room temperature. The following day, the mix-
tures were placed in an ultrasonic bath for 2 h to further assist particle
comminution, and to degas the solution. Next, 50 mL of the solutions
were poured into Petri dishes and left to dry in an oven overnight set
at 60 °C. Once completely dry, the clear ﬁlms were carefully removed
from the petri dish and checked for any imperfections – those that
had bubbles or crystals were discarded.
2.3. Diffusional release from thin ﬁlms
Ten 0.5 × 0.5 cm patches were excised from each drug loaded ﬁlm
and each patch was accurately weighed before being immersed in
1 mL of PBS solution in an Eppendorf tube for various durations (10 s,
20 s, 30 s, 1 min, 2 min, 5 min, 30 min, 1 h, 3 h and 6 h). The patches
were then carefully removed from the PBS solutionwith forceps. The re-
maining solutions were transferred to autosampler vials, prior to analy-
sis by HPLC (Section 2.8). The diffusional release was carried out over
the timescale of up to 6 h to broadly simulate an overnight dosage
Fig. 1. Corneal haze of Fuchs Dystrophy.
Fig. 2. The hazy and clouded vision of a Fuchs patient (left) as compared to normal vision.
Table 1
Working formulae to produce methylene blue and ROCK inhibitor Y-27632 ﬁlms.
Film Working formula
Methylene blue HPMC 0.175 g
PEG 400 0.25 g
CP 0.075 g
Methylene blue 0.01 g
DI H2O to 50 mL
ROCK inhibitor Y-27632 10 mg HPMC 0.175 g
PEG 400 0.25 g
CP 0.075 g
Y-27632·2HCl 10 mg
DI H2O to 50 mL
ROCK inhibitor Y-27632 5.2 mg HPMC 0.175 g
PEG 400 0.25 g
CP 0.075 g
Y-27632·2HCl 5.2 mg
DI H2O to 50 mL
ROCK inhibitor Y-27632 1.7 mg HPMC 0.175 g
PEG 400 0.25 g
CP 0.075 g
Y-27632·2HCl 1.7 mg
DI H2O to 50 mL
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application. Preliminary method development experiments were car-
ried out with methylene blue ﬁlm.
2.4. Transcorneal freezing of porcine eyes
Transcorneal freezing has been used as a therapeutic modality prior
to Y-27632 application in the formof eye drops (Koizumi et al., 2013). In
the experiments described here, to test if cryoprobe-treated eyeballs
achieved a better ingress of drug, transcorneal freezing was conducted
(Fig. 3) by gently touching the tip of a newly designed cryoprobe onto
the surface of freshly obtained porcine eyeballs for 3 s, which we have
shown to be optimal to produce reliable and reproducible areas of cor-
neal endothelial cell death. The cryoprobe tip is 3.4 mm in diameter
and reaches−50 °C via the internal expansion of a cryogen (medical
grade nitrous oxide), and is made of silver for heightened thermal con-
ductivity. Six of 12 eyeballs used for the experiment underwent
transcorneal freezing and six did not.
2.5. Formulation of eye drops
Eyedrops of equal concentration to themethylene blue and ROCK in-
hibitor Y-27632 ﬁlm were formulated to act as a control. The working
formulae of the eyedrops are detailed in Table 2. The concentration of
Y-27632 incorporated was designed to replicate the concentration
used previously, which is 10 mM (Koizumi et al., 2013).
2.6. Ocular delivery from applied formulations, in vitro
Freshly excised porcine eyeballs were placed, cornea uppermost, in a
6-well cell culture plate. Circular patches, 1 cm in diameter, were ex-
cised from the medicated (methylene blue or Y-27632) mucoadhesive
ﬁlms (n = 3) using a cork borer and applied to the corneas, which
had beenwetted beforehandwith 300 μL PBS, and a combination of cap-
illarity and ﬁlm deformability ensured contact with the cornea. Eye
drops of equal concentration were also applied to porcine eyeballs as a
comparator (n= 3 for Y-27632, n= 2 for methylene blue). To simulate
blinking and tearing, the eyes were periodically irrigated with 300 μL
isotonic PBS. Y-27632 eye drops were used based on the dosing proce-
dure reported by Koizumi et al. (2013), in which 50 μL of 10 mM Y-
27632 was applied six times a day. To limit dehydration the eyeballs
were placed in PBS, such that the solution reached half way up the eye
(not contacting the cornea). The set-up was covered with a plastic lid
to retainmoisture andwas incubated in awater bath at 37 °C overnight.
The eyes were periodically bathed with aliquots of PBS in an effort to
simulate tears (Chan et al., 2014).
After 24 h, ﬁlmswere carefully removed from the corneas using ﬁne
forceps and the corneal surface of eye-drop treated eyes were gently
wiped with cotton buds. Corneas were then excised from the eyes and
each was cut into small pieces before being comminuted to a ﬁne pow-
der using a mortar and pestle after being frozen in liquid nitrogen. The
powders were carefully recovered and extracted into water after
placing on a rotating blood tube mixer overnight. Tubes were then cen-
trifuged at 5750 rpm for 30 min, the supernatant decanted and evapo-
rated at 60 °C in an oven. The residue was reconstituted in 1 mL of
deionised H2O, prior to analysis by HPLC.
2.7. HPLC analysis of methylene blue and ROCK inhibitor Y-27632
The concentration of methylene blue and ROCK inhibitor Y-27632
released from each ﬁlm and extracted from each cornea was quantiﬁed
by reverse phase HPLC using an Agilent series 1100 HPLC system, ﬁtted
with a Phenomenex Kinetex 5μ C18 100 Å 150× 4.6mmcolumn, eluted
with a mobile phase comprised of H2O:ACN (50:50 v/v) with 0.5% of
TFA. The ﬂow rate was 1mLmin−1. For methylene blue thewavelength
was 246 nm and the retention time 3.9 min; for Y-27632 the wave-
length was 270 nm and retention time was 1.5 min. Calibration curves
of methylene blue and ROCK inhibitor Y-27632 were constructed
using standard solutions over the concentration range of 1–
3.91 × 10−3 mM. The linearity of the curves was as follows: R2 =
0.9999 for methylene blue; 0.9997 for Y-27632.
2.8. Statistical analysis
All data were analyzed using an InStat 3 statistical package
(GraphPad Software Inc., San Diego, CA, U.S.A). Comparisons of concen-
tration released from formulations into native and cryoprobe-treated
corneas were determined using ANOVA (Analysis of variance) and
Kruskal-Wallis post-tests, where p b 0.05 was considered statistically
signiﬁcant.
3. Results and discussion
3.1. Film preparation
Initially, a blank ﬁlm (i.e. not loaded with any medication) was pro-
duced and was found to have good clarity, transparency and pliability,
with the entire ﬁlm weighing approximately 500 mg and having an av-
erage thickness of 0.1mmasdetermined using a digitalmicrometer. Re-
covery (ﬁlm mass/total mass of additives except water) was 98.3%.
Representative images of the ﬁlms loaded with methylene blue or
ROCK inhibitor Y-27632 are shown in Fig. 4(a) and (b), respectively.
The ﬁlms appeared optically clear and were approximately 0.1 mm
thick. Both ﬁlms were pliable, which is important as they are to ﬁt
well to the curved cornea. Also, it was encouraging to ﬁnd no evidence
of drug crystals in theﬁlms at the levels added. Crystalswould be poten-
tially damaging to the cornea and would lead to unpredictable drug re-
lease rates.
Homogeneity and recovery were determined by sampling 5 × 1 cm
diameter patches from across the ﬁlm, dissolving in water and assaying
for drug by HPLC – no statistically signiﬁcant differences were found
(not shown). The recovery of the methylene blue ﬁlm was 111.8%
while the recovery of the Y-27632 ﬁlm was higher at 129.3%. Stability
was determined by sampling the ﬁlm stored at room temperature
over an 8 week period and assaying, again with no statistically signiﬁ-
cant differences found. The recovery of the medicated ﬁlms was higher
than that of the blank ﬁlm probably because the drugs attract a hydra-
tion shell, resulting in a higher water content. In the case of Y-27632,
which was added as the hydrochloride salt, the positive charge would
Fig. 3. Thaw forming in themiddle of the eyeball, showing transcorneal freezing has taken
place.
Table 2
Working formulae of methylene blue and ROCK inhibitor Y-27632 comparator eyedrops.
Eyedrops Working formula
Methylene blue Methylene blue 87.7 mg
DI H2O to 5 mL
ROCK inhibitor Y-27632 Y-27632 16 mg
DI H2O to 5 mL
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attract evenmorewatermolecules. This analysis is supported by the fact
that increasing the drying timedid not signiﬁcantly reduce the recovery.
The polymers hydroxyproplymethyl cellulose (HPMC), polyethylene
glycol 400 (PEG 400) and Carbopol 917 (CP) were used in the ﬁlm-
forming excipients described here. The suitability of a HPMC ﬁlm as a
drug vehicle considered several factors, such as the mechanical proper-
ties, the swelling of ﬁlms, and in vitro and in vivo bioadhesion evalua-
tions (Peh and Wong, 1999). Compared to SCMC (sodium
carboxymethyl cellulose) ﬁlm, another polymer, HPMC ﬁlms were
shown to possess a greater bioadhesive strength value in vivo, and
were reported to be tougher and more elastic. Consequently, we decid-
ed to use HPMC as our drug vehicle in this study. Moreover, PEG 400, a
commonly used solubilizer which exists in liquid form,was included for
its plasticizing properties, giving softness and pliability to the ﬁlms to
their ﬁtting to the curved corneas. In previous experiments, PEG of a
lower molecular weight (b300) had produced tough, brittle ﬁlms that
would not be suitable for ophthalmic applications (unpublished data).
Our use of PEG 400 is supported by the work of Llabot et al. (2007)
who revealed that its addition to ﬁlms enhancedmucoadhesion as com-
pared to the ﬁlm without it. This can be explained by the diffusion the-
ory of bioadhesion (Chickering and Mathiowitz, 1999) in which the
intra-chain polymeric interaction is reduced in the presence of plasti-
cizers, increasing the ﬂexibility of the chains. This would result in
strengthened mucoadhesive interactions by increasing the inter-pene-
tration and entanglement of bioadhesive polymer chains with mucin.
Carbopol is another polymer used to develop our polymeric ﬁlm. It is a
high molecular weight polymer containing a high content of carboxylic
groups (Rowe et al., 2012), which is believed to contribute to the
mucoadhesiveness of the ﬁlm (Chickering and Mathiowitz, 1999).
Carbopol plays an important role in increasing the softness, elasticity
and bioadhesive strength of polymeric ﬁlms (Lubrizol, 2015). Each of
the polymers used is an approved excipient. In conclusion, the combina-
tion of HPMC, PEG 400 and CP provided homogeneous, stable, soft, pli-
able and mucoadhesive ﬁlms, which are crucial properties of a viable
product.
3.2. Diffusional release
Diffusional release is the processwhereby drugmolecules spontane-
ously migrate from the polymeric system to the exterior of the polymer
and then into the releasemedium (Langer, 1990), which in our casewas
PBS to provide a basic model for tears. The diffusional release proﬁles of
loaded drug characterize the amount of drug released from the ﬁlm as a
function of time into a given receivingmedium. Low release is indicative
of low drug loading or interaction and extensive retention of loaded
drug within the ﬁlm matrix; whilst this can reduce the dose delivered,
it can also provide zero-order release. Zero-order kinetics is generally
desirable in drug delivery systems,where drug levels releasedwould re-
main constant throughout the delivery period (Ummadi et al., 2013).
This is generally considered to be important in improving therapeutic
outcomes and patient compliance and it also reduces the frequency of
drug administration (Gokhale, 2014), which is discussed in Section
3.5. On the other hand, high release gives rise to ‘burst’ kinetics, and re-
ﬂects excess drug added and/or weak retentionwithin the polymerma-
trix – it is generally considered undesirable in drug delivery devices as it
would not provide sustained release; furthermore excess drug is often
present as crystals.
3.2.1. Methylene blue ﬁlm
The purpose of producing a ﬁlm containing methylene blue was to
provide a model solute which was visible to the naked eye and allowed
us to develop the ﬁlm production technique – it is however, also used
clinically as a photosensitizer (Tardivo et al., 2005). A diffusional release
proﬁle of methylene blue was constructed as cumulative mass and
moles released, normalized per amount of ﬁlm, hence, mass
(mg drug mg−1 of ﬁlm) and amount (μMol mg−1 of ﬁlm) released are
presented as a double-Y plot in Fig. 5; for further comparison purposes
the percentage released (%) is also shown in Fig. 7 over the timescale of
6 h to reﬂect an overnight application. The intensity of the blue colora-
tion of the receiving PBS solution visibly increased the longer the ﬁlm
was retained in the Eppendorf tube. From this observation it is deduced
that an increased concentration of methylene blue diffused into PBS so-
lutionwith increased contact time. Thiswas veriﬁed following quantita-
tive analysis by HPLC analysis as shown in Fig. 5, where the
concentration of methylene blue released from ﬁlm increased with in-
creased immersion time. Fig. 5 shows an initial linear, or 0-order, rela-
tionship between cumulative amount and mass within the ﬁrst
60min. The rate constant, as determined from the plot gradient, was de-
termined to be 0.0448 mg min−1. The steady state phase was followed
by a tailing off due to drug depletion. Methylene blue was detected in
the ﬁrst sample taken at 10 s as 0.22 μMol mg−1 (0.07 mg mg−1) and
at 6 h was 48.84 μMol mg−1 (15.62 mg mg−1).
3.2.2. ROCK inhibitor Y-27632 ﬁlm
Diffusional release proﬁles of ROCK inhibitor Y-27632 were con-
structed as cumulativemass (mgmg−1 of ﬁlm) (Fig. 6a) and percentage
released (%) (Fig. 6b). For further comparison purposes the percentage
released (%) is also shown in Fig. 7. Drug was detected in the ﬁrst sam-
ples taken at 10s (10 mg ﬁlm; 1.94 mg mg−1: 5.2 mg ﬁlm; 1 mgmg−1:
1.7 mg ﬁlm; 0.99 mg mg−1), with release increasing rapidly until it ap-
proaches equilibrium between 40 and 60 min (10 mg ﬁlm; approxi-
mately 11.5 mg mg−1: 5.2 mg ﬁlm; 9 mg mg−1: 1.7 mg ﬁlm;
2.5 mg mg−1). Thereafter, there was no major increase, and both
amount and mass are proportionate to each other. Fig. 6 shows the cu-
mulative concentration and mass of Y-27632 released over the 6 h test
period. It is immediately apparent that the release proﬁle for Y-27632
differed markedly to that of methylene blue, in that there was no
Fig. 4. (a) Methylene blue ﬁlm. (b) ROCK inhibitor Y-27632 ﬁlm.
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major steady state phase. Instead, there was a rapid rise or burst within
the ﬁrst 10 min.
The diffusional release of Y-27632 was replicated using three con-
centrations of Y-27632 ﬁlms; 10 mg, 5.2 mg and 1.7 mg. The difference
in concentrations has resulted in the difference in mass of Y-27632 re-
leased (Fig. 6a), so that the higher the concentration of Y-27632 within
the ﬁlm, the higher the mass of drug released. Interestingly, the
difference between the 10 mg ﬁlm and the 5.2 mg ﬁlm was not large
(the difference in mass was mostly kept within 2 mg mg−1). However,
the 10 mg ﬁlm showed a clearer burst release. Mass released from the
1.7mg ﬁlmwasmuch lower than the others where the highestmass re-
leased was only 2.8 mgmg−1, but the overall release pattern was simi-
lar to both 5 mg and 10 mg ﬁlms. Though concentrations varied, the
percentage releasedwas fairly similar (Fig. 6b). All three concentrations
Fig. 5. Double Y-plot of methylene blue cumulative mass and μMol released over the timescale of 6 h, and normalized in terms of the mass of the ﬁlm sample (n = 3 ± SD).
Fig. 6. (a) Cumulative drug release from thin ﬁlms loadedwith 1.7, 5.2 and 10mg ROCK inhibitor Y-27632 over 6 h and normalized in terms of themass of the ﬁlm sample (n= 3± SD);
(b) percentage of drug released from thin ﬁlms loaded with 1.7, 5.2 and 10 mg ROCK inhibitor Y-27632 over 6 h (n = 3 ± SD).
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showed rapid release up to approximately 70% within 30 min with a
maximum release ≥80%. As the release kinetics were greatest from the
10 mg ﬁlm, this was chosen to progress to the in vitro ocular delivery
experiment.
3.3. Comparison of methylene blue and ROCK inhibitor Y-27632 release
Fig. 7 shows that both methylene blue and ROCK inhibitor Y-27632
were released from respective ﬁlms up to approximately 90% after 6 h
- the pathways appear very different, although further work will be
needed to conﬁrm this. High release indicates low retention of drug in
the polymericﬁlms,which is due to swelling andwould be cost effective
by reducing wastage of drugs to a minimal level. Y-27632 was found to
be more weakly retained within the polymeric ﬁlm than methylene
blue, meaning it is more easily released, allowingmore Y-27632 to pen-
etrate the cornea; hence, a burst release from Y-27632 was observed. It
is worth noting that the release of Y-27632 depleted after 40 min (ap-
proximately 80% has been released), which could have the potential
beneﬁt of getting more drugs into the eyes rapidly. While methylene
blue displayed zero-order release kinetics over the 6 h timescale, Y-
27632 showed mixed-order release, reaching equilibrium within
50 min. It is deduced that this is due to the lack of interaction of Y-
27632 with the ﬁlm polymers. It is assumed that methylene blue is
able to form stronger bonds with the polymers (Chickering and
Mathiowitz, 1999) and that this results inmore entrapment in the poly-
meric ﬁlm. It is also hypothesized that the burst release of Y-27632 was
facilitated by its low molecular size and the presence of the charge,
which the recovery data (Section 3.1) showed attracted more water.
This, in turn, accelerated release of the hydrated complex into the aque-
ous receiving medium. It should also be borne in mind that such rapid
release may be a concern if it gives rise to toxic levels in vivo (Shively
et al., 1995; Jeong et al., 2000).
On a side note, methylene blue is used clinically as a visual guide
during surgery or endoscopy (Tardivo et al., 2005), and is also a thera-
peutic agent for various conditions, including ifoasfamide-induced en-
cephalopathy (Patel, 2006) and methemoglobinemia (Sikka et al.,
2011) - the current delivery data of methylene blue using the thin
ﬁlm has potential relevance in such procedures.
3.4. Transcorneal freezing
As mentioned, transcorneal freezing achieved by touching the cor-
neal surface with a cold probe can cause corneal endothelial cell
death, either by forming intracellular ice that is lethal to the cell or by
the formation of extracellular ice, which will create an osmotic
imbalance leading to an increase in intracellular electrolytes and the
collapse of cellular membranes. It was previously reported that corneal
endothelial cells are expected to proliferate at the frozen wound sites
after cryotherapy (Buco et al., 1978; Staatz and Van Horn, 1980), and
potentially the application of Y-27632 eye drops enhances this recovery
(Koizumi et al., 2013). Fig. 8 shows a picture taken upon the excision of a
cryoprobe-treated cornea to which a methylene blue ﬁlm had been ap-
plied. From this observation it was evident that penetration of methy-
lene blue occurred predominantly at the centre of the cornea where
transcorneal freezing took place.
3.5. Corneal penetration
As the corneal endothelium is the target site for Y-27632 following
its surface application, it was important to ensure that the drug is pen-
etrating towards the back of cornea to reach endothelial tissue. Since
Y-27632 is colourless, methylene blue ﬁlm was used as a model. Fig. 9
shows a schematic diagram of the cornea throughout its full thickness
alongside a lateral view of the cornea from a cryoprobe-treated eyeball
under a microscope. The endothelium is stained blue, depicting that
drug is penetrating well through the cornea from the epithelial surface
where the patch had been positioned on eye.
3.6. Ocular drug delivery
Koizumi et al. (2013) reported some patients with FECD who were
successfully treatedwith ROCK inhibitor Y-27632 eye drops subsequent
to transcorneal freezing to remove diseased anddamaged corneal endo-
thelial cells. While the reported results are encouraging, the eye drop
application was repeated six times a day for 7 days. Eye drops have
long been used to treat ocular pathology and injury, however, it is wide-
ly appreciated that upon application an eye drop dose is rapidly elimi-
nated by dilution and washing out by tears and nasolacrimal drainage
mechanisms. More often than not the instilled dose that enters ocular
tissue is less than 1% (Morrison, 2015). Furthermore, ROCK inhibition
is known to have a hypotensive effect and vascular resistance, which
would result in potential adverse effects on unwanted systemic expo-
sure (Hahmann and Schroeter, 2010). Another reported adverse effect
of ROCK inhibitor eye drop application is ocular hyperemia because
ROCK inhibitors are vasodilators, and this has been evident in ongoing
clinical trials (Tanihara et al., 2013; Zhang et al., 2012). Drug wasted
via eye drop delivery also represents sub-optimal drug therapy for the
patient. Hence, the potential beneﬁt of the development of a
mucoadhesive ﬁlm that is capable of sustained delivery of higher
doses, speciﬁcally targeting the corneal endothelium.
Fig. 7. Diffusional release proﬁles of methylene blue versus ROCK inhibitor Y-27632 in
percentage released (%) (n = 2 or 3 ± SD).
Fig. 8. Delivery of methylene blue to a cryoprobe-treated porcine cornea.
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3.7. Run off and wash away
Run off of the dose applied as eyedrops is a well-known aspect of
this mode of delivery and was vividly depicted in this work involving
methylene blue (Fig. 10). In the experimental setup used, it was a
challenge to accurately mimic the washing out action of tears and
blinking. However, during the experiment the porcine eyeballs
were periodically irrigated with 300 μL PBS in an effort to crudely
simulate washing out. This revealed that methylene blue was visibly
washed away on wetting as the intensity of the blueness decreased
(as shown in Fig. 10). Methylene blue in ﬁlms, on the other hand,
remained and the drug did not drain away appreciably even after ir-
rigation. This indicates a major advantage delivery via mucoadhesive
ﬁlms over eyedrops, whereby drug run off and washing away by
tears are reduced, with the drug being retained at point of
application.
3.8. Delivery of methylene blue to the cornea
The delivery ofmethyleneblue fromﬁlmand eye drops of equal con-
centrations to untreated in vitro porcine corneas and cryoprobe-treated
porcine corneas (n = 2 or 3; ±SD) is shown in Fig. 11. It can be seen
that methylene blue delivered from the thin ﬁlm (0.072 mMol in un-
treated cornea and 0.081 mMol in cryoprobe-treated cornea) was sig-
niﬁcantly greater than the amount delivered from liquid eye drops
(0.046mMol in untreated cornea and 0.066mMol in cryoprobe-treated
cornea) for both untreated (p b 0.01) and cryoprobe-treated corneas
(p b 0.05). The ﬁlm delivered signiﬁcantly more methylene blue to the
cryoprobe-treated corneas as compared to native corneas (p b 0.05)
and this was even more apparent for the eye drop-delivered agent
(p b 0.0001). This is probably a consequence of the cryoprobe-treated
corneas being more “leaky” owing to a modulation or disruption the
cell and matrix components of the cornea cause by tissue freezing,
which allows more drug to penetrate.
3.9. Delivery of ROCK inhibitor Y-27632 to the cornea
The corneal delivery of ROCK inhibitor Y-27632 from ﬁlms and eye
drops of equal concentration into native unfrozen porcine corneas and
cryoprobe-treated porcine corneas (n = 2 or 3 ± SD) are shown in
Fig. 12. It can be seen that for cryoprobe-treated corneas, the rapid dif-
fusional release (Section 3.2.2) wasmanifested in the delivery of almost
3 times more Y-27632 (0.52 mMol) when compared to delivery via the
equivalent eye drop solution (0.177 mMol) (p b 0.01). For native cor-
neas, Y-27632 delivered from the thin ﬁlmwas greater than from liquid
eye drops, although this was not statistically signiﬁcant (p N 0.05). The
ﬁlms delivered signiﬁcantly more Y-27632 to the cryoprobe-treated
corneas (0.52 mMol) as compared to native corneas (0.23 mMol)
(p b 0.01). The eye drops appeared to deliver more Y-27632 across the
cryoprobe-treated corneas, although thiswasnot statistically signiﬁcant
(p N 0.05). Prior to the development of a 10 mM Y-27632 ﬁlm, a lower
concentration Y-27632 ﬁlm was produced (containing 10 mg of Y-
27632). The delivery onto the cryoprobe-treated corneas of this was
much lower (0.083 mMol) due to the lower concentration of the ﬁlm
(n = 3 ± SD).
Y-27632 has been reported to have no direct toxicity or signiﬁcant
effects on cell proliferation (Honjo et al., 2007), and a protective effect
was observed for mouse motoneurons in a cytotoxicity assay following
Y-27632 treatment (Günther et al., 2014). A clinical study involving an-
other ROCK inhibitor, SNJ-1656 proved that it is a safe topical agent and
effective in reducing intraocular pressure in the eyes of human volun-
teers (Tanihara et al., 2008).
4. Conclusions
This study has compared drug delivery to the cornea achieved via
eye drops or release frommucoadhesive thin ﬁlms. Initially, methylene
blue as a model agent, followed by 10 mMol of selective ROCK inhibitor
Y-27632, which is a drug used to treat vision loss caused by corneal en-
dothelial dysfunction as would occur in FECD and/or bullous
Fig. 9. Schematic diagram of the cornea layers and a microscopy lateral view of the cornea from a cryoprobe-treated porcine eyeball.
Fig. 10. Porcine eyeballs treated with ﬁlm patch (upper) or equivalent ‘eyedrop’ solution (lower) immediately after application (left). Lower left clearly shows run off of signiﬁcant
amounts of MB immediately following application. Lower right shows that upon irrigation further MB is washed away from the eyeball dosed with eyedrops. In contrast, upper right
shows no detectable wash out of MB from applied ﬁlms following irrigation (3 determinations).
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keratopathy. Themajor conclusions are: (1) drug delivery to the cornea
via thin mucoadhesive ﬁlms is a superior alternative to eye drop deliv-
ery because (at equal concentrations) signiﬁcantly higher concentra-
tions of Y-27632 were observed in the cornea after delivery from thin
ﬁlms compared to delivery via eye drops. This suggests the delivery of
ROCK inhibitor from thin mucoadhesive ﬁlms may produce better clin-
ical results compared to eye drops. (2) thin mucoadhesive ﬁlms have
advantages over eye drops in that dose is well retained at point of appli-
cation on thin ﬁlm application, whereas eye drops are easily washed
away by tearing and blinking of eyes. (3) thin ﬁlms result in a 3-times
higher delivery of Y-27632 over and above that achieved by eye drop
delivery on cryoprobed-treated corneas. This suggests that targeted de-
livery of Y-27632 to the cryoprobe-treated, freeze-damaged tissue at
the front of the cornea allows the ROCK inhibitor to penetrate more
readily into and across cornea. Thus, a combination of transcorneal
freezing and topical application of ROCK inhibitor via thin ﬁlms is a po-
tential non-invasive approach to deliver relatively higher concentra-
tions of drugs into the corneal endothelium. In summary, ﬁndings
from this study support the further development of mucoadhesive
thin ﬁlms as a modality for the targeted delivery of ROCK inhibitors to
the cornea (with or without transcorneal freezing) to treat corneal en-
dothelial dysfunction. The approach also has wider potential in the
use of thinmucoadhesive ﬁlms as an alternative to eye drop application
in other scenarios, and could possibly apply to other ocular diseases by
incorporating other disease-target drugs.
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Purpose. To examine the eﬀects of transcorneal freezing using a new cryoprobe designed for corneal endothelial surgery.Methods.
A freezing console employing nitrous oxide as a cryogen was used to cool a series of diﬀerent cryoprobe tip designs made of silver
for high thermal conductivity. In vitro studies were conducted on 426 porcine corneas, followed by preliminary in vivo
investigations on three rabbit corneas. Results. The corneal epithelium was destroyed by transcorneal freezing, as expected;
however, the epithelial basement membrane remained intact. Reproducible endothelial damage was optimally achieved using a
3.4mm diameter cryoprobe with a concave tip proﬁle. Stromal edema was seen in the pre-Descemet’s area 24 hrs postfreeze
injury, but this had been resolved by 10 days postfreeze. A normal collagen ﬁbril structure was seen 1 month postfreeze,
concurrent with endothelial cell repopulation. Conclusions. Transcorneal freezing induces transient posterior stromal edema and
some residual deep stromal haze but leaves the epithelial basement membrane intact, which is likely to be important for corneal
re-epithelialization. Localized destruction of the endothelial monolayer was achieved in a consistent manner with a 3.4mm
diameter/concave proﬁle cryoprobe and represents a potentially useful approach to remove dysfunctional corneal endothelial
cells from corneas with endothelial dysfunction.
1. Introduction
Corneal transparency is maintained in the healthy eye by a
monolayer of endothelial cells on the inner surface of the
cornea. Even though human corneal endothelial cells do
not possess the capacity for proliferation in vivo, the endo-
thelium as a whole has a functional reserve to cope with cell
loss via the spreading and enlargement of cells adjacent to
those lost [1, 2]. Excessive endothelial loss and deterioration
caused by eye pathologies such as Fuchs’ endothelial corneal
dystrophy (FECD), however, lead to corneal edema, cloud-
ing, and eventually loss of vision. FECD is a progressive
degenerative disorder that is a major indication for corneal
transplant surgery. Surgical intervention in the form of a
full-thickness-penetrating keratoplasty—or more commonly
nowadays a posterior lamellar graft—is the main treatment
option. But, despite the success of corneal graft surgery, some
questions about the long-term survival of the donor tissue [3]
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and the recurring problem of suﬃcient tissue availability
remains. These limitations have led researchers to seek
potential alternatives to corneal transplantation to treat
corneal endothelial dysfunction.
One promising route involves the use of selective inhibi-
tors of the Rho kinase pathway. The so-called ROCK inhibi-
tors regulate the actin cytoskeleton and inﬂuence vital cell
activities such as motility, proliferation, and apoptosis [4].
Owing to their demonstrable value, numerous studies have
been conducted in recent years which focus on the eﬀect of
ROCK inhibitors on corneal endothelial cells both in vivo
and ex vivo [5–9]. One approach involves transcorneal freez-
ing to damage corneal endothelial cells in the central portion
of the cornea in patients with FECD followed by the topical
delivery of a ROCK inhibitor, Y27632, in the form of eye
drops to encourage peripheral endothelial cells that had been
unaﬀected by the freeze injury to repopulate the central zone
of the corneal endothelium [10–12]. Freeze damage is
achieved by application of a cold probe to the corneal surface.
Another approach involves cell injection therapy whereby
cultivated human corneal endothelial cells are injected into
the anterior chamber of the eyes with FECD in a suspension
that includes Y27632 ROCK inhibitor [13]. This agent has
also been tested in the form of eye drops as a long-term
pharmacological treatment for bullous keratopathy [14].
A small series of ﬁrst-in-man surgeries to test the concept
of transcorneal freezing followed by short-term ROCK inhib-
itor eye drop application for the treatment of FECD was
conducted a few years ago and showed promise [10–12]. In
this approach, the tip of a stainless steel rod, 2mm in diam-
eter, was immersed in liquid nitrogen at −196°C before being
applied to the surface of the central cornea for an arbitrarily
chosen time of 15 sec. The assumption was that central cor-
neal endothelial cells located underneath the cold-rod appli-
cator would be destroyed by freeze injury, although this could
not be directly conﬁrmed in the human subjects because the
cloudy FECD corneas did not allow a view of the endothe-
lium by specular microscopy. The freezing of corneal tissue
has also been used as a modality to induce an injury to facil-
itate basic research into corneal wound healing [15–28]. If
corneal freezing is to be used in a clinical setting, however,
(either for the destruction of diseased cells in the central
endothelium prior to ROCK inhibitor eye drop application
for FECD as described above or to pretreat the cornea prior
to targeted drug delivery to combat conditions such as fungal
keratitis) we contend that it needs to be achieved in a more
sophisticated, reliable, and reproducible manner than that
achieved with an immersion-cooled steel rod. Here, we
report the development and validation of a new cryoprobe
based on the expansion of nitrous oxide as a cryogen and
its eﬀect, in vitro and in vivo, on the corneal epithelium,
stroma, and endothelium.
2. Materials and Methods
2.1. Cryoprobe Development. A console that uses nitrous
oxide as a cryogen was manufactured in conjunction with a
series of cryoprobes with newly designed tips, some of which
matched the cornea’s curvature (Figure 1). This prototype
project was carried out by Coronet Medical Technologies
Ltd., the ophthalmic arm of Network Medical Products Ltd.
Enclosed gas expanded within the tip and was recycled
therein, achieving a low temperature based on the Joule/
Thomson eﬀect. The tip of the cryoprobe, used to contact
the corneal surface, was circular around the probe’s main axis
and a number of designs were tested. Probe tips were 1.8mm,
2.4mm, or 3.4mm in diameter and were manufactured from
silver for high thermal conductivity. Larger diameter probe
tips were not considered because of the option of multiple
surface freeze placements should a wider area of the cornea
need to be treated. Probes had either a ﬂat surface proﬁle or
a concave one with a radius of curvature of 8mm. For ease
of use, a foot switch was incorporated into the design, which
initiates cooling at the cryoprobe tip and maintains the
reduced temperature throughout the whole time it is
depressed. The foot switch is linked to a timer on the main
console that provides a visual output of freezing time plus
an audible signal (with a mute option) at 1 sec intervals when
the foot switch is depressed. Freezing temperature at the
probe tip (−50°C) is reached within 2 sec of depressing of
the foot switch; after release, ambient room temperature is
achieved within seconds. The hand-held cryoprobe has an
ergonomic-angled design to allow easy application to the
corneal surface (Figure 1). Probes should be thoroughly
cleaned, inspected, and autoclaved prior to use.
2.2. Transcorneal Freezing In Vitro. The porcine cornea is
comparable to that of the human cornea in terms of its
structure and its overall dimensions and the pig eye is
thus often used for practice by trainee corneal surgeons.
The central corneal thickness in adult pigs is usually
around 660μm [29, 30], which approximates a representa-
tive measurement of edematous corneal thickness in indi-
viduals with FECD [31, 32]. The porcine eyes, therefore,
were well suited for our investigations, and the intact
eyeballs, including extraocular muscles, were obtained
soon after slaughter at a local abattoir (W. T. Maddock,
Kembery Meats, Maesteg, Wales, UK). These were brought
to the laboratory on ice and experiments were begun
within 2-3 h of death. When the eyes arrived at the home
laboratory, ultrasound measurements of central corneal
thickness were made with a Tomey SP-100 pachymeter
(Erlangen, Germany), which revealed that the corneas
had thickened (~1000μm) postmortem compared to those
of published values [31, 32]. Consequently, the eyes were
placed in a humidiﬁed incubator (Brinsea Octagon 100,
Egg Incubator, Sandford, UK) at 45°C for 30–45min to
reverse the postmortem swelling and attain a thickness
similar to what might be expected in humans with FECD.
In total, 426 porcine eyes were used for the in vitro exper-
iments in which the corneal thickness ranged from 483μm
to 831μm owing to diﬀerences in eye size and likely
diﬀerential postmortem swelling and deswelling.
Immediately after an eye was removed from the humidi-
ﬁed incubator, its central corneal thickness was recorded as
an average of eight measurements. The cryoprobe tip was
then applied to the corneal surface and cooling was activated
by pressing the foot switch to control the ﬂow of nitrous
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oxide gas. Freezing times of 3, 5, 9, and 13 sec were tested,
allowing an additional 2 sec for the freezing temperature to
be reached in all cases (thus, a 3 sec freeze required for a
5 sec application and foot-switch depression). The cornea
was then carefully excised at the limbus after which stain-
ing solutions of 0.2% alizarin red (~1ml) and 0.25% try-
pan blue were applied sequentially to the endothelial
surface for 60–90 sec each to identify dead cells. The stains
were then gently washed oﬀ using approximately 5ml of
0.9% sodium chloride buﬀer solution, after which digital
images of the corneal endothelial surface were captured
on a Zeiss Stemi 1000 light microscope (Carl Zeiss, Jena,
Germany). A successful freeze injury was deemed to have
occurred when a clear circular wound area was seen. The
endothelial wound area in each corneal image was manually
traced and calculated using Image J software (http://imagej
.nih.gov/ij/). Magniﬁcation was calibrated for each set of
experiments using the image of an eyepiece graticule. Aver-
ages of three measurements were calculated and data were
further collated using Microsoft Excel software (Microsoft
Corp., Redmond, WA, USA).
2.3. Statistical Analysis. Statistical analyses were carried out
operating IBM SPSS Statistics software (Version 23.0, IBM
Corporation, New York, USA). Spearman’s rank order corre-
lation test was run to determine the relationship between
central corneal thickness and endothelial wound areas
induced by the freezing.
Figure 1: The transcorneal freezing machine attached to a cylinder of medical grade nitrous oxide (the cryogen), which comprises a main
console with a monitor screen that illustrates freeze time, cryogen levels, and readiness for freeze plus interchangeable probe tips and a
footswitch (not shown). Inset: the 3.4mm diameter concave probe tip manufactured from silver for high thermal conductivity.
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2.4. Scanning Electron Microscopy. To investigate the endo-
thelial damage morphologically, four treated corneas were
examined by scanning electron microscopy (SEM). Imme-
diately after excision, the corneas were ﬁxed in 2.5%
glutaraldehyde and 2% paraformaldehyde in 0.1M sodium
cacodylate buﬀer, pH 7.3, for at least 2 h. Samples were
then washed in PBS followed by the gradual dehydration
through a graded ethanol series (from 50% to 100% in
30min steps), after which the ethanol was replaced by
hexamethyldisilazane for 20min to minimize the shrinkage
of the specimens. After drying, the corneas were placed on
stubs (Agar Scientiﬁc, Stansted, UK) and sputter coated
with gold (Edwards S150 sputter coater, Edwards High
Vacuum Co. International, Wilmington, USA) to allow
imaging in a JEOL JSM 5600 scanning electron micro-
scope (JEOL Company, Tokyo, Japan) operating with a
beam acceleration voltage of 15.0 kV.
2.5. Transcorneal Freezing In Vivo. Three adult New Zealand
White rabbits were used to investigate corneal recovery after
transcorneal freezing. At all stages, animals were treated in
accordance with the ARVO Statement for the Use of Animals
in Ophthalmic and Vision Research, and the research was
approved by the IRB of Doshisha University. As reported
later, the 3.4mm concave cryoprobe was found to be the
most eﬀective in inducing endothelial damage in the porcine
eye in vitro, but owing to the thinner cornea of the rabbit, the
2.4mm concave cryoprobe was chosen for the in vivo trans-
corneal freezing experiments.
Under general anesthesia, a 2.4mm probe was applied to
the corneal surface of the rabbit eyes for a total of 5 sec. The
contralateral eye was used as a control. Transcorneal freezing
did not induce any severe general adverse eﬀects. After 24 h,
10 days, and 1 month of treatment, the anterior segment of
each eye was assessed by the use of a slit-lamp microscope
and the rabbits were then euthanized. Corneal thickness
was determined by the use of an ultrasound pachymeter
(SP-2000; Tomey, Nagoya, Japan), and the mean of eight
measured values was calculated. Intraocular pressure was
measured by the use of a Tonovet tonometer (292000;
KRUUSE, Langeskov, Denmark). Transmission electron
microscopy (TEM) was conducted, as described below, on
the corneas of the rabbits that were euthanized at 24h- and
1-month time points after transcorneal freezing.
2.6. Transmission Electron Microscopy. The rabbit corneas
were examined by TEM 24h and 1 month postfreeze was
conducted in Doshisha University, Japan. Brieﬂy, after ani-
mals were euthanized, corneas were excised at the limbus
and ﬁxed in 2.5% glutaraldehyde and 2% paraformaldehyde
in 0.1M Sörensen buﬀer (pH 7.2–7.4) overnight at 4°C.
Samples in fresh ﬁxative were then express shipped to the
UK. Full-thickness-dissected portions of the corneas were
then subjected to alcohol dehydration and resin inﬁltration,
after which they were embedded in epoxy resin (Araldyte
CY212 resin, TAAB Laboratories, England, UK). Ultrathin
sections were stained with uranyl acetate and lead citrate
and examined on a JEOL 1010 microscope operating at
80 kV (JEOL Company, Tokyo, Japan).
3. Results
3.1. In Vitro Transcorneal Freezing. Initial experiments into
the degree of endothelial damage caused by transcorneal
freezing induced by four diﬀerent types of cryoprobe
tip—that is, 1.8mm diameter/ﬂat proﬁle, 2.4mm diameter/
ﬂat proﬁle, 2.4mm diameter/concave proﬁle, and 3.4mm
diameter/concave proﬁle—revealed that the time of contact
with the corneal surface did not aﬀect the area of endothelial
damage, with freezing times of 3, 5, 9, and 13 sec tested (data
not shown). Based on this outcome, a freezing time of 3 sec
was chosen for all the in vitro experiments described herein.
It also became apparent during the initial investigations that
the probe tip had to be in contact with the corneal surface
before the foot switch was depressed to initiate cooling. If
the probe tip was cooled in air prior to being brought into
contact with the cornea, no appreciable endothelial damage
was seen; no matter how long, up to 15 sec, the probe
remained in contact with the cornea.
Light microscopy of the endothelial surfaces of the post-
freeze, trypan blue-stained corneas indicated the area of cell
damage caused by the four diﬀerent probes used in these
experiments. Representative images of 426 technical repli-
cates denoting the typical extent of endothelial damage are
shown in Figure 2, with examples of what were considered
to be successful or unsuccessful freeze injuries. A successful
freeze injury was deﬁned as one that resulted in a well-
delineated circular area of cell damage. An unsuccessful
freeze injury, on the other hand, was considered to have
occurred either when there was no evidence of any cell dam-
age or when the area of damage was irregular. Based on these
criteria, only 14 of 102 eyes (14%) treated with the 1.8mm
diameter/ﬂat proﬁle probe were judged to have been success-
fully wounded, whereas 78 of 108 (72%) treated with the
larger (i.e., 2.4mm diameter) ﬂat proﬁle probe contained suc-
cessful endothelial injuries. A similar number of the eyes
exhibited corneal endothelial freeze damage—that is, 76 eyes
of 108 (70%)—when the 2.4mm diameter cryoprobe with a
concave proﬁle was used. Our data clearly indicated, how-
ever, that the 3.4mm diameter/concave proﬁle cryoprobe
induced the most consistent endothelial damage with 90 eyes
of 108 (83%) being successfully wounded in a reproducible
manner (Table 1).
To quantify the extent of endothelial cell damage, we
used Image J to manually trace around each wound deemed
to have been successfully created (i.e., n = 258 of 426 techni-
cal replicates). The area of each wound was calculated, which,
unsurprisingly, disclosed that larger probe tips led to more
extensive endothelial damage (Table 1). All of the 426
corneas examined were subjected to multiple pachymetry
measurements immediately prior to transcorneal freezing.
This revealed that the average corneal thickness was 649μm
(±61μm SD), which is a fair representative value for corneal
edema in humans with endothelial dysfunction [31, 32].
Moreover, when the corneal thickness of the individual cor-
neas was taken into account, a statistical Spearman’s rank
order correlation test identiﬁed that there was a weak
relationship between central corneal thickness and endothe-
lial damage when treated with the smallest and largest probes
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1.8 mm
flat 
595 휇m ± 6.6 556 휇m ± 3.7
(a) (b)
2.4 mm
flat
496 휇m ± 15.7 483 휇m ± 4.8
(c) (d)
2.4 mm
concave 
562 휇m ± 6.4 533 휇m ± 1.8
(e) (f)
3.4 mm
concave 
651 휇m ± 4.6 628 휇m ± 1.8
(g) (h)
Figure 2: Representative images of corneal endothelial freeze injury on the pig eyes ex vivo induced by 3 sec freeze with four diﬀerent
cryoprobe tips and assessed by trypan blue staining. The thickness of each cornea is indicated on each panel (±SD) based on eight
pachymetry readings. The area of cell damage is seen via the blue stain, and successful and non/less successful freeze injuries are shown in
the left and right columns, respectively. Freezing with the 1.8mm diameter/ﬂat proﬁle probe only rarely resulted in a reproducible wound
(a and b). Endothelial freeze injury was more reliably achieved with 2.4mm diameter probe tips with ﬂat or concave proﬁles (c–f), but the
optimal result and best consistency was achieved using the 3.4mm diameter/concave proﬁle cryoprobe (g and h). Scale bar, 3mm. See
Table 1 also.
Table 1: Data summary of transcorneal freezing for 3 sec on porcine eyes.
Probe tip (mm)/proﬁle Number
of eyes
Number of eyes with
successful freeze (%)
Mean/SD damaged
area (mm2)
Mean diameter (mm)
Mean/SD
corneal
thickness (nm)
1.8/ﬂat 102 14 (14) 0.79/0.4 1.0 642/64
2.4/ﬂat 108 78 (72) 2.12/1.0 1.6 650/71
2.4/concave 108 76 (70) 2.29/1.0 1.6 645/87
3.4/concave 108 90 (83) 6.91/1.9 2.9 654/59
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(a) (b)
(c) (d)
(e) (f)
(g) (h)
Figure 3: SEM of the endothelium of transcorneally frozen pig corneas. (a) An untreated pig cornea with cell boarders in white showing a
characteristic hexagonal mosaic. The outline if the cell nucleus is evident as a slightly lighter area within each cell. Scale bar, 10μm. (b) A
representative image taken at the same magniﬁcation of the freeze-damaged area after treatment with a 2.4mm diameter/concave proﬁle
tip, illustrating severe damage to endothelial cells by freezing. Scale bar, 10 μm. (c and d) Lower magniﬁcation images of endothelial
freeze-injured wounds showing circular areas of endothelial cell damage including some endothelial debridement, exposing Descemet’s
membrane (c): 2.4mm diameter/concave proﬁle cryoprobe (scale bar, 200μm); (d): 3.4mm diameter/concave proﬁle cryoprobe (scale bar,
500μm). As expected, the larger probe induces more widespread damage (see Table 1 also). (e–h) Transition zones between unfrozen
endothelial cells and those that were destroyed by freeze injury are often sharp (e) and (g); same area but diﬀerent magniﬁcation (scale
bars,10μm, apart from (g) which is 50 μm).
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(1.8mm diameter (r = –0 208, n = 102, p = 0 408) and
3.4mm diameter (r = –0 258, n = 108, p = 0 007) but a
stronger relationship using the 2.4mm diameter probe tips
with concave and ﬂat proﬁles (r = –0 433, n = 108,
p < 0 001; 2.4mm (r = –0 466, n = 108, p < 0 001, respec-
tively) (Table 1).
To provide higher resolution information as to the status
of the cells after freeze injury in the in vitro pig eye model, we
conducted a series of SEM studies (Figure 3). This indicated
that the corneal endothelial monolayer was severely
disrupted in the central portion of the cornea beneath the site
of the cryoprobe injury. Injured cells tended to become
damaged and/or disassociated from each other, whereas
noninjured cells adjacent to the area of damage exhibited
classic hexagonal endothelial cell morphology. Interest-
ingly, there appeared to be two transition zones between
healthy nonfrozen cells and the more centrally damaged
ones. The immediate transition at the inner edge of the
morphologically normal cells was fairly abrupt; and in
some cases, this was on a μm scale (Figures 3(e), 3(f),
and 3(g)). More centrally, there was evidence of cellular
dissociation (Figure 3(e)) and also total removal of large
areas of frozen endothelial cells, exposing a bare Desce-
met’s membrane (Figures 3(d) and 3(h)).
To investigate endothelial healing after transcorneal
freeze, a smallnumberof rabbit corneaswere studied.For these
investigations, a 2.4mm diameter/concave proﬁle cryoprobe
was used rather than the 3.4mm concave one owing to the
relative thinness (approximately 350–400μm) of the rabbit
cornea compared to that of the pig (approximately 660μm
[29, 30]). This revealed that one day after a 3 sec surface freeze,
the rabbit cornea had become signiﬁcantly edematous, with its
thickness approximately twice the normal value (Figure 4(a)).
The central corneal thickness returned to normal values by
day 7, and this was maintained up to one month post-
freeze (Figure 4(c)). Slit-lamp images showed some evi-
dence of corneal haze at the level of the posterior stroma
or Descemet’s membrane at 10 days and 1 month
(Figures 4(b) and 4(c), resp.).
TEM examinations of rabbit corneas 24 hrs after freeze
indicated that the corneal epithelium peripheral to the
wound area was structurally normal, with typical epithelial
stratiﬁcation, cell-cell contact and surface microvilli
(Figure 5(a)). As expected, the corneal epithelium was
severely damaged in the central freeze-injured region of the
cornea, with considerable cellular vacuolation and mem-
brane destruction (Figure 5(b)). However, it was clear that
the epithelial basement membrane remained intact, which
presumably is important to aid subsequent epithelial resurfa-
cing of the wound area. In the deep stroma, increased
collagen ﬁbril spacing accompanied by disorder in the ﬁbril
arrangement was sometimes observed focally 24 hrs post-
freeze (Figure 5(c)), but this had been resolved by the 1-
month timepoint at which time the stromal architecture
appeared normal throughout the cornea (Figure 5(d)). These
structural matrix changes likely contribute to the increased
corneal thickness and opacity seen at 24 hrs (Figure 4(a)).
Just as with the corneal epithelium, the corneal endothe-
lium in the periphery of the cornea away from the region of
the tissue under the surface wound zone remained unaﬀected
CCT 769 휇m
IOP 9 mmHg
CCT 383 휇m
IOP 11 mmHg
PostfreezePrefreeze
24 h
CCT 385 휇m
IOP 17 mmHg
CCT 378 휇m
IOP 9 mmHg
10 days
(a) (b)
CCT 366 휇m
IOP 8 mmHg
CCT 389 휇m
IOP 11 mmHg
1 month
(c)
Figure 4: Eﬀects of a 3 sec freeze on the rabbit cornea in vivo using the 2.4mm diameter/concave proﬁle cryoprobe tip. (a) 24 hrs after freeze,
central corneal thickness (CCT) is increased considerably (769 μm) compared to that before freeze (383 μm), and the cornea is hazy,
indicative of corneal endothelial damage, as well as epithelial and stromal cell damage. (b) 10 days after a freeze injury (in a diﬀerent
animal), CCT was at normal levels. (c) This was the case also, 1 month after treatment. (b and c) Some corneal haziness at the level of the
posterior stroma or Descemet’s membrane is evident at 10 days and 1 month.
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24 hrs after transcorneal freeze of the central rabbit cornea
(Figure 6(a)). The endothelium more centrally, however,
began to exhibit clear signs of damage (Figure 6(b)). The
central endothelium was often fully debrided with a bare
Descemet’s membrane that showed no apparent structural
changes (Figure 6(c)). One month after freeze, the central
corneal endothelium had reattained its normal character,
although occasionally ﬁbrous tissue deposition between
Descemet’s membrane and the recovered endothelium was
observed (Figure 6(d)), which perhaps contributes to the
deep stromal haze seen at this time (Figure 4(c)).
4. Discussion
A number of investigative surgical procedures, which utilize
the selective ROCK inhibitor, Y27632, to combat FECD
and bullous keratopathy are under investigation, including
cell-injection therapy [10–14]. However, one alternative
approach for FECD, especially in its early stage, involves
freezing the central cornea using a cold probe to damage
corneal endothelial cells beneath the surface contact area; this
is then followed by the short-term delivery, for one week, of
Y27632 in eye drop formulation [10–12]. In these surgeries,
freezing was achieved by touching the corneal surface with
a stainless steel rod, which had been immersed in liquid
nitrogen. An arbitrary freezing time of 15 sec was chosen
for these experiments, along with a 2mm diameter for the
steel rod. Encouragingly, the outcomes of these surgeries
showed some promise, especially if the extent of the corneal
endothelial dysfunction was not widespread, but if the
approach is to be adopted more widely by the ophthalmic
community, the corneal freeze would probably need to be
achieved in a more reliable manner and with more knowl-
edge of the nature and extent of the freeze damage.
Historically, and up to the present day, corneal freezing
has been carried out by a variety of methods, most of which
use it to induce an experimental injury for research into
corneal wound healing [15–17, 28]. Freezing studies tend to
employ either a brass rod or dowel, which had been
immersed in liquid nitrogen [17–21] or similarly cooled steel
ones [22, 23]. Retinal cryoprobes have also been used in
investigational studies of transcorneal freezing [24, 33]. Here,
we report the design and manufacture of a corneal cryoprobe
that uses circulating nitrous oxide as a cryogen and report the
type of freeze damage it induces.
Typically, the tips of cryoprobes that use high-pressure
gas as a cryogen are made of stainless steel owing to the need
to contain high-pressure gas safely. In our design, however,
St
BM
Ep
1 휇m
BM
Ep
St1 휇m
(a) (b)
0.5 휇m
St
(c) (d)
Figure 5: TEM of the corneal epithelium (Ep), epithelial basement membrane (BM), and stroma (St) following a 3 sec transcorneal freeze
injury using a 2.4mm diameter/concave proﬁle cryoprobe on rabbit cornea in vivo. (a) The peripheral epithelium away from the wound
zone, 24 hrs after the cryoprobe was applied and appeared morphologically normal. Arrowheads indicate microvilli on apical surface of
epithelial cells. (b) Intact basement membrane is observed in the central freeze-injured area 24 hrs postfreeze. (c) After 24 hrs freeze injury,
occasional focal regions of stromal matrix disruption were evident in the cornea, manifesting as tissue regions with increased spacing
between collagen ﬁbrils. (d) One month after the freezing, throughout the cornea, the spacing between collagen ﬁbril appeared normal.
Scale bars, 1 μm (a and b) and 0.5μm (c and d).
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the use of stainless steel would have resulted in a freeze that
started in the center of the tip and thereafter spread, albeit
quickly, to its outer circumference at a speed which relies
on the thermal conductivity of the metal. To achieve a more
uniform cooling across the probe tip, we manufactured a
cryoprobe tip out of silver, which has a higher thermal con-
ductivity than that of steel. The beneﬁt of this design feature
is that the diameter of the freeze in the cornea is decoupled
from the depth of the freeze. Cooling in this design is based
on the expansion and internal recycling of nitrous oxide
inside the cryoprobe tip. At the point of its transition
from liquid to gas, nitrous oxide exists at a temperature
of −88.5°C, and this transition, which occurs inside our
probe tip, of course, rapidly cools it. Owing to thermal
conductivity within the whole probe and thermal loss at
ambient room temperature, an equilibrium is reached,
which in our design means that the temperature at the
outer surface of the probe tip reaches −50°C.
The response of a cell to freezing is explained by
Fraunfelder in his comprehensive review of corneal cryo-
therapy, the main mechanisms of cell damage being a
piercing of the cell membrane by ice crystals or the
creation of a sizeable osmotic imbalance between the
inside and outside of the cell because of the removal of
liquid water into the ice crystals [34]. Armitage also
describes, from the other side of the coin, how careful
freezing using time-mediated freeze-thaw protocols accom-
panied by the use of cryoprotectants can lead to cell sur-
vival [35]. The freezing we achieve here can probably be
thought of as being fairly conservative in terms of the rate
of endothelial cooling, but our current observations clearly
indicate that suﬃcient levels of endothelial damage are
achieved after a single freeze treatment. Experiments that
applied additional treatments to the same surface location
did not enhance the extent of the freeze injury (data not
shown). We also found that if the foot switch was
depressed to initiate cooling of the probe tip before it
was brought into contact with the corneal surface, then
no appreciable endothelial freeze damage was seen, even
if the cryoprobe was kept in contact with the cornea for
periods up to 15 sec. It is not immediately clear why this
is the case, but perhaps, frosting of the probe tip when it
is cooled in the moist air could contribute to this. This
likely lack of frosting also might help facilitate the easy
DM
n
2 휇m
Endo
DM
2 휇m
(a) (b)
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(c) (d)
Figure 6: TEM of corneal epithelium following a 3 sec transcorneal freeze injury using a 2.4mm diameter/concave proﬁle cryoprobe on the
rabbit cornea in vivo. (a) An endothelial cell (Endo) at 24 hrs postfreeze in a region peripheral to the freeze-injured area appeared
morphologically normal, with normal organelles and nucleus (n). It adhered to Descemet’s membrane (DM). (b) Closer to the region
below the cryoprobe surface application, there were clear signs of cell damage including the destruction of the cell membrane, while even
more centrally, (c) the cell damage was more extreme revealing a bare Descemet’s membrane, consistent with the SEM analysis (Figure 3).
(d) One month after the transcorneal freezing was performed, the central region of the inner cornea contained fairly normal endothelial
cells that were sometimes accompanied by extracellular matrix material (white arrowheads) in the area posterior to Descemet’s
membrane. Scale bars, 2 μm.
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release of the probe tip from the corneal surface after the
foot switch is released, which we found to happen within a
second or two of the cryogen circulation being suspended.
In the experiments described here, the central corneal
epithelium was destroyed by the application of the cryo-
probe, as we would expect. But, it is of potential importance
that the corneal epithelial basement membrane remains
intact as seen by TEM. The lack of epithelial basement mem-
brane damage will presumably aid the epithelial resurfacing
of the debrided epithelial area. Fibril arrangement changes
are also apparent focally in the stromal matrix after the
in vivo rabbit freeze injury, but these are transient, and the
increased collagen ﬁbril separation and disorganization
which are seen 24 hrs after the treatment subsequently
decrease as corneal thickness reduces. The obvious conclu-
sion is that the recovering endothelium is mostly responsi-
ble. Of course, the in vivo healing studies reported here do
not reﬂect the situation in the human cornea because of
the diﬀerent behavior of the endothelial cells and their
limited replicative ability in humans. TEM also discloses
the presence of ﬁbrotic extracellular matrix tissue in the
region of Descemet’s membrane one month after freeze
injury (Figure 6(d)). This might contribute to the deep
stromal haze seen at this time, although a potential contri-
bution to light scatter by freeze-damaged keratocytes can-
not be discounted.
As mentioned, the use of ROCK inhibitors has aided the
recovery of the corneal endothelium in situations where
diseased corneal endothelial cells have been scraped away
surgically [13] or frozen with a cooled steel rod applied to
the corneal surface [10–12]. A report by Balachandran et al.
[36] and Shah and associates also suggests that corneal endo-
thelial cells can repopulate in FECD patients after damage
alone [37–39]. The data presented here show that endothelial
cells can be functionally damaged and/or removed by the
application of a cryogenic cold probe and that this can be
done in a targeted and reproducible manner with cell damage
restricted to the area below the surface contact. Of course, the
transcorneal freezing technique is unlikely to induce any
signiﬁcant change to the guttae which exist in FECD and
their continued presence will conceivably hinder the refor-
mation of a normal endothelial layer. Nevertheless, cell
damage can be achieved through use of a silver 3.4mm
diameter cryoprobe with a concave proﬁle, which was
discovered to be the optimal design of the cryoprobes
tested in the experiments described here. It thus has the
potential to rapidly and reliably induce damage to the
human corneal endothelium via transcorneal freezing,
leaving the epithelial basement membrane intact. This
has the potential to be used prior to the application of
ROCK inhibitors to the eye in the form of eye drops
[10–12] or as slow-release chemicals from thin ﬁlms [40]
to aid the recovery of corneal endothelial function.
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